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Abstract
The increased use of dietary supplements in today’s society has been 
attributed to the general public’s greater awareness of what constitutes a 
healthy diet. The elemental content (Ca, Cd, Cr, Co, Cu, Fe, Mg, Mn, Mo, Ni, 
Pb and Zn) of seventy-four dietary supplements (tablets, capsules and 
powders) was analysed by inductively coupled plasma mass spectrometry 
(ICP-MS). Different digestion methods (wet open vessel and microwave) were 
developed for the dissolution of dietary supplements, utilising both 
concentrated nitric acid and hydrogen peroxide. Both digestion procedures 
were found to give no significant statistical difference between the 
experimental results and certified values at a 99% confidence limit (Paired t- 
test) for all element values in two certified reference materials, namely NIES 
Rice Flour and IGGE Tea. For both certified reference materials, there was. 
The elemental content of the dietary supplements ranged from 0.1-200 mg/g 
for macro essential elements (Ca, Fe and Mg), 1-500 pg/g for trace essential 
elements (Cr, Co, Cu, Mn, Mo, Ni and Zn) and 0.4-10 pg/g for non-essential 
elements (Cd and Pb), all on a dry weight basis. Comparison of experimental 
results with commercial label values for dietary supplements showed: (1) 
calculated Ca and Mg concentrations were systematically lower than the label 
values; and (2) the experimental results for the other essential elements were 
in good agreement. The essential element contribution of base materials was 
investigated, though the results were inconclusive. Dietary supplements 
containing fat-soluble vitamins were analysed for retinol acetate, 
ergocalciferol (D2), cholecalciferol (D3), tocopherol (E), tocopherol acetate and 
phylloquinone (Ki) using a modified simultaneous high performance liquid 
chromatography (HPLC) method. For each vitamin, a recovery of >90% was 
obtained with the use of a direct solvent extraction procedure. An in vitro 
study into the bioavailability of iron and zinc in yeast-based supplements was 
accomplished. This study provided results suggesting that iron supplements 
containing vitamin C were more bioavailable than yeast or tablet-based 
supplements that contained no vitamin C. Zinc bioavailability was observed to 
be greater in multi-component and yeast-based dietary supplements.
Zoë Bentley -  July 2001
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Chapter 1 Introduction
1.0 Dietary Supplements
There is a growing Interest In traditional and alternative medicine coinciding 
with a general decline in the belief of conventional medicine throughout the 
Western World [Benzi & Ceci, 1997]. According to a report published by the 
Department of Health, in 1999 five million people consulted one of the United 
Kingdom’s 50,000 practitioners of complimentary therapy [Lesslie, 2001] The 
Internet Is Increasingly used to search for health advice, especially as 
complimentary and alternative medicine practitioners and manufacturers use 
the web to promote their services and products [Kingston, 2001]. 
Newspapers and magazines Increasingly promote herbal medicines, whilst 
often presenting orthodox medicines in an unfavourable light by scare- 
mongerlng stories. This growing Interest Is principally part of a modern drive 
towards foods as sources or enhancers of a fitter, healthier lifestyle [Zeisel, 
1999] An essential factor in the attainment of good health Is an adequate 
and appropriate diet [Bender, 1993]. In terms of this statement health Is the 
“state of complete mental, physical and social wellbeing and not merely the 
absence of disease of infirmity” [Bender, 1993].
Ten years ago a general survey reported an Increasing awareness among the 
general population of the ideal and benefits of a healthy lifestyle [Gregory et 
al., 1990]. The survey looked at the daily Intake of nutrients In a typical 
Western diet. It was recorded that the taking of supplements was not related 
to social class, and In general it was found that 17% of women took 
supplements compared to 9% of men. Table 1 states the percentages of 
women and men by age, taking any form of dietary supplement. The 
percentage of women taking any form of supplement Increases with age. This 
trend is not seen in men, where the age group 25-34 yrs has the highest
percentage for taking any supplement. The two most common groups of 
supplements taken were multivitamins with or without iron followed by cod 
liver oil supplements.
Table 1. Percentage of men and women taking a kind of supplement
Age (yr) Men % Women %
16-24 6 10
25.34 11 15
35-49 8 19
50-64 9 23
*Source: Gregory et al., 1990
Today, fortÿ percent of Americans take some form of dietary supplement 
[Halstead, 2000]. Half of the supplements consumed are of herbal origin. In 
the United Kingdom one third of the population buy some form of dietary 
supplement, 70% are women aged between 35-65 years. A breakdown from 
the sales is illustrated below In Table 2.
Table 2. A breakdown of the current sales of nutritional supplements
Type of dietary supplement Total sales (million)
Fish oils 66
Multl-vitamlns 62
Single vitamins 35
Evening primrose oil * 35
Garlic 21
Other 19
* Evening primrose & other gamma-llnolenic acid (GLA) products 
**Source Mason, 1995; OTC Healthcare Report, 1994
Dietary supplements are not designated as a food or an Item In a meal or diet 
[Halsted, 2000]. They are designed to supplement the body by Increasing the 
intake of bioactlve agents that are thought to enhance health and lifestyle 
[Zeisel, 1999]. Due to their “natural” state dietary supplements and
alternative medicine are seen as safe by the general public [Penharic et al., 
1994]. According to the United States Dietary Supplement Health and 
Education Act (DSHEA) of 1994 [FDA 1995], a dietary supplement:
(1) is a product (other than tobacco) that is intended to supplement the 
diet that bears or contains one or more of the following dietary 
ingredients: a vitamin, a mineral, an herb or other botanical, an 
amino acid, a dietary substance for use by man to supplement the 
diet by increasing the total daily intake, or a concentrate, 
metabolite, constituent, extract, or combinations of these 
ingredients;
(2) is intended for ingestion in a pill, capsule, tablet, or liquid form;
(3) is not represented for use as a conventional food or as the sole item 
of a meal or diet;
(4) is labelled as a "dietary supplement”; and
(5) includes products such as an approved new drug, certified 
antibiotic, or licensed biologic that was marketed as a dietary 
supplement or food before approval, certification, or license (unless 
the Secretary of Health and Human Services waives this provision).
Dietary supplements fall into several categories, which can often overlap with 
the herbal remedy market. The categories of dietary supplements are 
described below [Mason, 1995].
(i) Vitamins and minerals:
(a) multi-vitamins and minerals, which contain 100% of recommended 
nutrient intake (RNl) for vitamins, with varying amounts of minerals 
and trace elements;
(b) single vitamins and minerals, which contain very high 
concentrations (megadoses);
(c) combinations of vitamins and minerals, marketed for specific 
population groups: athletes, children, pregnant women; and
(d) combinations with other substances e.g. evening primrose oil.
(ii) Unofficial vitamins and minerals for which requirement and deficiency 
disorder in humans is not yet recognised e.g. choline, germanium, silicon.
(iii) Natural oils containing fatty acids with some evidence of beneficial effects.
(iv) Natural substances containing ingredients with recognised 
pharmacological actions but where composition and effects have not been 
fully defined e.g. garlic, ginkgo biloba.
(v) Natural substances whose composition and effects are not well defined 
but which are marketed for their “health giving properties” e.g. chlorella, 
royal jelly, spirulina.
(vi) Enzymes with known physiological effects but of doubtful efficacy when 
taken by mouth e.g. superoxide dismutase.
An herb is' defined as any plant that is used for its medicinal properties 
[Bateman at al., 1998]. Herbal remedies can be divided into three different 
types: (a) raw materials for self-preparation by self-collection or through 
commercial channels; (b) semi-finished non-medical and medicine-like 
products e.g. dietary supplements, health foods and recreational foods; and
(c) licensed medicines [Da Smat, 1995] The United Kingdom market for 
herbals products has grown to £240 million per annum [Kingston, 2001]
At present dietary supplements and herbal remedies are not considered as 
medicines, so they do not legally require to be tested before being sold to the 
public. In the United Kingdom the Herbal Remedies Order of 1977, 
established that no licence is required in the case where (a) the herbal 
remedies used were prescribed by herbal practitioners, and (b) no written 
recommendation (whether on the label or in the package leaflet) is given to 
the customer [Banzi & Caci, 1997]
The European Union (EC directive 65/65/EEC) defines “any substance or 
combination of substances, presented for treating or preventing disease... or 
which may be administered with a view to making a medical diagnosis or to 
restoring, correcting or modifying physiological functions” as a medical 
product and as such requires a licence of a marketing authorisation
[Kingston, 2001] The difference between a medicine and a non-medicine 
product is a grey area and is usually defined by the individual European Union 
Member State. Consequently, there is no uniformity across Europe for the 
legislation of herbal remedies.
In the United States, the Federal Drug Agency (FDA) acknowledges that 
dietary supplements are thought by the general public to help augment daily 
diets and provide health benefits and as such dietary supplements are not 
subject to pre-market safety evaluations required by other new food 
ingredients. Instead the Federal Drug Agency (FDA) states that it is the 
manufacturer's responsibility to ensure that the dietary supplement is safe 
before being marketed and that they [FDA, 1995]:
(a) do not contain any claims about the use of the dietary supplement 
to diagnose, prevent, mitigate, treat or cure a specific disease; and
(b) are labelled with all dietary ingredients including quantities and 
where appropriate with respective established daily consumption 
intake recommendations.
The Federal Drug Agency (FDA) only analyses dietary supplements thought 
to be fraudulent or in violation of the law and does not routinely analyse the 
composition of food products or dietary supplements because of money 
constraints [FDA, 1999]
Proposed legislation from the UK Medicines Control Agency includes the 
requirements of safety and quality of herbs used as ingredients but not the 
clinical efficacy of these herbs. This would enable the public to see that the 
herbs are safe and then make up their own mind on the herbs potential 
benefit to their health [Kingston, 2001]
1.1 Active Ingredients in Dietary Supplements
Active ingredients are the compounds added to dietary supplements that 
benefit health. These compounds include essential elements, vitamins, 
herbs, roots, barks, fruits, amino acids and enzymes. The two groups 
considered for analysis are the essential elements and vitamins. Both groups 
can also be called nutrients. Nutrients are substances that have been defined 
as having nutritive value, i.e. they participate in metabolism or are used to 
build structures [Zeisel, 1999].
All nutrients are essential but the term essentiality is mostly associated with 
elements needed for optimum health. A number of elements have been found 
to be essential to life. The discovery of an essential element usually begins 
with the noting of a detrimental condition and its coincidence with the 
elements deficient state within the body. An element was originally 
considered essential if its [Cotzias, I960]:
(a) presence was found in all healthy tissue of living things;
(b) constant concentration from one animal to another;
(c) withdrawal from the body induces reproducibly the same physiological 
and structural abnormalities, regardless of species studied;
(d) addition either reduces or prevents these abnormalities;
(e) the abnormalities induced by the deficiencies are always accompanied 
by specific biochemical changes; and
(f) that these biochemical changes can be prevented or cured when 
deficiency is prevented of cured.
in 1974 the definition was shortened to include only three provisos. “A/7 
element is essential if (a) it is present in living matter; (b) it interacts with living 
systems; and (c) a dietary deficiency must consistently result in a reduction of 
a biological function from optimal to sub-optimal, preventable or reversible by 
physiological amounts of the element" [NIertz, 1974]
More recently essentiality was redefined removing the requirements for an 
essential element to have a well-defined mode of action. '"An element is 
considered essential to an organism when a reduction of its exposure below a 
certain limit results consistently in a reduction of an physiologically important 
function or when the element is an integral part of an organic structure 
performing a vital function in an organism" [WHO, 1996; Stovell, 1999]
All vitamins have been defined, as essential organic compounds required in 
small amounts for normal functioning in the body [Basu & Dickerson, 1996]. 
The normal functioning of the body includes the functions of growth and the 
maintenance of normal cell and organ activity. Due to the small quantities 
required the term micronutrient is often associated with vitamins [Jackson, 
1997]. Vitamins are considered essential, because the human body cannot 
synthesise dr synthesise a large enough quantity to meet the body’s need. 
Therefore, they must be found within the diet [Basu & Dickerson, 1996]. 
Deficiency of a vitamin causes a specific disease which is cured by restoring 
the vitamin to the diet [Bender, 1993].
The biological activity of many vitamins is typically attributed to a number of 
structurally related compounds known as vitamers. Vitamers, usually have 
similar qualitative biological properties to one another, but due to slight 
differences in their chemical structure, they exhibit different degrees of activity 
[Ball, 1998]. There are two types of vitamins: water-soluble and fat-soluble as 
illustrated in Table 3.
Table 3. Classification of vitamins
Fat-soluble vitamins Water-soluble vitamins
A D 
E K
Bi B2 B3 Pantothenic acid 
Biotin Be Folic acid B12 0
The water-soluble vitamins act as conenzymes accelerating enzymatic 
reactions and are often carriers of a particular chemical grouping. The fat- 
soluble vitamins function as integral parts of cell membranes and are more
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akin to steroid hormones than water-soluble vitamins [Basu & Dickerson,
1996]. Due to time and money constraints only the fat-soluble vitamins will be 
considered in this research.
1.1.1 Essential elements
Essential elements can be divided into two groups; these are macro and trace 
elements. Table 4 lists the essential elements categorised in this manner.
Table 4. Categorisation of essential elements
Macro Trace
0 H N 0  S 
Ca 01 K Mg Na P
Ar Co Or Cu F Fe 1 LI 
Mn Mo Ni Se Si Sn V Zn
Sources: Emsley, 1991
There is no clear definition of a macro or trace inorganic element. 
Classification is traditionally based on the concentration of the element in the 
body or need within the diet. The terms originate from a time when trace 
levels were reported but the actual concentration could not be quantified 
[O’Dell & Sunde, 1997]. Macro elements are traditionally defined as elements 
found in the diet at levels of grams per kilogram and trace elements at 
milligrams, or micrograms per kilogram. Due to the ambiguity over this 
classification other terms have arisen, which include major elements, micro 
elements, minor elements, trace constituents and oligoelements [Versieck & 
Cornelius, 1989].
Essential elements perform three main functions in the human body [WlAFF,
1995]; they act as:
(1  ) constituents for bones and teeth;
(2 ) soluble salts, controlling the composition of body fluids and cells; and
(3) essential adjuncts to many enzymes, and other proteins.
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For the purpose of this research ten essentia! elements will be analysed, 
namely calcium, cobalt, chromium, copper, iron, magnesium, manganese, 
molybdenum, nickel and zinc. With the exception of nickel all the other 
elements are routinely added to dietary supplements for their specific 
biological functions. In the following sub-sections each element will be 
discussed in relation to their function, absorption, metabolism, and deficiency / 
toxicity syndromes.
1.1.1.1 Calcium
There is 1.0 -1.2 kg of calcium in the average adult human body; 99% of this 
calcium is found in the skeleton (bones and teeth) [Schaafsma, 1997]. 
Calcium is found in large amounts in dairy products and small amounts in 
vegetables.' Milk is one of the best providers of calcium in the human diet 
(Table 5). '
Table 6. Calcium dietary sources
Food source Calcium concentration (mg)
Milk, 34 pt 350
Cheddar (50g) 360
Spinach 150
1 large orange 70
Whitebait (100g) 860
*Souce: Mason, 1995
Calcium function
The main role of calcium in the human body is as a structural component of 
bones and teeth. Other roles include an involvement in intracellular hormonal 
secretion regulation, muscle contraction, blood clotting, electrolyte balance 
and activation of some enzyme systems [Kendrick et al., 1992].
Calcium absorption
In the gastrointestinal tract calcium complexes are broken down to the more 
soluble forms of free ionic calcium (Ca "^') or ionic complexed calcium
[Schaafsma, 1997]. Calcium precipitates from solution at pH 6.1, 
consequently calcium is highly available in the duodenum and jejunum 
sections of the small intestine where the pH is 6.0-6.7 [Allen, 1982]. 
Therefore, most of the pH-dependent enzymes that break down calcium are 
found at these sites in the small intestine. Intestinal absorption of calcium 
occurs via two processes; (a) active transcellular calcium transport, mainly in 
the duodenum and jejunum involving a calcium binding protein; (b) passive 
paracellular transport in the ileum [Anderson, 1991; Schaafsma, 1997]. A 
calcium binding protein called calcitroi, mediates the active transport process 
[Schaafsma, 1997] Calcitroi is the active component of vitamin D that is 
released from the liver [Allen, 1982]
Calcium inhibition I enhancement
Two types'of factors control the absorption of calcium, endogenous and 
exogenous factors (Table 6 ). The exogenous factors controlling calcium 
absorption can be divided into two groups, those that are dietary variables 
and those that affect calcium urinary excretion. Each set of factors includes 
inhibitors and enhancers of calcium absorption (Table 7).
Table 6. Factors controlling calcium absorption
Endogenous Exogenous
Age
Sex (male / female) 
Pregnancy & Lactation
Calcium, Vitamin D, Fibre, Phytate, 
Oxalate, Fat, Lactose 
Sodium, Phosphorus, Protein, 
Alcohol, Caffeine, NH4CI
Source: Schaafsma, 1997
The major regulator of calcium absorption is vitamin D. Vitamin D is absorbed 
via the skin or the gastrointestinal tract, and is converted to either 1,25- 
(0 H)2D3 , 24,25-(0H)2D or more Importantly calcitroi. In general under 
conditions of increased growth, calcitroi dependent active transport is 
stimulated. This stimulation also occurs at low calcium intakes [Schaafsma, 
1997]. The absorption mechanisms have not been established and those that
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have been proposed are considered to be controversial. At present all that is 
clearly known is that the production of calcitroi is physiologically regulated 
[Allen, 1982].
Table 7. Inhibitors and enhancers of calcium absorption
Inhibitors Enhancers
Phytate Vitamin D
Fibre Lactose
Oxalate Protein
Alcohol
Sources: Allen, 1982; Groff et al., 1995; Weaver et al., 1999.
Phytate significantly inhibits calcium absorption in the small intestine. Oxalate 
is also knoVvn to impair calcium absorption but to a lesser extent. However, 
their presence in plants guarantees low bioavailability of calcium from these 
food sources [Weaver et al., 1999]
Calcium metabolism
Calcium losses are present in urine, endogenous intestinal secretion and 
sweat. The amount of calcium excreted by the human body is relatively 
unaffected by the level of dietary calcium [Allen, 1982].
Total body calcium is largely regulated by the amount of calcium absorbed 
[Allen, 1982]. Biochemical functions of calcium are protected by; (a) 
intracellular calcium stores and large extra-cellular nutrient reserve (skeleton); 
and (b) the elaborate endocrine control system that includes the parathyroid 
hormone, vitamin D and calcitroi [Heaney, 2000]
Calcium deficiency I toxicity
Calcium deficiency does not relate to the impairment of calcium’s biochemical 
roles but instead induces three different effects [Heaney, 2000]:
(1 ) the calcium reserve is reduced in size;
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(2 ) a decrease in unabsorbed dietary calcium occurs; calcium absorption 
increases; and
(3) an inducement of collateral effects on other regulatory body systems 
that protect against hypocalcemia.
Adequate calcium intakes have been shown to protect the skeleton, lower 
blood pressure, reduce risk of colon cancer, lesson symptoms of pre­
menstrual syndrome and reduced risk of renal stone formation [Heaney, 
2000]. In recent years the media has emphasised the link between calcium 
and osteoporosis. Although calcium deficiency is not the only contributing 
factor to bone loss, adequate levels of dietary calcium during the first three 
decades of life minimises subsequent bone loss [Weaver et al., 1999].
Dietary overconsumption of calcium is virtually unknown and toxicity is almost 
always associated with the breakdown of control mechanisms [DH RHSS 41, 
1999].
1.1.1.2 Chromium
The essentiality of chromium is still debated as much of the evidence for its 
essentiality is still considered by some to be circumstantial. Because of this 
the British Government has not set a RNl value for chromium, instead an 
intake above 25 pg for adults has been considered to be of an adequate level. 
The United States has set a dietary recommendation of 50 pg/d chromium for 
adults [NRG, 1989; Nieisen, 1994a]
Foods with a high chromium content include brewers yeast, meat and nuts 
[Mason, 1995]. Especially important is brewers yeast as it contains the 
biologically active, glucose tolerance factor (GTF) chromium [Mertz, 1975].
Chromium function
Chromium appears to improve glucose tolerance [Mertz, 1993b] and is 
reported to aid in the action of insulin. It is thought that GTF initiates 
disulphide bridging between insulin and the insulin receptor [Mertz, 1993b].
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The exact structure of GTF has not been characterised, yet it is believed to 
resemble a hormone (insulin) being released into the blood in response to a 
physiologic stimulus. Investigations are being carried out into the potential role 
in chromium carbohydrate and lipid metabolism [Vincent, 2000].
Chromium absorption
Absorption of chromium is thought to occur in the jejunum section of the small 
intestine. The mode of absorption is likely to be carrier mediated with 
diffusion contributing to absorption when dietary intakes are high [Anderson, 
1987]. The GTF complex is absorbed at a much higher rate compared to 
trivalent chromium (Cr^ '*‘), whose absorption is considered to be poor [Mertz, 
1975]. In animal studies, the presence of ascorbic acid and amino acids in 
the diet has' been shown to increase chromium absorption [Hunt & Stoecker,
1996]. 
Chromium metabolism
In blood, chromium is transported according to its related complex. As GTF is 
biologically active it is not stored or metabolised but is immediately 
transported to cells requiring it. Inorganic chromium (Cr^ )^ is bound to 
transferrin in the blood and is transported to the liver [Groff et al., 1995]. 
Evidence of a transferrin transport mechanism has been recorded by in vitro 
experiments but not in vivo experiments [Vincent, 2000]. The main route of 
excretion is via urine [Mertz, 1975].
Chromium deficiency / toxicity
Gross chromium deficiency has not been seen except in patients on long term 
parenteral nutrition [DH RHSS 41, 1999] Marginal nutritive chromium status 
contributes to progressive impairment of glucose tolerance with age; this is 
typical in several industrial societies [Mertz, 1992]. A marginal chromium 
deficiency may increase the risk of diabetes and possibly heart. disease 
[Schroeder, 1968].
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Toxicity resulting from excessive amounts of chromium in the diet has not 
been recorded. This is due to the low availability of trivalent chromium, which 
is the most commonly found biological form of chromium. However, industrial 
exposure to airborne chromium VI can cause allergic dermatitis and increased 
risk of lung cancer [Hunt & Stoecker, 1996].
It should be noted that most chromium supplements are in the form of 
chromium picolinate. This form of chromium requires the reduction of the 
chromic centre before use. This process can potentially lead to the 
production of harmful hydroxyl radicals [Vincent, 2000].
1.1.1.3 Cobalt
Elemental cobalt is not considered essential but cobalt is an integral part of 
vitamin B12 that is considered to be essential. Humans cannot synthesise 
vitamin B12: therefore it has to be found within the diet. Vitamin B12 enters the 
food chain by the eating of animal meats that contain vitamin B12 producing 
micro-organisms in their liver [Schjonsby, 1989; Scott, 1997] Consequently, 
a rich source of vitamin B12 is the liver. Other food sources of vitamin B12 are 
shown in Table 8 .
Table 8. Vitamin B12
Food sources Vitamin B12 concentration (pg)
Milk, 34 pt 1 . 0
Cooked lambs liver (90g) 70
Pilchards, canned (lOOg) 1 2
Tuna, canned (95g) 4
*Source: Mason, 1995 
Cobalt function
Vitamin B12 is the metabolic active form of corrinoids (Figure 1) [Scott, 1997]. 
Corrinoids are cofactors for the following enzymes: methionine synthase and 
methylmalonyl CoA mutase.
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Figure 1. Cyanocobaiamin
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*Source: Scott, 1997
These enzymes are involved in two specific biochemical reactions in the 
human body [Chanarin, 1979]. Methionine synthase converts homocysteine 
to methionine, providing methyl groups for méthylation steps in building 
structures e.g. myelin. Methylmalonyl CoA mutase recycles folate coTactor 5- 
methyltetrahydrofloate back to tetrahydrofolate thus allowing continuous
15
recycling of the folate co-factor for the biosynthesis of purines, pyrimidines 
and thus DMA [Chanarin, 1979; Scott, 1997].
The Department of Health has set reference nutrient intakes for cobalt of 1.5 
pg/d for both men and women aged 19-50 years.
Cobait absorption
The primary types of vitamin B12 found in food are methyl, deoxyadenoysl and 
hydroxy [Schjonsby, 1989; Scott, 1997]. In dietary supplements vitamin B12 
is found in the form of cyanocobaiamin, (Figure 8 ). Absorption occurs in the 
ileum and requires a gastric intrinsic factor (IF) for efficiency [Schjonsby, 
1989]. Intestinal absorption can be described in four stages:
(1 ) Intradastric events -  vitamin B12 is released from dietary proteins by 
the facilitation of acid [Cooper & Castle, 1980] and digestion of food 
by pepsin [Kittang & Schjonsby, 1987]. Once free, vitamin B12 is 
bound to R binders, a range of glycoproteins secreted in saliva, due to 
the acidic pH in the stomach;
(2) Duodenal & Jejuna events -  vitamin B12-R binder complex is degraded 
by pancreatic enzymes and vitamin B12 is exclusively bound to IF due 
to the alkaline conditions [Allen et al., 1978].
(3) Ileal events -  vitamin B12-IF complex passes down to the ileum where it 
is bound to specific membrane receptors and absorbed (phagocytosis). 
Vitamin B12 is transported across enterocyte and is bound to 
transcobalamin II in portal blood; and
(4) Enteroheoatic circulation -  billiary excretion of vitamin B12 bound to R- 
protein. Vitamin Bi2-R-protein complex is degraded by pancreatic 
proteases and vitamin B12-IF complex is formed. Vitamin Bi2 is mostly 
reabsorbed in the ileum, if not it undergoes faecal excretion.
The intrinsic factor has a high affinity for vitamin B12 in alkaline pH but low 
affinity at acidic pH. This is illustrated by the binding of vitamin B12 to R- 
binder in the stomach, where the R-binder has a higher affinity for vitamin B12
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[Scott, 1997]. Vitamin B12 will only be absorbed in the ileum when bound to 
intrinsic factor. Because of this the intrinsic factor is secreted in excess in the 
stomach. However, due to limited sites of absorption in the Ileum, absorption 
of vitamin B12 is restricted to small amounts [Schjonsby, 1989].
Cobalt metabolism
Vitamin B12 is primarily stored in the liver [Cooper & Rosenblatt, 1987]. 80% 
of the body’s vitamin B12 content is found in the liver and turnover is extremely 
slow [DH RHSS 41,1999]. Excretion of vitamin B12 mostly occurs via the bile 
and further faecal excretion, Urinary excretion has also been detected but 
only in small amounts [Groff et al., 1995].
Cobalt deficiency / toxicity
Deficiency of vitamin B12 caused by dietary intake is unlikely and most cases 
reported are in relation to the failure of intrinsic factor (a protein co-factor) 
secretion [DH RHSS 41, 1999]. When deficiency does occur it happens in 
stages. Firstly, serum vitamin B12 concentrations diminish, followed by 
decreasing cell concentration of vitamin B12 and finally biochemical deficiency 
occurs resulting in the occurrence of anaemia. It is the process of 
demyelination of nerves that causes megaloblastic anaemia and neuropathy. 
Prolonged deficiency can lead to irreversible neurological damage. Symptoms 
of vitamin B12 deficiency differ in children and adults. In children and infants, 
symptoms include diarrhoea, vomiting and delayed growth. In adults, 
weakness and paresthesias are symptoms [Cooper & Rosenblatt, 1987].
Toxicity from high intakes of vitamin B12 has not been recorded and as such 
vitamin B12 is considered to have extremely low toxicity levels [DH RHSS 41, 
1999].
1.1.1.4 Copper
Copper is considered essential due to its role as a component of many 
enzymes [DH RHSS 41,1999] The human body contains approximately 110 
mg of copper; 75% is found in the skeleton and skeletal muscle, the rest being
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found in the brain, blood and liver [Linder et al., 1988]. Rich food sources of 
copper include shellfish, liver, kidney, nuts and wholegrain cereals; individual 
values are shown in Table 9. Drinking water from a soft acidic area provided 
by copper pipes also makes a significant contribution to the total copper in the 
diet [Falrweather-Tait, 1997].
Western diets typically provide copper at or below the recommended daily 
allowance (RDA) values [Uauy, 1998]. In the United Kingdom, the copper 
reference nutrient intake (RNl) value for adults aged 18-50+ years is 1.2 mg/d 
for both men and women [DH RHSS 41,1999]
Table 9. Copper dietary sources
Food sources Copper concentration (mg)
Liver, lambs, cooked (90g) 9.0
Liver, calf, cooked (90g) 1 1 . 0
Plain chocolate (lOOg) 0.7
*Source: Mason, 1995 
Copper function
Copper is an integral component of many enzymes including ceruloplasmin, 
cytochrome oxidase, superoxide dismutase, lysl oxidase (involved in the 
formation and function of connective tissue) and tyrosinase (involved in the 
synthesis of melanin pigment) [Fairweather-Tait, 1997]. Ceruloplasmin is an 
oxidative enzyme that is involved in the oxidation of elements, specifically the 
binding of iron to transferrin [Uauy, 1998]. Cytochrome oxidase contains 2-3 
atoms of copper and catalyses the terminal step in mitochondrial electron 
transport, where oxygen is reduced to water and adenosine triphosphate 
(ATP) is formed. Superoxide dismutase (SOD) is a copper and zinc 
dependent enzyme that protects against superoxide radicals by catalysing the 
reaction illustrated in Equation 1.
20^- + 2H- H2O2  + O2 eqn(1)
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Superoxide radicals cause perioxidative damage of phospholipid components 
of cell membranes [Groff at al., 1995].
, Copper absorption
Dietary copper can be absorbed throughout the small intestine and the 
stomach but the major site of absorption is the duodenum [Lonnerdal, 1996; 
Fairweather-Talt, 1997]. The mechanisms of absorption are still unclear but 
are believed to be a saturable active transport at low concentrations and a 
non-saturable passive diffusion mechanism at high concentrations [Groff et 
al., 1995]. Only 30-40% of copper from a Western diet is absorbed in the 
gastrointestinal tract [Wapir, 1998]. This figure can be depressed or 
increased depending upon other dietary components. Inhibitors of copper 
absorption 'are vegetable protein, divalent cations (e.g. Zn, Fe and Mo), 
carbon, phosphate, ascorbic acid and a high copper content [Johnson et al., 
1998; Wapir, 1998]. Enhancers of copper absorption include amino acids, 
animal protein, fructose and a low copper content [O'Dell, 1993]. Unlike other 
essential elements, phytate does not act as an inhibitor of copper absorption 
[Lonnerdal, 1996]. Age also affects copper absorption as it has been found 
that the elderly absorb less copper than young adults [DH RHSS 41,1999].
Copper metabolism
Once absorbed, copper is transported to tissues in two phases. In the first 
phase, copper is transported from the small intestine to the liver bound 
predominantly to albumin but also possibly bound to transcuprein and / or an 
amino acid [Linder et al., 1998] Once in the liver, copper is incorporated into 
apoceruloplasmin to form ceruloplasmin. The second phase involves 
ceruloplasmin being released from the liver into the blood where it can be 
transported to the kidneys, heart and brain [Fairweather-Tait, 1997; Linder 
et al., 1998; Turnlund, 1998]. The main storage site of copper in the human 
body is the liver. Copper is also found in relatively high quantities in the 
kidneys, bone, muscle and skin [Groff et al., 1995].
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Homeostasis, though not well understood, is controlled by strong mechanisms 
in the human body [Turnlund, 1998]. Copper concentrations in the human 
body are regulated by absorptive efficiency and billiary excretion 
[Falrweather-Tait, 1997]. During high intakes of dietary copper, absorption is 
depressed and endogenous excretion is increased.
Copper deficiency / toxicity
Copper deficiency is usually associated with decreased copper stores at birth, 
inadequate copper intake and an elevated requirement induced by rapid 
growth or Increased copper losses [Uauy, 1998] Copper deficiency can lead 
to the following conditions: hypochromic, microcytic anaemia, neutropenia, 
leukopenia, depigmentation of skin and hair, impaired immune system and 
skeletal déminéralisation [Groff et al., 1995]. However, most of these 
conditions are rare and the most common conditions are leucopenia and 
skeletal fragility in infants and neutropenia in adults [DH RHSS 41,1999].
Toxicity caused by high intakes of copper in the diet has not been reported in 
the United Kingdom. However, some cases have been reported in the USA 
and Germany as a result of contaminated drinking water [DH RHSS 41, 
1999]. Copper toxicity is also closely associated with Wilson’s disease, a 
genetic disorder characterised by the accumulation of copper in the brain and 
liver leading to deleterious effects on these organs [Wapir, 1998]
1.1.1.5 Iron
In an adult man there Is approximately 4 g of iron present. An adult female 
contains a lower amount of approximately 2.5 g [Hercberg et al., 1987]. The 
iron present in both sexes can be divided into different uses: 85% is found in 
functional iron compounds (haemoglobin and myoglobin), 1-3% is found as 
part of enzymes and the remaining percentage of iron is found in the blood or 
in storage [Sherwood et al., 1998]. Iron in the diet is found in twp forms: 
haem and non-haem. Haem iron is present in animal produce and constitutes 
10-15% of dietary iron. Non-haem iron is found in vegetable produce and 
constitutes 85-90% of dietary iron [Fairweather-Tait, 1998] Rich food
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bone marrow [Kaim & Schwederski, 1994]. Iron is predominantly stored as 
ferritin, a soluble protein found in all cells, but the bulk of ferritin is found in the 
liver [Sherwood et al., 1998]. In excess iron overload, storage in 
hemosiderin occurs from which iron can be mobilised in the presence of low 
molecular-weight ligands. Iron stores are influenced by long-term dietary 
intakes and can account for up to 30% of total body iron [DH RHSS 41,1999].
Iron is excreted in small amounts; most iron losses are represented by 
unabsorbed iron and cell losses [Haliberg, 1992] The process of absorption 
and not the process of excretion controls iron homeostasis [McCance & 
Widdowson, 1938]. In an iron deficient state, the absorption mechanism of 
iron is increased [Hurrell, 1997].
Iron deficiency / toxicity
Iron deficiency is a global concern; it is the most common Worldwide 
nutritional deficiency [Du et al., 1999]. There are three stages of iron 
deficiency; (a) depleted iron stores; (b) defective haemoglobin production; and
(c) decreased haemoglobin levels [Roodenburg, 1995]. Iron deficiency leads 
to the reduction of physical work capacity, impairment of the ability to adapt to 
cold temperatures, and increased lead absorption [Lynch, 2000]. During 
pregnancy, iron deficiency is associated with low birth weights, premature 
delivery and increased perinatal mortality.
Toxicity can occur with chronic absorption and accumulation of iron that 
exceeds normal iron transport and storage mechanisms [Beard & Dawson,
1997]. In the colon, excess unabsorbed dietary iron can increase free radical 
production that could cause mucosal cell damage or increased production of 
carcinogens [Lund et al., 1999]. Laboratory and clinical experiments have 
shown that iron exerts carcinogenic effects by catalysing the formation of 
hydroxyl radicals, suppressing activity of host defence cells and promoting 
cancer cell multiplication [Weinburg, 1996].
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1.1,1.6 Magnesium
The adult human body contains 20-28 g of magnesium, of which 55% is found 
in bone, 27% in muscle and 1% in plasma [Shills, 1984; Schaafsma, 1997]. 
Magnesium is mainly present in vegetable food sources (Table 12). In 
general, magnesium can be found in whole grain cereals, nuts, legumes and 
seafood [Groff et al., 1995]. Contributions from hard water should also be 
considered as this can provide a significant intake [Mason, 1995].
Table 12. Magnesium dietary sources
Food sources , Magnesium concentration (mg)
1 bowl of muesli (45 g) 90
Bread, brown, 2 slices 40
Milk, % pt 35
Lentils, kidney beans (105 g) 50
1 small can of baked beans ( 2 0 0  g) 60
"Source: Mason, 1995
Magnesium function
Magnesium is involved in three hundred different enzyme reactions [Wester, 
1987; Shills, 1990]. Within cells, magnesium is found bound to phospholipids 
(as part of cell membranes), in nucleic acids and proteins [Groff et al., 1995]. 
Although the mechanism is unclear, magnesium influences the balance 
between extra-cellular and intra-cel I ular potassium [Wester, 1987]. 
Magnesium’s primary function is to bind phosphate groups in the complex 
adenosine tri-phosphate (ATP). This binding action assists in structural 
stability (Figure 3) and the transfer of ATP [Shills, 1994].
Magnesium also plays a fundamental role in the following physiological 
processes: glycolysis, Kreb’s cycle, hexose monophosphate shunt, DNA 
synthesis and degradation as well as the physical integrity of the DNA helix, 
transcription of DNA and RNA, amino acid activation and protein synthesis 
[Levine & Coburn, 1984; Shills, 1990].
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Figure 3. Proposed magnesium-ATP stable complexes
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Magnesium absorption
The site and mechanism of magnesium absorption has not been established. 
However, it is likely that two separate transports systems exist; (1) carrier- 
mediated system that saturates at low luminal magnesium concentrations 
and; (2 ) a simple diffusion system which occurs at higher magnesium 
concentrations [Shills, 1984; Schaafsma, 1997]. Both the jejunum and the 
ileum are thought to be sites of magnesium absorption in the small intestine. 
The level of magnesium absorption varies between 35-70% depending upon 
dietary intake. High intakes of magnesium results in a decrease of fractional 
absorption [Fine et al., 1991].
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Magnesium inhibition / enhancement
In animal studies excess dietary calcium has been shown to reduce 
magnesium absorption [Spencer, 1980; O’Dell, 1989]. Excess phosphorous 
also decreases magnesium absorption and accentuates signs of magnesium 
deficiency [O’Dell, 1989] However, in human nutrition both calcium and 
phosphorous intakes may have little effect, even though magnesium is known 
to interact with calcium, as it is has an important role in calcium homeostasis 
resulting from magnesium's role in parathyroid hormone secretion [DH RHSS 
41, 1999]. Calcium and magnesium are also antagonists in blood 
coagulation; calcium promotes clotting whilst magnesium inhibits it [Weaver, 
1987]. Known inhibitors of magnesium are phytate and unabsorbed fatty 
acids. Enhancers of magnesium absorption include lactose, vitamin D and 
vitamin Be [Schaafsma, 1997].
Magnesium metabolism
Mechanisms for magnesium homeostasis are unclear but appear to depend 
on gastrointestinal absorption, renal excretion and transmembranous cation 
flux [NRG, 1989] The kidneys play a pre-dominant role in the excretion and 
potential re-absorption of magnesium. At low magnesium intakes, tubular re­
absorption increases sharply so that plasma magnesium concentration is 
maintained (1.3-2.1 mEq/L) [NRG, 1989] Tubular re-absorption is regulated 
predominantly by the plasma magnesium concentration [Schaafsma, 1997]. 
Vitamin Be also appears to play a role in magnesium metabolism. Evidence 
for this was reported in a study on vitamin B6  low diets that resulted in a 
negative magnesium balance, despite an adequate magnesium intake 
[Turnlund et al., 1992].
Magnesium deficiency / toxicity
Magnesium deficiency is very hard to induce due to the regulation of 
magnesium concentrations in plasma by tubular re-absorption [Schaafsma,
1997]. Therefore, magnesium deficiency cases are generally associated with 
other illnesses e.g. alcoholism, renal disease [Shills, 1984]. Deficiency 
causes the progressive decrease of the magnesium concentration in plasma.
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followed by a slower decrease of the magnesium content in erythrocytes. 
Within a few days urinary and faecal excretion is decreased to very low 
values. Deficiency symptoms include a decrease in growth rate, tremors and 
spasms resulting from muscle weakness and neuromuscular dysfunction 
[O’Dell, 1989].
Toxicity is rarely seen in conjunction with high dietary intakes but is observed 
in conjunction with cases of renal insufficiency and failure [Gibson, 1990]. 
Acute doses of magnesium from intravenous administration produce 
symptoms of nausea, depression, anaesthesia and loss of reflexes [O’Dell, 
1989]. Small amounts of calcium have been shown to counteract these 
symptoms.
1.1.1.7 Manganese
The human body contains 12-20 mg of manganese. Most is located 
intracellular, of which 25% is found in the skeleton. Officially there is little 
evidence of manganese dietary intakes affecting levels in the human body, as 
such there is no reference nutrient intake value stated for manganese [DH 
RHSS 41, 1999]. However, a safe daily intake is proposed to be 1.4 mg for 
adults and 16 pg for infants and children. In the United Kingdom, half of the 
total manganese intake (approx. 6  mg/person/d) is provided by tea 
consumption [DH RHSS41, 1999]. Table 13 presents other food sources of 
manganese.
Table 13. Manganese dietary sources
Food source Manganese concentration (mg)
Bread, brown, 2 slices 1 . 0
Lentils, kidney beans (105g) I T ) -1.5
Pineapple, canned (150g) 1.5
30 Hazel nuts 1 . 0
^Source: Mason, 1995
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Manganese function
Manganese functions as a co-factor for a large number of co-enzymes; most 
of these co-enzymes are not affected by a low dietary intake [Hurley, 1982]. 
However, the glycosyl transferase co-enzymes are effected. Manganese 
specifically activates glycosyl transferase in a reaction (illustrated in Equation 
3) that transfers a sugar moiety from uridine diphosphate (UDP) to an 
acceptor [Groff et al., 1995]. This reaction Is important for the synthesis of 
glycosaminoglycans and glycoproteins.
UDP-sugar + acceptor transféras^  UDP + acceptor-sugar eqn (3)
Manganese is present in pyruvate carboxylase and superoxide dismutase. 
Pyruvate carboxylase catalyses the first step in the carbohydrate synthesis of 
pyruvate. Superoxide dismutase catalyses the dismutation of the superoxide 
free radical to hydrogen peroxide and water [Hurley, 1982]. Consequently, 
superoxide dismutase protects cells against the deleterious effects of free 
radicals and is especially recognised in the prevention of lipid oxidation [Groff 
et al., 1995] Manganese also plays a biochemical role in carbohydrate and 
lipid metabolism [KIrschmann & Kirschmann, 1996].
Manganese absorption & metabolism
There is little information on the mechanism of manganese absorption. 
However, it has been established that the process of absorption occurs 
throughout the length of the small intestine [Thomson et al., 1971]. In rats, 
the absorption has been found to be a high-affinity, active transport 
mechanism. In humans, levels of absorption range from 3-50%, depending 
upon dietary intake and other dietary components. No storage organ has 
been identified but manganese is found in relatively high amounts in bone, 
liver and kidneys.
There is some evidence that histidine and citrate enhance the absorption of 
manganese [Garcia-Aranda et al., 1983] In animal studies fibre, phytate, 
oxalic acid, calcium and phosphorous cause precipitation of manganese in the
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gastrointestinal tract, making it unavailable for absorption. This has not been 
collaborated in human studies. Competition for absorption can occur with iron 
at binding sites in the small intestine. Consequently, low levels of manganese 
in a low level iron diet can illicit iron deficiency-like effects [Kirchgessner at 
a!., 1982]. Regulation of manganese body levels is carried out by both biiliary 
excretion and absorption [Groff at al., 1995],
Manganasa daficiancy I toxicity
Deficiency rarely occurs from a typical diet in humans [DH RHSS 41, 1999]. 
Toxicity by dietary intake is Just as unlikely; manganese is the least toxic of 
the all the essential elements. Reported toxicity cases are usually associated 
with industrial manganese mines. Inhalation of manganese oxide fumes or 
manganese alloy dust can cause neurological disorders producing a 
Parkinson-like syndrome [Hurley, 1982].
1.1.1.8 Molybdenum
In the human body molybdenum is found in relatively large amounts in dental 
enamel [Mill & Davis, 1987]. The essentiality of molybdenum is based on a 
genetic deficiency of sulphite oxidase and xanthine oxidase. Both enzymes 
require molybdenum as a co-factor and the disorder can result in severe 
pathology [Johnson et al., 1980]. Molybdenum has no official RNI value but 
safe intakes are believed to be in the range of 50-400 pg/d [DH RHSS 41, 
1999] Rich food sources of molybdenum include dairy products (especially 
milk), beans and cereals [Mason, 1995].
Molybdenum function
Molybdenum dependent enzymes are needed for the metabolism of purines, 
pyrimidines, pteridines, and aldehydes and also in the oxidation of sulphite 
[Mill & Davis., 1987]. In humans, three enzymes have been identified that 
contain a molybdenum co-factor called molybopterin, which is illustrated in 
Figure 4. The three enzymes containing molybopterin are xanthine oxidase / 
dehydrogenase, sulphite oxidase and aldehyde oxidase.
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Figure 4. Molybopterin
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*Source: Kramer et al., 1987.
Xanthine oxidase / dehydrogenase is found in the liver, lungs and kidney and 
participates' in the hydroxylation of purines, pteridines and pyrimidines 
[Johnson et al., 1980]. In the human body, the dehydrogenase form is 
predominantly used. Both enzyme forms catalyse the production of uric acid 
from xanthine but xanthine dehydrogenase transfers electrons from the 
substrates to nicotinamide adenine dinucleotide (NAD) while xanthine oxidase 
forms hydrogen peroxide as illustrated in Equation 4 [Mill & Davis, 1987]. 
Due to the formation of hydrogen peroxide and superoxide (O2"), xanthine 
oxidase activity is considered damaging and is associated with molybdenum 
toxicity.
Xanthine oxidase / dehydrogenase reactions
xanthine oxidaseXanthine
Xanthine xanthine dehydrogenase Uric acid
O2 H ,0  NAD NADH + H+
eqn (4)
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Sulphite oxidase is a mitochondrial enzyme which catalyses the final step in 
the metabolism of sulphur containing amino acids (methionine and cysteine) 
[Mills & Davis, 1987]. The enzyme also exhibits narrow substrate specificity 
for the oxidation of sulphite (SOa" )^ to sulphate (SO4  ^ ).
Aldehyde oxidase is presumed to function as a "true" oxidase using molecular 
oxygen as its physiological electron acceptor. Although its function has not 
been clearly established, aldehyde oxidase is believed to be important in drug 
metabolism [Beedhman, 1985].
Molybdenum absorption and metabolism
The mechanism of absorption for molybdenum has not been established, but 
is believed' to involve active transport at low concentrations and passive 
diffusion at'high concentrations. Absorption sites are the stomach and the 
small intestine, where absorption is believed to occur more at the proximal 
section rather than the distal section [Groff et al., 1995] Molybdenum can be 
absorbed in many forms; these include water-soluble forms (sodium 
molybdate and ammonium molybdate) and insoluble forms (molybdenum 
trioxide and calcium molybdate) [Mills & Davis, 1987]. However, 
molybdenum sulphate is not absorbed. This is due to competition for 
absorption sites between sulphate and molybdenum. Consequently, sulphate 
is an inhibitor of molybdenum absorption.
In blood, molybdenum is transported as the compound molybdate or bound to 
a protein such as albumin and/or a  - macroglobulin [Groff et al., 1995]
Elimination of molybdenum occurs through urine and bile, with urine being the 
major route of excretion [Turnlund et al., 1993].
Molybdenum deficiency I toxicity
Deficiency by dietary intake is rarely encountered. However, high intakes of 
molybdenum (10-15 mg/d) are associated with the altered metabolism of 
nucleotides and impaired copper bioavailability [Turnlund, 1988]. In the
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Soviet Union, abnormally high concentrations of molybdenum in soil and 
plants have led to a high incidence of gout in the affected areas [Mills & 
Davis, 1987]. Symptoms of molybdenum toxicity include anaemia and 
depressed growth rate [Kirschmann & Kirschmann, 1996].
1.1.1.9 Nickel
Nickel containing enzymes have been identified in plants and micro­
organisms but not in humans [Nielson, 1987]. Consequently, no specific 
biochemical function has been established for nickel and as such nickel has 
not been given an official RNI value [DH RHSS 41, 1999]. The human 
requirement for nickel could be as low as 5 pg/d which is easily acquired as 
the average intake of nickel in the United Kingdom is 140-150 pg/d [DH RHSS 
41,1999]. Food sources include nuts, leguminous seeds, shellfish and cacao 
products [Nelson, 1987].
Nickel function
Nickel essentiality is based upon its potential roles in hormone and lipid 
metabolism and cell membrane integrity [Kirschmann & Kirschmann, 1996]. 
It is believed that nickel partially alleviates iron deficiency by its potential 
involvement in iron utilisation [Nielson, 1987]
Nickel absorption and metabolism
Limited studies suggest that the fractional absorption of nickel in humans is 
less than 10% [Nielson, 1987] Nickel appears to compete with iron for 
common transport in the proximal intestine. Excretion occurs via the kidneys 
in the urine [Patriarca et al., 1997] In blood, serum albumin primarily 
transports nickel. Nickeloplasmin, a histidine-rich protein may also act as a 
transport protein.
Nickel deficiency /toxicity
Deficiency in animal and birds causes depressed growth and haemopoesis 
[DH RHSS 41,1999] In humans, nickel deficiency may cause elevated levels 
of zinc and iron affecting their metabolism [Nielson, 1987]. Toxicity due to
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oral intake is uncommon but can be a factor in parenteral nutrition [Nielson, 
1984]. Symptoms and effects of nickel toxicity include headaches, vertigo, 
nausea, respiratory problems, chest pain, stroke and uterine cancer 
[Kirschmann & Kirschmann, 1996].
1.1.1.10 Zinc
Zinc is the most abundant intracellular element in the human body and as 
such is found in all organs, tissues and fluids [King et al., 2000]. The human 
body contains 1-2 g of zinc, of which, approximately 90% is found in bone and 
skeletal muscle. Both systems act as a zinc reservoir [Sandstrôm, 1997]. 
The zinc RNI values for adults aged 19-50+ years are 9.5 mg/d for men and 
7.0 mg/d for women [DH RHSS 41,1999]. Even though zinc is found in many 
staple foods as illustrated in Table 10, zinc deficiency is a Worldwide problem 
[Prasad, 1996; Lonnerdal, 2000].
Table 14. Zinc dietary sources
Food sources Zinc concentration (mg)
1 beef, steak, (155 g) 7.0
Crab (100 g) 6 . 0
Lentils, kidney beans (105 g) 1 . 0
1 bowl ALL BRAN (45 g) 3.0
1 bowl CORN FLAKES (45 g) 1.5
Source: Mason, 1995 
Zinc function
Zinc is an integral component of catalytic sites in at least one enzyme in every 
enzyme class [Hambridge, 2000] Zinc dependent enzymes are involved in 
the synthesis and degradation of carbohydrates, lipids, proteins, nucleic acid 
[Sandstrôm, 1997]. Oxidation and conversion of retinol to retinal for night 
vision requires a zinc dependent enzyme called retinol dehydrogenase 
[Christian & West Jr, 1998]. In zinc fingers, zinc performs a structural role 
as well as being specific for the binding of DNA in gene expression [Prasad,
1996].
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Physiologically zinc is involved in the regulation of bone formation, where zinc 
has a stimulatory effect on mineralisation and an inhibitory effect on bone 
resorption [Yamaguchi, 1998]. Zinc is essential for reproduction in both men 
and women being involved in many reproductive processes including: the 
synthesis and secretion of lutenizing hormone and follicle stimulating 
hormone, gonadal differentation, tescular growth, formation and maturation of 
spermatozoa, testicular steridgenesis and fertilisation [Salgueiro et al., 2000]. 
Zinc also has unique roles in the immune system, growth and development 
[Prasad, 1996; Sandstrôm, 1997].
Zinc absorption
Absorption of zinc occurs mainly in the duodenum and jejunum [Krebs, 2000]. 
The mechanism of absorption occurs via a specific saturable carrier mediated 
transport process [Lônnerdal, 2000]. Zinc is efficiently absorbed in small 
quantities; large amounts inhibit zinc absorption [Whittaker, 1998]. Other 
inhibitors of zinc absorption are phytic acid, hemicellulose, oxalate, calcium, 
iron, copper and tin [Jackson & Lowe, 1992]. Enhancers of zinc absorption 
are animal protein, histidine, and congeners found in red wine [Sandstrôm
1997]. 
Zinc metabolism
The pancreas is the primary organ in the regulation of zinc homeostasis 
[Oberleas, 1993] Secretion of zinc from the pancreas occurs throughout the 
day and is 2-4 times higher than the amount of zinc absorbed from the diet 
[Oberleas, 1996]. Therefore, it is essential that a large proportion of the 
secreted zinc be reabsorbed to ensure constant physiological levels of zinc. 
Zinc homeostasis is regulated by the processes of intestinal endogenous 
excretion and intestinal absorption [Sandstrôm, 1997]. Each process adapts 
differently to physiological zinc levels. The excretion process changes quickly 
but only small amounts of zinc are involved. Absorption reacts slower but 
greater quantities of zinc are involved [King et al., 2000]. Zinc homeostasis is 
illustrated in Figure 5.
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Figure 5. Zinc homeostasis
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Zinc is transported in blood bound to albumin, a-2 macroglobulin and amino 
acids. There is no conventional store of zinc in the human body. Zinc is 
transported across biological membranes depending upon the following 
conditions: time, temperature, and pH [McMahon & Cousins, 1998].
Zinc deficiency / toxicity
Deficiency of zinc is a Worldwide nutritional problem [Salgueiro et al., 2000]. 
Acute zinc deficiency is relatively uncommon and usually follows from 
parenteral nutrition. Chronic zinc deficiency is more common and results from 
low dietary intakes. Sub-acute or marginal zinc deficiency is the most 
common but is the hardest to identify [Henkin & Aamodt, 1983]. Conditions 
resulting from zinc deficiency vary according to the severity. A severe (acute) 
zinc deficiency will affect the epidermal, gastrointestinal, central nervous, 
immune, skeletal and reproductive systems [Hambridge, 2000] A milder 
deficiency will result in the impairment of physical growth and neurophysical 
performance, also diarrhoea, pneumonia, a loss of appetite and childhood 
morbidity [Ronette et al., 2000] During pregnancy a mild zinc deficiency is
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associated with increased maternal morbidity, prolonged gestation, inefficient 
labour and increased risk to foetus [Prasad, 1996]
In general, zinc is relatively non-toxic at moderate levels but at elevated levels 
zinc can become detrimental to health [Ronette et a!., 2000]. Levels of zinc 
greater than 15 mg/d are not recommended unless upon medical advise [DH 
RHSS 41 1999]. Elevated levels of zinc through ingestion of high quantities of 
zinc are associated with respiratory and gastrointestinal toxicity, copper and 
iron deficiency, impaired immune system and inhibition of neurological 
development [Briefel et al., 2000]. The large quantities of zinc required to 
result in these conditions is normally associated with the consumption of 
excessive quantities of dietary supplements and water from galvanised 
containers [Ronette et al., 2000]
1.1,2 Fat-soluble vitamins
All of the fat-soluble vitamins are regularly added to dietary supplements. Fat- 
soluble vitamins and carotenoids are relatively non-polar species and are 
represented by vitamins A, D, E and K [Jackson 1997]. Due to their non­
polar nature fat-soluble vitamins are dependent upon micellular solubilsation 
for absorption [Jackson, 1997]. In general absorption and transport of fat- 
soluble vitamins is similar to dietary lipids [Groff et al., 1995]. Transport of 
fat-soluble vitamins begins with incorporation into chylomicrons and leads to 
circulation via lymphatic pathways [Jackson, 1997].
1.1.2.1 Vitamin A
Vitamin A is the term used to refer to retinol, which has three main 
components: (1 ) a R-ionone ring (hydrophobic head); (2 ) a conjugated 
isoprenoid side chain; and (3) a polar terminal group [Biesalski, 1997]. The 
structure of retinol is presented in Figure 6 .
Pro-formed vitamin A or provitamin A refers to p-carotene and other 
carotenoids that can be converted by the body into retinol [Groff et al., 1995].
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Carotenoids are red / yellow pigments found in plants (e.g. carrots) these 
combined with retinal esters including retinal palmitate are the predominant 
precursors of retinol in food sources. Retinol is found in large quantities in 
the liver of animals and certain fish (e.g. cod liver oil); specific values for 
retinol and carotenoids are presented in Table 15 [Mason, 1995]. In the 
United Kingdom and the United States margarine is regularly supplemented 
with vitamin A [Basu & Dickerson, 1996].
Figure 6, Trans-retinol
Table 15. Retinol and p-carotene dietary sources
Food source Retinol (pg) Food source p-carotene (pg)^
2 tsp Cod liver oil 1800 Carrots (lOOg) 7560
Liver, calf (90g) 3600 Spinach (lOOg) 3840
*For retinol equivalent values divide by 6 
"Source: Mason 1995
The vitamin A reference nutrient intake values for men and women aged 19- 
50+ years are 700 pg retinol equivalent/d and 600 pg retinol equivalent per 
day respectively [DH RHSS 41,1999].
Vitamin A function
Vitamin A is essential for vision, as it is a vital component of rhodopsin, a 
visual pigment [Kingston, 1999]. It is also important in general growth, cell 
differentation and maintenance of epithelial tissue [Basu & Dickerson, 1996]. 
Each form of vitamin A performs a specific task. Retinol is essential for 
reproductive processes in both men and women and is also essential in bone 
development and maintenance. Retinal is essential and specific to rhodopsin.
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which undergoes light-inducing isomerization that triggers a phototransduction 
cascade resulting in a signal transmission to the neurones of the optical nerve 
[Azais-Braesco & Pascal, 2000]. Retinoic acid is a lipid soluble hormone 
. that controls gene transcription through receptor-mediated events [Azais- 
Braesco & Pascal, 2000] Retinoic acid is also involved in the maintenance 
of normal structure and function of epithelial cells [Ross & Turnus, 1993]. 
Another metabolite of vitamin A called 14-hydroxy-4,14-retro retinol is 
potentially involved in the immune system, but mechanisms of action are 
unknown [Azais-Braesco & Pascal, 2000]
Vitamin A absorption and metabolism
The mechanism of absorption is a non-saturable process [Azais-Braesco & 
Pascal, 20Ô0]. Bile salts facilitate absorption by promoting rapid cleavage of 
retinyl esters and assisting In the transfer of lipids to mucosal cells [Biesalski, 
1997]. Absorption of vitamin A is typically 80-90%, but depends upon the 
quality and quantity of dietary fat consumed at the same time. Fat serves as 
a vehicle of transport as well as a stimulator for bile flow. The liver is the 
primary store of vitamin A; it also converts retinol to retinal and retinoic acid by 
oxidation reactions [Lambert et al., 1985].
The intestinal absorption of retinyl esters and provitamin carotenoids involves 
the part cleavage by retinyl ester hydrolase producing retinol in enterocytes 
[Azais-Braesco & Pascal, 2000] Once absorbed the retinol is incorporated 
into chylomicrons and is re-converted back to retinyl esters [Basu & 
Dickerson, 1996]. The chylomicron remnants are then taken up by 
hepatocytes in the liver, here the retinyl esters are hydrolysed back to retinol 
and subsequently released bound to transthyretin (TTR) and retinol binding 
protein (RBP) [Biesalski, 1997].
Vitamin A deficiency / toxicity
Vitamin A deficiency is characterised by night blindness caused by insufficient 
amount of the visual pigment, rhodopsin [Kingston, 1999]. Night blindness 
refers to the time required for eyesight to adapt from light to dark conditions
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[Ball, 1998]. Another symptom of vitamin A deficiency is a depressed 
immune system brought on by the non-secretion of mucus by the epithelial 
tissues leading to a greater susceptibility to infections [Ball, 1998]. The 
transmission of HIV-1 from mother-to-child has been shown to increase during 
a vitamin A deficient state [Azais-Braesco & Pascal, 2000].
Large doses of vitamin A have been linked with birth defects [Basu & 
Dickerson, 1996; Kingston, 1999] A dose of 10 mg (retinol equivalent) of 
vitamin A can result in hypervitaminosis, which symptoms include dry, itchy 
and desquamating skin and alopecia [Groff et al., 1995].
1.1.2.2 Vitamin D
Vitamin D has two main vitamers, which are ergocalciferol (D2) and 
cholecalciferol (D3). Both vitamers exhibit biological activity at equal potency 
[Basu & Dickerson, 1996]. The biological activity of vitamin D is dependent 
upon three identifiable structural features; (1 ) a free hydroxyl group at carbon 
3; (2) an intact side chain preferably of cholesterol type; and (3) three 
conjugated double bonds at carbons 5-6, 7-8 and 10-19. Both vitamer 
structures are presented in Figure 7.
Figure 7. Vitamin D: ergocalciferol and cholecalciferol
Ergocalciferol Cholecalciferol
HO""
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Ergocalciferol is found in plants and is derived from ultra-violet radiation of 
ergosterol. Cholecalciferol is derived from the action of ultra-violet radiation 
on 7-dehyrocholesterol in the skin of animals and man [DH RHSS41, 1999]. 
Oily fish are rich sources of vitamin D (tinned tuna (100 g) 5.0 pg, tinned 
salmon (100 g) 12.5 g), so is cod liver oil (21.0 pg in 10 ml), [Mason, 1995]
Vitamin D function
Vitamin D has important roles in calcium and phosphate metabolism and is 
especially essential for the regulation of calcium homeostasis [van der Berg, 
1997; Kingston et al., 1999] Calcitrol (1,25-(0H)2D3) functions as a steroid 
hormone that regulates calcium absorption in the small intestine, calcium and 
phosphate re-absorption in the kidneys and calcium bone metabolism. 
Vitamin D also appears to improve muscle strength and tone, although the 
mechanism'of action is unclear [Basu & Dickerson, 1996].
Vitamin D absorption and metabolism
Dietary sources of vitamin D are absorbed via a common route of 
émulsification into mixed micelles, uptake into enterocytes then followed by 
incorporation into chylomicrons [van der Berg, 1997]. The mechanism is a 
non-saturable passive diffusion mechanism. The synthesis of vitamin D in 
the skin from sunlight is illustrated in Equation 5. The synthesis of 
cholecalciferol by the skin is dependent upon geographical location, season, 
atmospheric conditions; time spent outdoors, clothing and skin pigmentation.
In the blood, vitamin D from both sources is transported to the liver by plasma 
proteins called vitamin D-binding protein [Basu & Dickerson, 1996]. At the 
liver vitamin D is hydroxylated to 25-hydroxy-vitamin D, which is released into 
circulation bound to a vitamin D-binding protein. In the kidneys a second 
hydroxylation occurs to produce 1,25-(OH)2D [van der Berg, 1997]. Vitamin 
D is primarily stored in adipose tissue and voluntary muscle.
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Synthesis of Vitamin D3
Sunlight
/ I  \
skin surface
7-dehydrocholesteroI
Tachsterolj Previtamin D3  Lumisteroig
Cholcalciferoi gqp 5^ ^
'^ Source: Basu & Dickerson, 1996
Vitamin D deficiency / toxicity
Vitamin D deficiency results in rickets in children and osteomalacia in adults 
[Kingston, 1999]. Both conditions are characterised by bone 
demineralisation and symptoms include skeletal pain and muscle weakness 
[Basu & Dickerson, 1996]. Vitamin D toxicity is characterised by 
hypercalcaemia, hypercalciuria and subsequent calcification of soft tissues 
[van der Berg, 1997],
1.1.2.3 Vitamin E
Vitamin E is the name given to eight compounds, which are classified into two 
groups. The two groups are the tocols, which have a saturated side chain 
and the tocotrienols, which have an unsaturated side chain. Each group or 
class has four vitamers with a differing number and location of methyl groups. 
All eight vitamers (tocols and tocotrienols) show biological activity but at 
varying degrees [Basu & Dickerson, 1996]. a-Tocopherol has the greatest 
biological activity followed by beta, showing a decreasing trend down to delta, 
which has the lowest activity of the four tocols [Cohn, 1997]. Of the
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tocotrienols only a-tocotrienol shows any significant biological activity. The a -  
P-, X- and 0-tocotrienols have the same R-group structure as the respective 
tocopherol; illustrated In Figure 8 .
Figure 8. General structures of tocopherol and tocotrienol
Tocopherol
Tocotrienol
R1 R2 R3
a CHs CHs CHa
P CHa H CHa
y H CHs CHa
5 H H CHa
*Souce: Diplock, 1984.
Vitamin E is synthesised by plants; hence the main dietary source of vitamin E 
is plant oil (maize oil 530-1620 mgkg‘\  olive oil 50-150 mgkg"^ ) [Basu & 
Dickerson, 1995].
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Vitamin E function
Vitamin E functions as a natural antioxidant by scavenging free radicals in cell 
membranes and preventing oxidation of unsaturated fatty acids [Grundman, 
2000]. Hydroxyl radicals are very reactive and remove electrons from organic 
components of phospholipid membrane. Vitamin A prevents oxidation 
damage by reacting with peroxyl radical and consequently preventing 
extraction of hydrogens from fatty acids [Groff et al., 1995]. Unsaturated fatty 
acids are found in larger quantities in phospholipid membranes of 
mitochondria and endoplasmic reticulum compared to plasma membranes. 
Therefore, the lungs, brain and erythrocyte tissues are more highly 
susceptible to oxidation [Diplock, 1984].
Vitamin E absorption and metabolism
Absorption of vitamin E as a free alcohol occurs primarily in the jejunum by a 
non-saturable passive diffusion process [Coombs, 1992]. The passive 
diffusion process can be divided into steps: émulsification, solubilization, 
diffusion across unstirred water layer, permentation through enterocytes, 
incorporation into lipoprotein particles and finally transport out of mucosal 
cells and into circulation via lymphatic pathway [Cohn, 1997]. Absorption is 
facilitated by simultaneous digestion of dietary fat and bile salts in lumen 
[Cohn, 1997; Grundman, 2000]. The amount of vitamin A absorbed from a 
meal can vary greatly (20-50%), sometimes as high as 80% [Coombs, 1992].
In the blood, vitamin E is transported bound to low density lipoproteins. 
Within cells, vitamin E is found bound to tocopherol-binding proteins [MachUn, 
1991]. There is no single storage organ for vitamin E but large amounts are 
found in adipose tissue, the heart and muscle [Sokol, 1988] Excretion of 
vitamin A occurs predominantly through biiliary pathways [Cohn, 1997],
Vitamin E deficiency I toxicity
Deficiency syndromes of vitamin E in adults are rarely seen due to 
widespread sources in foods, specifically vitamin E’s presence in vegetable 
oils [Cohn, 1997; Kingston, 1999]. However, deficiency can occur in
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premature babies and low birth-weight infants in relation to a malabsorption 
syndrome [Groff et al., 1995]. Symptoms of vitamin E deficiency in infants 
include haemolytic anaemia, oedema, colic and failure to thrive [Ball, 1998]. 
A prolonged severe deficiency can lead to neurological syndrome 
characterised by ataxia, tendon areflexia, a “large fibre” sensory neuropathy 
and muscle weakness [Cohn, 1997].
Vitamin E is the least toxic of the fat-soluble vitamins and only a few adverse 
affects have been noted from large doses of vitamin E [Coombs, 1992]. High 
intakes of vitamin E can interfere with the absorption of other fat-soluble 
vitamins [Ben et al., 1983].
1.1.2.4 Vitamin K
Vitamin K refers to a homologous group of fat-soluble vitamins that have a 
common nucleus of 2-methyl-1,4-naphthoquinone but differ in structures of 
the side chain at position 3 [Shearer & Bolton-Smith, 2000]. There are two 
natural forms of vitamin K these are vitamin Ki and vitamin K2 . Vitamin Ki or 
phylloquinone (by nutritionists) or phytomenodione (by pharmacopoeia) or 2 - 
methyl-3-phytyl-1,4-naphthoquinone is synthesised by plants and 
consequently the predominant form of vitamin K found in foods [Lefevere et 
al., 1985; Ball, 1998] The structure of vitamin Ki is illustrated in Figure 9. 
Vitamin K2 is a family of menaquinones synthesised by a gram positive 
bacteria in lower digestive tracts of animals [Basu & Dickerson, 1996]. 
Menaquinones contain 6-10 isoprenoid units (Figure 10).
Leafy green vegetables are excellent sources of vitamin K (e.g. 100 g of boiled 
spinach provides 400 pg, lOOg of boiled kale provides 700 pg) [Mason, 1995]. 
However, no RNI value has been set for vitamin K, although an estimate of 
0.5-1.0 pg/kg/d has been stated as the amount needed for normal blood 
clotting functions [DH RHSS 41,1999]
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Figure 9. Phylloquinone structure
CK CH.
C H -C H IIC — C H d -C H —CH— C H -C H H -H
Figure 10. Menaquinone general structure
CK
CH;rCHZ:C— CH -H
Vitamin K function
The main function of vitamin K in the human body is its involvement in blood 
coagulation [Kingston» 1999], It is essential as an antihaemorhagic factor for 
the synthesis of prothrombin (factor II) and clotting factors VII, IX and X in the 
liver [Lefevere et al., 1985]. All of these vitamin K dependent clotting factors 
function as pro-coagulants in a coagulant cascade that once initiated, 
culminates in the conversion of fibrinogen to fibrin and the formulation of a 
“homeostatic plug” [Shearer & Bolton-Smith, 2000] Through other vitamin 
K dependent proteins, vitamin K may be important as an inhibitor of 
calcification in arteries due to the matrix Gla-protein and skeletal integrity due 
to the protein osteocalcin [Shearer & Bolton-Smith, 2000]
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Vitamin K absorption and metabolism
Vitamin Ki is absorbed at the proximal small intestine by a saturable energy 
dependent process [Basu & Dickerson, 1996]. Bile salts and pancreatic 
juices enhance absorption, which can vary between 10-70%. Dietary 
menaquinones are absorbed at the distal small intestine and colon by passive 
diffusion [Coombs, 1992]. Menaquinones (vitamin K2) are synthesised by 
bacteria in the lower digestive tract and can be absorbed by passive diffusion 
at the colon. However, the ability to absorb this type of vitamin K differs from 
one human to the next [Suttie, 1985]. Once absorbed vitamin K is 
incorporated into chylomicrons, where remnants are transported to plasma, 
bound to lipoproteins and subsequently transported primarily to the liver but 
also to the lungs, adrenal gland, bone marrow and the kidneys [Basu & 
Dickerson, 1996].
Vitamin K deficiency / toxicity
In adults, deficiency conditions of vitamin K are rarely seen [Ball, 1998]. 
However, there have been reported cases in infants up to 6  months old with 
respect to blood coagulation [Shearer & Bolton-Smith, 2000] Natural forms 
of vitamin K ingested in large amounts have produced no symptoms of toxicity 
[Olsen, 1987] However, menadione, a synthetic vitamin K compound has 
been shown, in acute doses, to cause oxidation of phospholipids in cell 
membranes [Esmon, 1993].
1.2 Inactive Ingredients In Dietary Supplements
Inactive ingredients have no dietary value. Tablet and capsule forms of dietary 
supplements usually have agents required for the formulation of tablets or 
bulking matter added to them. These agents are often called tabletting 
ingredients or base materials. The term base materials encompasses both 
dietary supplement forms and as such will be used in this research. Base 
materials often consist of a number of different compounds that contain 
essential and non-essential elements. Non-essential elements are elements
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that are been shown to have no essential biological function related to human 
health and elements whose possible essentiality has not yet been proven. 
Figure 11 illustrates the Periodic Table divided into the two groups, essential 
elements and non-essential elements.
Figure 11. Periodic Table of essential elements
H He
Li Be B C N 0 F Ne
Na Mg Al Si P S Cl Ar
K Ca Sc Ti V Cr Mn Fe Co Ni Gu Zn Ga Ge As Se Br Kr
Rb Sr Y Zr Nb Mo Tc Ru Rh Pd Ag Gd In Sn Sb Te 1 Xe
Cs Ba La Hf Ta W Rè Os Ir Pt Au Hg Ti Pb Bi Pô At Rh
Fr Ra Ac
* Key: essential, non-essential elements
**Source: Hazeii, 1985; Underwood & Mertz, 1987; Tsang & Nichols, 1988; Versieck & 
Cornelius, 1989; Groff et al., 1995.
1.2.1 Base materials
The type of base material used varies widely, depending upon the 
specification of the dietary supplement. Compounds used as base materials 
range from natural compounds such as rice flour and cellulose, to inorganic 
compounds, like dibasic calcium phosphate and silica. As some of their 
names suggest a number of base materials contain essential elements, for 
example calcium in dibasic calcium phosphate. It is evident then that the 
essential element content of base materials needs to be quantified so that 
their contribution to the overall concentration of an essential element in a 
dietary supplement can be calculated. This is important, as every element is 
toxic at a high enough dose. The French scientist Gabriel Bertrand 
established a law that states “for each biological system there is a range of 
elemental exposure, compatible with and essential for optimal function and
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that below and above that range, function deteriorates, resulting in disease 
and ultimately death" [Shroeder, 1973; Mertz, 1981]. A dose response curve 
is used to illustrate the effects essential nutrients have on living matter, this is 
presented in Figure 12 [Bertrand, 1912; Mertz, 1996].
Figure 12, Dose-response curve
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*Source: Shroeder, 1973; Mertz, 1981.
The concentration range for normal health is characteristic of each individual 
essential element. As the concentration of the element increases, deficiency 
decreases leading to normal health. Homeostasis occurs for a given 
elemental range until the body can no longer excrete the excess amounts, 
subsequently regulation breaks down and toxicity occurs [Hale et al., 1995]. 
In some cases toxicity can result in fatality.
In conclusion, the analysis of essential elements in base materials is required 
so that their contribution to the total concentration in a dietary supplement 
does not cause the total concentration of a essential element to exceed the 
safe intake of that essential element.
1.2.2 Non-essential elements
Two non-essential elements are to be analysed for in dietary supplements; 
namely cadmium and lead. Both of these elements were chosen due to their
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toxic nature. A number of the dietary supplements involved in this study 
contain organic compounds that may potentially be contaminated with 
cadmium or lead. For example Blocal™ and Spriocal™ contain a type of 
seaweed called Lifhthamnion Cafcareum that is harvested off of the West 
Coast of Ireland.
1.2.2.1 Cadmium
Cadmium is considered toxic to virtually every biological system [Kostial, 
1986]. Cadmium intakes vary according to geographical region; in Europe 
and the United States the average intake of cadmium is 15-20 pg/d, in 
polluted areas of Japan the cadmium intake can increase to > 2 0 0  pg/d 
[Kostial, 1986]. It is the differing concentrations of cadmium in soil that 
causes these regional variations. Contributions of cadmium pollution to soil 
originate from urban sewage sludge, waste disposal, coal combustion, iron 
and steel production, phosphate fertilisers and zinc production [Spivey Fox, 
1976]. Most government agencies consider the exposure to cadmium from 
food as highly important. There is particular concern connected to cadmium 
soil pollution and the following foodstuffs; rice, wheat, fruits and potato. 
These foodstuffs are known to selectively concentrate cadmium in their 
tissues [Frieberg et al., 1974, Kostial, 1986]
Cadmium toxicity
The main feature of cadmium toxicity is renal tubular dysfunction, this can 
cause elemental disturbance in bone, which is associated with "itai-itai" 
disease [Piscator, 1982]. Itai-itai disease is a condition of severe 
osteomalacia found in women living in cadmium polluted areas of Japan, in 
which the smelting of zinc and copper ores results in cadmium discharge into 
local rivers and rice paddies [Frieberg et al., 1974].
Oral exposure of cadmium can be divided into two groups, short-term and 
long-term. Short-term oral exposure to cadmium causes symptoms of 
nausea, vomiting and abdominal cramps [Kostial, 1986]. Long-term 
exposure to cadmium results primarily in the renal tubular proteinuria and
50
damage to absorptive cells of intestinal villi, changes in blood pressure, 
cardiac hypertrophy and kidney damage. The kidney is the first organ to be 
affected by cadmium accumulation [Lauwerys, 1979]. In pregnancy 
exposure to cadmium is associated with increased placenta! accumulation of 
cadmium and zinc causing reduced delivery of zinc to foetus and reduced 
birth weight [DH RHSS 41,1999].
Cadmium absorption and metabolism
Approximately 2% of cadmium in the diet is absorbed in the gastrointestinal 
tract [Bremner, 1979]. No,mechanism for absorption has been established 
but a number of dietary and physiological factors are expected to affect 
absorption. Cadmium absorption is increased when calcium and iron are 
present at low levels in the diet, due to the diminished competition of binding 
sites. Increased absorption is also observed in diets with low levels of zinc 
and copper [Kostial, 1986; DH RHSS 41, 1999]. In the human body, 
cadmium accumulates in liver and kidney where it is bound to metallothionein 
[Spivey Fox, 1982] Due to the lack of an effective homeostatic control 
mechanism cadmium accumulates over a lifetime in the two storage organs, 
the liver and kidneys. Continuous synthesis of metallothionein in the liver and 
kidneys causes cadmium to become trapped resulting in slow elimination of 
cadmium from the body [Kostial, 1986]. However, the largest losses of 
cadmium occur in the faeces [Bremner, 1979].
1.2.2.2 Lead
Lead is traditionally thought of as a toxic heavy metal. However, there has 
been two lead depletion experiments on rats that have produced evidence of 
retarded growth, decreased carcass and decreased tissue iron concentrations 
[Schwarz, 1974; Quarterman, 1986]. Sources of lead include food produce, 
drinking water (lead pipes were commonly used in the 1930’s and lead 
soldering on copper pipes was only banned in 1986), lead-glazed 
earthenware, car emissions, pica, cosmetics and coal combustion [MAFF, 
1972]. Staple food types (cereal, potato, and meat) have low levels of lead; 
high levels of lead can be found in certain shellfish [Quarterman, 1986].
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Lead levels in food produce, like other elements, are predominantly 
dependent upon the lead content of the soil. Soil adjacent to a major 
motorway has a higher content of lead than soil near no traffic system; this is 
illustrated in the Table 16. '
Table 16. Lead levels in food produce
Food produce Lead concentration (pg/g)
Uncontaminated soil Soil adjacent to M25
Cabbage 0.08 0 .1 2 2
Cauliflower 0.06 0.123
Sprouts 0.04 0.101
"Source: Ward & Savage, 199^L
Lead toxicity
Intakes of lead result in the inhibition of several enzymes. This inhibition 
impairs cytochrome production, heme synthesis, globin synthesis and induces 
erythrocyte membrane defects [Quarterman, 1986] Cytochrome production 
is impaired by the inhibition of all five enzymes involved in the process, but at 
differing extents. Two enzymes are strongly effected by lead, these are Ô- 
aminolevulinic acid synthetase (sulphydri enzyme) and ferrocheletase (a 
heme synthase) [Smith, 1976]. Both of these enzymes are found at the 
beginning and the end of cytochrome production (Figure 13) and their 
inhibition represents the major source of lead toxicity and causes virtually total 
impairment of the process.
Toxicity becomes a concern when the concentration of lead in blood reaches 
0.4 pmol/L, a level set by Centres for Disease Control and Prevention 
[Sargent et al., 1999]. Effects of lead toxicity in adults include optical 
atrophy, tremors, demyelination, slow conductance velocity and is frequently 
associated with cardiac disease [Quarterman, 1986]. In children advanced 
lead toxicity can result in encephalopathy with vascular damage and neuronal 
degeneration in brain.
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Figure 13. Cytochrome production
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Lead absorption and metabolism
Little is known about the processes of lead absorption and metabolism. 
Approximately 10% of lead from the diet is absorbed. This value has been 
shown to decrease in women. Animal studies indicate that phosphorous and 
sulphur in the diet will inhibit lead absorption in the gastrointestinal tract 
[Sargent et al., 1999]. Iron, zinc and magnesium also cause inhibition; 
enhancers of lead absorption include citrate, ascorbate, amino acids, protein, 
fat and vitamin D [Flanagan et al., 1982, Mahaffey & Michealson, 1980]. In 
the human body, lead is found in relatively high concentrations in bone, liver, 
kidneys, aorta and hair. Lead can be found bound strongly to mitochondria in 
respect to its protein, membrane and matrix [Quarterman, 1986].
1.3 Aim and Objectives of this Thesis
The dietary supplements market is expanding each year, as the Nation's 
population becomes more health conscious and accepting of alternative
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homeopathic medicine. At present the Government does not regulate the 
dietary supplement market in the same way it does for the drug and medicine 
market. There is no legislation that requires dietary supplements to be tested 
for safety before being sold to the general public. This lack of legislation also 
exists in some member states of the European Community and the United 
States. In the United States, the Federal Drug Agency (FDA) places the onus 
of testing dietary supplements, on the respective manufacturers and not itself, 
the governing body. Therefore, the aim of this research is to develop 
methods for the determination of active ingredients in dietary supplements. 
The main active ingredients in dietary supplements were Identified as 
essential elements and vitamins. The objectives are as follows: -
(1 ) to develop an analytical method for the determination of essential and 
non-essential elements in dietary supplements by inductively coupled 
plasma mass spectroscopy (IGP-MS);
(2 ) to validate the developed method with the use of certified reference 
materials and alternative analytical instruments (flame atomic absorption 
spectrometry):
(3) to compare the essential element content in dietary supplements stated on 
the label with the experimental data;
(4) to investigate the essential element content of inactive ingredients, namely 
base materials;
(5) to develop an analytical method for the measurement of fat-soluble 
vitamins in dietary supplements by high performance liquid 
chromatography (HPLC);
(6 ) to validate the developed method with the use of spike recoveries and 
comparison with the dietary supplements content stated on the label; and 
finally
(7) to investigate the bioavailability of zinc and iron in yeast-based and tablet- 
based dietary supplements.
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1.4 Thesis Structure
The layout of the thesis is as follows: -
Chapter 1 is an introduction to the use of dietary supplements. This chapter 
highlights the specific biological functions, absorption, metabolism and 
deficiency / toxicity syndromes of the active and inactive ingredients in dietary 
supplements.
Chapter 2 provides an account of the elemental analysis of dietary 
supplements by inductively coupled plasma mass spectrometry (ICP-MS).
Chapter 3 provides an account of the fat-soluble vitamin analysis of dietary 
supplements by high performance liquid chromatography (HPLC).
Chapter 4 is an investigation into the bioavailability of iron and zinc in yeast- 
based and tablet-based dietary supplements from three different 
manufacturers (Higher Nature, Nature's Own and superdrug).
Chapter 5 gives a discussion of the results obtained from this work and 
provides recommendations for further work.
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Chapter 2 Elemental Analysis
2.0 General Introduction
In this study there are seventy-four different dietary supplements. Each 
supplement is to be analysed for twelve elements (Mg, Ca, Cr, Mn, Fe, Co, Ni, 
Cu, Zn, Mo, Cd and Pb). The dietary supplements vary greatly in purpose, 
materials and packaging. They include: -
(a) combined vitamin and essential element supplements (e.g. Optimum 
Nutrition, Dino Chews and MaxiMulti);
(b) singular vitamin supplements (e.g. B-Vital);
(c) formulations for specific conditions (e.g. Menophase designed for 
menopausal and post-menopausal women); and
(d) herbal remedies (e.g. Biobifidus, contains 3 species of 
biobifidobacteria with fructo-oligosaccharides to stimulate growth of 
beneficial bacteria).
The dietary supplements in this study can be categorised by (a) use (as 
above), (b) manufacturer or (c) form (e.g. tablet, capsule, etc.). Since this 
research is dedicated to the analysis of essential, non-essential elements and 
fat-soluble vitamins, the seventy-four dietary supplements can be divided into 
those that contain essential elements (twenty-four) and fat-soluble vitamins 
(eighteen) as active ingredients and those that don’t. The results of this 
categorisation are shown in Table 17. The twenty-four dietary supplements 
with essential element concentrations stated on the label can be used for 
comparison with experimental data and hence provide an assessment criteria 
for quality assurance in the manufacturing process. This quality assurance 
criteria is deemed important due to the lack of legislation provided by the 
Government concerning dietary supplements.
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Table 17. Categorisation of dietary supplements by active ingredient
content
No essential 
elements or vitamins
Acidobifidus, Biobifidus, Boswellia, Cat's Claw and Aloe Vera, Cat's 
Claw Concentrate, Cat's Claw Herbal Tea, Cat's Claw Rainforest 
Bark, Cat's Claw Rainforest, Chlorella, Citricidal, Citricldal liquid 
concentrate, Citrilean, Citrimmune, Coenzyme Q10, Coloclear, 
Colofibre, Easigest, Ginkgo, Ginseng, L-Glutammrne, Lecithin, Maxi- 
Coenzyme-QI 0, Mexican Yam, Ocean Kelp, Organic Feverfew, 
Organic Linseeds, Paraclens, Probiogest, Supergar.
Essential elements & 
vitamins
Antioxidant Aces, Calcium ascorbate, Cal-M, Calma, Dino Chews, 
Dolamite, Immune Prevention, Maxi-Multi, Menophase, Optimum 
Nutrition, Osteo Food, Positive Nutrition, Pre-mens, Prostaflorum, 
Superantioxidant, Supernutrition Plus, Ultra C plus, Yang Drive, Zinc 
Citrate.
Essential elements Biocal, Biominerals, Candi Clear, Easy Iron, Easy Magnesium, Glucosammine, Se 200, Spirocal, Zinc 20mg with Copper.
Vitamins
p-carotene, Brain Food, B-vital, Cr as Polynicotinate, E400, Folacin, 
Herbal Clear,. Niacin, Pantothenic Acid, Rosehips C l 00, Super B 
Complex, Starflower oil 500mg/1 OOOmg, True Food C, Vitamin - B6. 
with Coenzyme, Vitamin B12.
Before analysis of dietary supplements takes place two aspects need to be 
considered. Firstly, the validation of the sampling, digestion and analysis 
methods using inductively coupled plasma mass spectrometry (ICP-MS). 
Validation can result from the use of certified reference materials (CRM’s) and 
alternative methods of analysis. The alternative method of analysis employed 
in this study is flame atomic absorption spectrometry (FAAS). This method 
will be discussed with ICP-MS in section 2.1. Sampling procedures are 
discussed in section 2.4. The analysis of CRM’s and an In-house reference 
material is discussed in section 2 .6 .
Secondly, the contribution of essential elements found in base materials or 
inactive ingredients towards the concentration stated on the label for the 
respective essential element, needs to be quantified. The question “is there a 
significant contribution to the essential element concentrations from inactive 
ingredients?” needs to be answered. The elemental analysis of inactive 
ingredients and their calculated contribution to active essential elements is 
presented in section 2.11. Finally, the analysis of all seventy-four dietary 
supplements Is presented in section 2.10.
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2.1 Instrumentation
Two types of instrumentation will be used in the determination of essential 
elements in dietary supplements, namely, inductively coupled plasma mass 
spectrometry (ICP-MS) and flame atomic absorption spectrometry (FAAS). 
Each method has its own characteristic sample preparation requirements, 
elemental detection limits, linear dynamic range, sensitivity and potential 
interference problems.
2.1.1 Inductively coupled plasma mass spectrometry
inductively coupled plasma mass spectrometry (ICP-MS) was the main 
technique used for analysing essential elements in this research. In 
comparison, to flame atomic absorption spectrometry (FAAS), ICP-MS is 
associated .with greater elemental sensitivity, a large linear dynamic range 
(typically over 1 0 ® orders of magnitude) and multi-element capability.
In general, sample solutions are introduced to the plasma as an aerosol in a 
stream of argon gas. The argon plasma heats the aerosol to approximately 
7000 K where the droplets are consequently desolvated, vaporised / atomised 
and ionised before extraction into a series of high vacuum compartments. 
The positively charged ions are collected and focused into a quadrupole mass 
analyser, which separates the ions according to their mass-to-charge ratio 
(m/z). In the case of a Finnigan MAT SOLA instrument, the separated ions 
exit to either a Faraday Cup detector (Faraday detector) or a Channeltron™ 
Electron Multiplier detector (CEM detector). The two detectors on the 
Finnigan MAT SOLA instrument enable a linear dynamic range of over 1 0  
orders of magnitude [Finnigan MAT Ltd., 1993a].
An ICP-MS instrument can be divided into six main units: - sample 
introduction; inductively coupled plasma (ICP); interface; focusing unit; 
quadrupole and data acquisition. Each unit can be identified in Figure 14, 
which was reproduced with permission from Lyndon Dudding, 2000.
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2.1.1.1 Sample introduction
There are several different forms of sample introduction including ultra-sonic 
nébulisation (USN) for liquid samples, electrothermal vaporisation (ETV) for 
small volumes of liquid samples, laser ablation for solid samples and hydride 
generation for volatile hydrides. The main form of nébulisation for liquid 
samples is pneumatic nébulisation (PN). The sample solution is introduced at 
a constant rate to a high velocity argon gas stream, producing an aerosol of 
fine droplets. A peristaltic pump enables a constant rate of sample solution to 
reach the plasma. Although transport efficiency is low in pneumatic 
nébulisation, usually 1%, the advantages of convenience and reasonable 
stability outweigh this disadvantage.
There are several different types of nebuliser, including the V-groove, 
concentric and cross-flow. The V-groove nebuliser was used during this 
research as it less prone to blocking compared to the other two nebulisers 
with sample solutions of a relatively high percentage of dissolved solids 
[Williams, 1989]. A V-groove nebuliser is illustrated in Figure 15.
Figure 15. A V-groove nebuliser
Sample Injector
/     ^ ____
—  Gas In
A
Coolant Intermediate 
Gas In Gas In
*Source: Dudding 2000
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The sample solution enters the nebuliser at one end and emerges at the 
other, where there is a V-shaped groove in the body. The sample runs down 
the groove and is converted into an aerosol at the point where the cross-flow 
exits.
The fine aerosol of sample solution is carried to the spray chamber where 
droplets larger than 10 pi in size are removed. This removal occurs when the 
gas flow carrying the aerosol undergoes a sharp change in direction; the 
smaller droplets are able to manoeuvre the corner, but the larger droplets can 
not and consequently fall out to waste. A uniform droplet size is 
advantageous as it provides even loading of the plasma which reduces 
condensed-phase vaporisation interferences, i.e. signal depression or 
enhancement due to differences in the rate of release of metal atoms in the 
plasma [Smith & Browner, 1984]. It also prevents high solvent loading of the 
ICP that may result in a significant reduction of its excitation properties 
[Boumons & Boom, 1982].
The spray chamber is usually made of quartz and has an outer jacket in which 
coolant is pumped, so that a low temperature is maintained. The low 
temperature, typically 10®C, is required to lessen the effect of polyatomic 
interferences, specifically "^ Ar^ ^O^  on ^Fe"^.caused by the combination of 
water and argon gas.
2.1.1.2 Inductively coupled plasma (ICP)
An argon plasma is the ionisation source of ICP-MS and is maintained by the 
interaction of a radio frequency (RF) field and ionised argon gas as illustrated 
in Figure 16. The formation of the plasma begins with the passing of auxiliary 
argon gas through a quartz tube. At the tip of the quartz tube a water-cooled 
copper induction / load coil is supplied with a RF power current (usually 27 - 
40 MHz) producing an oscillating magnetic field.
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Figure 16. Plasma
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The plasma is ignited by a spark from a Tesla coil that creates free (seed) 
electrons. These electrons couple with the magnetic field of the coil and 
subsequently gain enough energy to ionise the argon atoms by collisional 
excitation. This process occurs simultaneously.
Due to the high temperatures generated (7000 K) a second stream of argon 
gas is used to provide a vortex flow of argon, which cools the inside of the 
torch walls. The torch used for this research is based on a Scott-Fassel 
design and is made from quartz. This second stream of argon has two main 
effects on the plasma; namely, it helps stabilise the plasma and radially 
centres it. The characteristic toroidal shape of the plasma is produced by the 
“skin-effect” at a frequency of 27 MHz [Willard et al., 1988]. This toroidal 
shape lengthens the resident time of the sample solution in the interior high 
temperature zone. The sample solution enters through an innermost tube 
(injector) of the torch. At the initial radiation zone various species have 
become atomised. As they reach the normal analytical zone all of these
species are atomiseçl and ionised creating a high population of singly charged 
ions. The ions are sampled from this normal analytical zone [Gray, 1986a].
There are other types of plasma commercially available, including: the direct 
current plasma (DCP), which is more popular with ICP-AES; and microwave 
induced plasma (MIP), which is often used for samples of a gaseous nature.
2.1.1.3 Interface
The interface consists of a system of cones devised to extract an ion beam 
from the plasma to the quadrupole mass analyser. The Finnigan MAT SOLA 
ICP-MS instrument has a three-cone system with a pressure gradient that 
drops from ambient to approximately 2x10"® mbar. The cones are typically 
made from'nickel or platinum, in this research the former was used. The 
three cones consist of: -
(a) sampling cone -  positioned 14 mm from the end of the torch and has 
an aperture of 1 .1  mm;
(b) skimmer cone -  positioned 8  mm from the sampling cone and has an 
aperture of 0 . 8  mm (the pressure in the interspace between the first 
two cones is 2 - 3 mbar); and
(c) accelerator cone -  positioned 8  mm from the skimmer cone and has 
an aperture of 1 mm, this cone is unique to the SOLA instrument and 
its function Is to focus the ion beam by the application of a negative 
charge (the pressure after the third cone is 1 x 1 0 ”^  mbar).
In conclusion, the difference in temperature and pressure between the two 
ends (plasma 8000 K, 1 atm; quadrupole room temperature (RMT), 10"® 
mbar) is overcome by this three cone system interface.
2.1.1.4 Ion focusing unit
The ion focusing unit conveys the ions leaving the interface to the quadrupole 
mass analyser. The unit is based upon Turner Optics and consists of 
electrostatic lenses placed so that the ion beam is directed from the interface
63
to the mass analyser Each lens consists of a number of electrodes that are 
applied with controllable potential. The use of electrostatic lenses maximises 
the number of ions reaching the quadrupole mass analyser.
2.1.1.5 Quadrupole mass analyser
A quadrupole mass analyser separates the ion beam according to the ions 
mass-to-charge (m/z) ratio. Four metal straight rods suspended parallel to 
each other and equidistant from the ion beam axis form a quadrupole mass 
analyser. Opposite pairs of rods are connected together, to one pair a positive 
direct current potential is applied, to another pair a negative potential is 
applied. Each pair is applied with a radio-frequency (RF) potential of the 
same amplitude but of opposite sign (i.e. 180° out of phase). Specific 
selection of the radio frequency (RF) and D.C. voltages enables ions of the 
desired m/z ratio to assume a stable path through the rods. Ions of undesired 
m/z ratio are deflected towards the rods, neutralised and lost.
2.1.1.6 Data acquisition
The Finnigan MAT SOLA ICP-MS has two detection systems, namely, the 
Channeltron™ Electron Multiplier (CEM) and the Faraday Cup (Faraday).
The CEM consists of a curved tube that flares out to a funnel at one end. On 
the inside of this curved tube is a resistant coating which has a negative 
potential applied to it at one end and is earthed at the other. Positive ions 
from the ion beam strike the coating causing an ejection of one or more 
secondary electrons from the surface, which are accelerated down the tube. 
Further collisions of the secondary electrons with the coated walls occur due 
to the curved, flared shape of the tube. From these collisions electrons are 
released which results in a cascade of electrons. At the bottom of the tube 
the space charge fills up with these electrons. Eventually, the space charge 
becomes sufficiently full of electrons causing the inhibition of further 
multiplication. This action makes sure that all outward pulses are of equal 
size. The electrons are then transferred to a collector electrode and used to 
produce an analogue signal.
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There are several advantages to a CEM detector including, robustness, a long 
life, high electrical gain, fast response and low background counts. However, 
there is one major disadvantage, the CEM detector has a low tolerance to 
high currents generated by strong ion beams. Therefore, ion beams greater 
that 10® ions s’ '^ should not be measured by the CEM detector. Instead the 
Faraday detector should measure ion beams of this intensity.
The Faraday detector is a metallic plate maintained at a relatively high 
potential compared to the remainder of the Instrument and this allows ions to 
be captured. From the quadrupole mass analyser the ions pass through a 
collimator slit and through one or more suppresser grids or electrodes where 
they finally strike the Faraday Cup. The potential of suppresser electrodes 
ensures that any secondary ions emitted during the bombardment of the cup 
are returned to the cup. The current produced from these bombardments is 
converted to a potential then subsequently amplified and transmitted to a 
read-out device.
2,1.2 Flame atomic absorption spectrometry
Free elements in the ground state will absorb electromagnetic radiation of a 
characteristic wavelength. Within a particular concentration range there exists 
a linear relationship between the degree of absorption and concentration of 
the element present. This relationship is described by the Beer Lambert Law 
illustrated in equation 6 .
A = E . c. I eqn (6)
Where, A = Absorbance, E = molar absorptivity of the sample, c = 
concentration of analyte and 1 = path length
A flame atomic absorption spectrometer measures the peak absorption of an 
analyte. It can be divided into five components, namely, the light source,
65
sample introduction, flame, monochrometer and the detector. Figure 17 
shows a schematic of a FAAS instrument.
Figure 17. A Flame Atomic Absorption Spectrometer
Light source Monochromator
Flame
NebuliserSample
Detector
Read-out Device
2.1.2.1 Light source
The function of a light source is to emit a narrow line of radiation, which is 
required to obtain an analytical signal of low noise level for better elemental 
precision and detection limits. The most popular commercially available light 
source is a hollow cathode lamp. The main feature of this light source is a 
hollow cylindrical cathode, which is lined with the element of interest. The 
lamp is filled with an inert gas, usually argon or neon at a pressure of 2  torr. 
When sufficient electrical current (usually 2 - 3 0  mA) is passed through the 
cathode the inert gas is ionised and the ions accelerate towards the anode, 
where they collide with the metal coating. From the collision, metal ions from 
the cathode are ejected and form an atomic vapour. The metal ions absorb 
energy from colliding with inert gas ions and are consequently elevated to an 
excited state. As this transition occurs, ground state resonance lines 
characteristic of each element are emitted and pass through the flame to the 
monochromator. A great advantage of modern hollow cathode lamps is their 
short warm-up period [Ebdon et al., 1998]. Multi-element lamps are now 
commercially available but in this research only single element lamps were 
used for greater specificity and sensitivity.
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2.1.2.2 Sample introduction
The sample is drawn up the sampling tube to the nebuliser by a low pressure 
created at the capillary sampling tube from a stream of carrier gas moving into 
the spray chamber. At the nebuliser a fine aerosol is produced and droplets 
of a diameter greater than 5 pm are removed by collisions with the sides of 
the spray chamber. This waste eventually ends up at the drain, which is 
sealed to provide a back-pressure for the flame. The fine uniform droplets are 
carried into the flame by an intimate mixture of a carrier gas and fuel gas. As 
in ICP-MS it is critical that there is a steady continuous flow of sample towards 
the flame. There are a number of commercial nébulisation units available. 
The one used in this research was a pneumatic nebuliser.
2.1.2.3 The* flame
The main function of the flame is to produce ground-state atoms. The sample 
solution enters the flame and is desolvated, vaporised and atomised. There is 
no need for excitation as in ICP-AES or ionisation as in ICP-MS. Flames are 
non-uniform in composition, length and cross-section and consist of four main 
sections. The most important part of the flame is the interconal zone, 
illustrated in Figure 18. The interconal zone has thermodynamic equilibrium 
and is therefore used as the analytical window for the measurement of the 
resonance lines.
Figure 18. The Flame
Secondary combustion zone
Interconal zone
Primary combustion zone
Pre-heating zone
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There are several different mixtures of fuel and oxidant used to form a flame. 
The most commonly used mixture is an air / acetylene flame. In experiments 
where analytes form a large number of refractory compounds or where 
interferences are encountered then a nitrous oxide / acetylene mixture is 
preferred. In this research an air / acetylene flame was used with a 100 mm 
slot burner. The use of a slot burner enables a greater portion of the flame to 
be used for analysis, thereby increasing the path length. The burner on the 
PE 5000 (Perkin Elmer FAAS) instrument was a Premix design with a Ryton 
mixing chamber that is internally coated with polypropylene. The average 
temperature of an air / acetylene flame is 2300 °C and it is convenient and 
safe for analysing wavelengths above 2 0 0 0  Â with minimal chemical 
interference problems.
2.1.2.4 Monochromator
The monochromator isolates the resonance lines emitted by the hollow 
cathode lamp and analyte from the non-absorbing lines situated close to its 
source spectrum. It is placed in the optical path of the flame. There are two 
types of monochromator, namely prism and grating monochromators. Both 
types discriminate between atomic emission and atomic absorption resonance 
lines occurring at the same wavelength. The prism monochromator achieves 
this by a series of prisms, while the light entering a grating monochromator 
falls on the grating by reflection upon a mirror and is reflected out through the 
exit onto the detector. The PE 5000 FAAS instrument has a Czerny-Turner 
monochromator system. The grating selection of this system was 
automatically controlled by the microcomputer depending upon the 
wavelength range (i.e. UV or visible).
2.1.2.5 Detector
The photomultiplier tube is the most commonly used detector in FAAS 
instruments. Photomultiplier tubes convert the light signal to an electrical 
signal for direct readout. The intensity of the current produced is directly 
proportional to the absorption and therefore proportional to the concentration 
of the analyte. The current is converted to a voltage using a high resistance
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feedback loop of a high-input-impedance operational amplifier. The 
processed signal is presented to the analyser by meter, recorder or digital 
system. The detector system in the PE 5000 is a double-beam, time shared 
and space-shared photometer system. There is an optional double beam 
UV/vis background corrector and a deuterium arc lamp is used in all UV 
measurements.
2.2 ICP- MS Analysis Conditions
The ICP-MS used in this research is a Finnigan MAT SOLA ICP-MS 
instrument. Pneumatic nébulisation was used with liquid sample introduction 
in conjunction with a V-groove nebuliser. This nébulisation system was 
chosen due to the possibility of the sample solutions containing a relatively 
high amount of dissolved solids. This section outlines the conditions for the 
Finnigan MAT SOLA ICP-MS during analysis, including the choice of isotope 
with respect to interferences, limits of detection, use of internal 
standardisation and specific operating conditions.
2.2.1 Interferences
There are two types of interferences inherent .to ICP-MS: spectroscopic and 
non-spectroscopic. Spectroscopic interferences can be sub-divided into two 
groups isobaric and polyatomic. Both groups enhance analyte signal, which 
can lead to incorrect quantitative interpretation of analyte data. Non- 
spectroscopic interferences cause suppression or enhancement of analyte 
signal through a number of processes.
2.2.1.1 Spectroscopic interferences - isobaric
Isobaric interferences are defined as “an interference due to isotopes of 
another element having the same mass number”. Table 18 presents the 
isobaric interferences of the twelve analytes under investigation in this study.
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Table 18. Isobaric Inteferences of analytes
Mass Number Analyte isotope . (Relative intensity %)
Interfering element 
. (Relative Intensity %)
24 Mq (79.0)
25 Mq (10.0)
26 Mg (11.0)
42 Ca (0.7)
43 Ca (0.1)
44 Ca(2.1)
48 Ca (0.2)
50 Cr(4.4) V (0.3), Ti (5.4)
52 Cr(83.5)
53 Cr(9.5)
54 Cr (2.4), Fe<5.8) Fe.(5.8), Cr(2.4)
55 Mn (100)
56 Fe (91.7)
57 • Fe (2.2)
58 Fe (0.3), Ni (68.3) Ni‘(68.3), Fe (0.3)
59 Co (100)
60 Nr (26.1).
a i Ni (1.1)
62 Ni (3.5)
63 Cu (69.2)
64 Zn (30.8), Ni (0.9) Ni (0.9), Zn (30.8)
' 65 Cu (30.8)
66 Zn (27.9)
67 Z n (4 .t)
68 Zn (18.8)
70 Zn (0.6) Ge (20.5)
92 Mo (14.8) . Zr (17.2)
94 Mo(9.3) Zr (17.4)
95 Mo (15.9)
96 Mo (16.7) Ru (5.5)
97 Mo (9.6)
98 Mo (9.8) ' Ru (1.9)
100 Mo (9.6) Ru (12.6)
106 Cd (1.3) Pd(27.3)
. 108 Cd (0.9) Pd(26.5)
110 Cd (12.5) Pd (11.7)
111 . Cd (12.8)
112 Cd(24.1) 8n (1.0)
113 Cd (12.2) ' In (4.3)
■ 114 Cd (28.7) Sn (0.4)
116 Cd (7.5) Sn (14.5)
204 Pb(1.4) Hg (6.9)
^ 0 6 Pb (24.1)
207 Pb (22.1)
208 -pb (52.4)
"Source: V^'ndercasteele & Block, 1993
As an example, iron has four isotopes. Two of these isotopes have isobaric 
interferences, namely ^Fe^ and ^ F e \ Zinc has five isotopes, the . most
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abundant isotope- ^ Z n \ has an isobaric interference. Therefore, zinc 
measurements will have to occur using a lower naturally abundant isotope, for 
instance Z^n"^ .
2.2.1.2 Spectroscopic interferences -  polyatomic
Polyatomjc interferences are produced from the formation of compounds that 
collectively have an identical mass number to the analyte isotope. This 
includes the formation of oxide, hydroxide and doubly charged ions with the 
same mass number as the analyte isotope. Most polyatomic ions consist of 
only two ,components, one of which is typically A^r"*" as it is the heaviest 
nuclide found at high concentrations in the plasma. Therefore, important 
background peaks are only observed below mass 81.
The majority of polyatomic interferences arise from elements added to the 
plasma by dilute acid sample solutions. Nitric acid is the preferred mineral 
acid for digestion and dilution of samples. By using nitric acid the respective 
polyatomic interference are reduced as only the nitrogen concentration in the 
plasma is greatly increased. Due to nitrogen’s high first ionisation energy 
(14.53eV| this increase only yields small peaks from positive ions 
[Vandercasteele & Block, 1993]. Polyatomic inteferences of analytes arising 
from a cjilute (5%) nitric acid sample solution are stated in Table 19. 
Polyatomic interferences produced by the acid solution can be corrected for 
by matrix matching the samples and calibration standards and by the use of a 
reagent blank.
Table 19. Polyatomic interferences from acid solution
Analyte isotope (Rel. Int. %) H2O (5%HN03)
'"Ca* (2.06)
(83.76)
'^Mn*(1 0 p) '^Ar14NH*
°'Fe* (2.2) ‘^Ar'“OH*
"Source Va^idercasteele & Block, 1993
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Interferences from oxides and doubly charged ions can be corrected for by 
the use of a reagent blank correction only if the sample itself does not contain 
a high amount of the respective interfering element. Table 20 illustrates the 
only oxide and doubly charged ions that can interfere with the twelve analytes.
Table 20. Polyatomic interferences from oxide and doubly charged ions
Analyte isotope Interferences
'“Ca" d^ sr^ ", B»sr^ "
‘"Co" '“Ca’“=0"
■"Cu" 4/Ti'BO"
■^n" Bi>Pjieo+, B‘V^ '^ 0 ", ‘"Cr^‘^ 0 ",
■‘ ’Cd"
*Source Vandercasteele & Block, 1993
From the interferences stated in Table 20 only molybdenum is found in dietary 
supplements in relatively high amounts. An experiment was carried out to 
prove that the formation of ^ IVIo%* did not affect the signal of
polyatomic interference on
Solutions of increasing molybdenum concentration were run while analysing 
for ^^^Cd\ The results of this experiment are firesented in Figure 19. The 
cadmium signal (^ ^^ Cd^ ) . increased with the formation of molybdenum oxide 
that resulted from the high concentrations of molybdenum in the sample 
solutions. This polyatomic interference was not corrected for as the 
concentration of molybdenum in dietary supplements is low (typically, lOmg/g) 
resulting jn an insignificant contribution to the cadmium signal. Therefore, 
sample solutions after dilution will not contain concentrations of molybdenum 
greater tlian 50 ng/ml and as such will not affect the ^^ C^d signal.
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Figure 19. polyatomic interference on
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2.2.1.3 Non-spectroscopic interferences
High levels of conœmitant elements and un-dissolved solids in a sample 
matrix can cause non-spectroscopic interferences. High concentrations of 
salts can gradually block the sample uptake tubing, the injector or the 
aperture of the sampler cone. Over time these blockages can lead to a 
decrease of analyte intensity. Therefore, the maximum acceptable level of 
dissolved solids for solution nébulisation is 1% [Williams & Gray, 1988].
High levejs of easily ionised concomitant elements in the sample matrix can 
cause suppression of the analyte signal by ionisation suppression and space 
charge effects in the plasma. Easily ionised elements contribute strongly to 
the electron density of the plasma causing a shift in the ionisation equilibrium. 
Hence aqalyte ions are ionised to a lesser extent [Vandercasteele & Block, 
1993] Large positive ions from the matrix also cause a knock-out effect, 
whereby the lighter analyte ions are deflected from the optical path by 
collisions with the heavier positive ions. This knock-out effect is also called 
the “space charge" effect. Sodium is a typical concomitant element as it has a 
low first ionisation energy (5.193 v) and is a heavy positive ion. Calcium at 
high concentrations is also known to cause signal suppression.
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Figure 2^ illustrates the analyte signals at increasing concentrations of 
sodium. Figure 21 shows the same analyte signals but corrected by an 
internal standard (^ ^^ In*).
Figure 20. Sodium suppression
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Figure 21. Correction of Sodium suppression with internal standard
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Figures 22 and 23 show selected analyte signals that illustrate signal 
suppression with increasing calcium concentrations and the same signals 
corrected by an internal standard (^ ^^ In*). To overcome non-spectroscopic 
interferences standards are matrix-matched with the sample solution or an 
internal standard is used.
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Figure 22. Calcium suppression
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Figure 23- Correction of calcium suppression with internai standard
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2.2.2 internai standardisation
Internai standardisation is based upon the assumption that “an internal 
standard responds in a similar manner to the analyte, to any variable that may 
affect the detector response”. If all variables are controlled a constant signal 
for the internal standard ion should be produced. When variables are added 
the analyte and the internal standard should be equally affected so that a ratio 
between the intensities of the analyte and the internal standard can be used 
as the analyte signal. Internal standardisation not only corrects for 
suppression and enhancement of major interfering ions but also for signal
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drift. In ICP-MS an internal standard needs to have a similar mass number 
and first ionisation energy to the analyte under investigation. An internal 
standard is added to both calibration standards and sample solutions at equal 
concentrations. Three elements were investigated for possible use as internal 
standards; these were 209gj+ Germanium, indium and
bismuth were chosen as candidates because they satisfy the criteria 
mentioned above and this is illustrated in Tables 21 and 22.
Table 21. ionisation Energies of Analytes
Analyte Mg Ca Cr Mn Fe Co
Mass no. 26 44 52 55 57 59
lEeV 7.65 6 . 1 1 6.77 7.43 7.87 7.86
Analyte Ni Cu Zn Mo Cd Pb
Mass no. 60 63 / 65 6 6 95 1 1 1 208
lEeV 7.64 7.72 9.39 7.06 8.99 7.42
*Source: Emsley, 1991
Table 22. Ionisation Energies of Proposed Internai standards
*Source: Ei
Analyte Ge In Bi
Mass np. 74 115 209
IE (eV)‘ 7.88 5.79 7.29
: rjisley, 1991
The GEM detector was chosen to study the proposed internal standards. A 
50 pg/L solution of germanium, indium and bismuth was measured at 5 
minute intervals for 4 hours, then at 10 minute intervals for a further 2 hours. 
The results are illustrated in Figure 24. This experiment also evaluates the 
stability of the analyte signal over a typical analysis period.
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Figure 24. CEM stability experiment
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The relative standard deviations (RSDs) of the proposed internal standard 
signals can be used to find the most ‘stable’ internal standard (Figure 24). 
The RSD values are ^"Ge" ± 4%, ” ®ln" ± 4% and “ ^Bl* ± 6 %, All three RSDs 
are below ± 10%; germanium and indium both have values below 5% (± 4%). 
A number of studies have investigated the use of a single internal standard for 
multi-element analysis and have all suggested ^^ ®ln* due to it’s absence in 
most matrices and its high natural abundance, 95.7% [Jarvis et al., 1992]. 
The high natural abundance of ^^ I^n is of particular important in this research, 
as measurements will be carried out on both the CEM and Faraday Cup 
detector. Consequently, indium (^ ^^ In*) was chosen as the internal standard 
for the elemental analysis of dietary supplements.
A standard solution of the twelve analytes (50pg/L) was run under the same 
operating conditions used in the stability experiments with the addition of an 
^^ I^n* internal standards solution (lOOpg/L) added on-line via a t-piece. The 
analyte signals for each measurement were corrected for by the internal 
standard before the relative standard deviation (RSD) values of each analytes 
set of measurements was calculated. The RSDs were calculated to show any 
variance in the analyte signal after internal standardisation, these values are 
reported in Table 23.
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Table 23. RSD values of the analyte and internal standard signals
Analyte RSD% Analyte RSD%
“ Mg" 4 '"Ni* 8
■“Ca" 7 '"Cu* 3
“ Cr" 2 ^Zn* 2
*Mn" 2 ""Mo* 4
■"'Fe* 9 ”^ Cd* 2
■"Co* 2 A«pb+ 2
All of the RSD values stated in Table 23 are found to be below ± 10%, as 
such they confirm that ^^ I^n* is an adequate choice for the internal standard.
As the Faraday Cup detector was also to be used for the analyte 
determinations, a stability experiment was carried out on the detector with a 
Img/L indium solution. Measurements were taken every 5 minutes for 4 
hours and then every 1 0  minutes for a further 2  hours, these are reported in 
Figure 25. The relative standard deviation of the ^^ I^n* signal by the Faraday 
detector is ± 10%. This is also of adequate precision.
Figure 25. Faraday Cup Stability Experiment
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In all experiments the internal standard solution was added on-line via a t- 
piece. On-line addition negates the need for individual sample spiking. It is of
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particular use when having to spike a large number of samples with several 
internal standards and yields a more reproducible concentration. The 
disadvantage to on-line addition is a dilution factor (x2 ) reducing elemental 
sensitivity.
2.2.3 Limits of detection
The detection limit is defined as “the concentration of analyte that gives a 
signal, significantly different from the ‘blank’ or background signal [Willard et 
al., 1988]. The International Union of Pure & Applied Chemistry (lUPAC) 
states that detection limits should be defined in terms of either concentration 
or amount and recommends the use of Equation 7 [Vandercasteele & Block, 
1993]. The numerical constant k is recommended to be 3, so that 99,87% of 
measurements will fall within this range if a normal distribution. This definition 
of the limit of detection is also called the lower limit of detection. The upper 
limit of detection or the limit of determination is the smallest signal that can be 
quantitatively measured and where k is equal to 6 . Using Equation 7, with k 
equal to 6  the analyte determination limits for both detectors are given in 
Table 24.
X l  = Xb + kse eqn (7)
where, X l = smallest measurable signal, X b = mean of blank measurements, k 
= a numerical constant and se = standard deviation of blank measurements.
2.2.4 Calibration
A series of standards with known concentrations were used to produce a 
calibration line. Unknown concentrations in samples can then be calculated 
from the best line of fit (linear regression) data. The calibration standard 
range should encompass the unknown analyte concentration. If the unknown 
analyte concentration falls above the calibration range a dilution of the sample 
solution should be carried out. Elements of a ‘high’ concentration were 
determined using the Faraday detector. Elements with relatively low
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concentrations were analysed for using the CEM detector. Since both 
detectors were used on the Finnigan MAT SOLA ICP-MS, two sets of 
standards were required.
Only five analytes were analysed by the Faraday detector, these were 
57Fe+, ^Mn"  ^and ^^ Zn"". All the analytes were measured using the CEM
detector (^Ga^ ^^^Cd\ % o \  ^ C r \ ^ C u \ ^^Fe\ ^M g \ ^ M n \ ^ M o \ ^ N i\ 
^Pb^ and ^Zn*). Table 25 states the calibration standards for both detectors 
in all ICP-MS determinations.
Table 24. Analyte determination limits for Faraday Cup and CEM
detectors
Analyte Faraday Cup (mg/L) CEM (ug/L)
Cadmium (^ ^^ Cd'') <1 . 0 0.7
Calcium rC a ") 2 . 0 5.3
Cobalt rCo-^) 0.5 1.4
Chromium f^ ^Cr^ ) 0.5 3.0
Copper rCu+) 0.5 0 . 1
Iron Fe*) 3.0 6.4
Lead (^ P b l <1 . 0 0.3
Magnesium (^ M^g"") 0.5 13.4
Molybdenum (^Mo*) <1 . 0 0.5
Manganese (^Mn‘*‘) 0.5 1.9
Nickel (^ N il 1 . 0 15.4
Zinc C^ Z^n") 1 . 0 0 . 1
Table 25. ICP-MS Calibration Standards
Standards Faraday Cup (pg/ml) CEM (ng/ml)
1 0.5 5.0
2 1 . 0 1 0 . 0
3 2.5 2 0 . 0
4 5.0 50.0
5 1 0 . 0 1 0 0 . 0
6 - 2 0 0 . 0
2.2.5 Operating conditions
The two most important ICP-MS operating conditions are the plasma RF 
power and the nebuliser flow-rate. By altering the nebuliser flow-rate the zone
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containing the maximum density of ions is moved inside or outside the 
sampling zone. This movement in position is based upon the assumption that 
an equal residence time is required before ionisation occurs. If the flow-rate is 
lowered the zone shifts towards the induction coil, as at a reduced flow-rate 
the residence time of the analyte ions is obtained at a shorter distance. If the 
RF power is increased the zone moves towards the load coil, as a shorter 
residence time is required to achieve ionisation due to the higher power. 
Consequently, a higher nébulisation rate is required to shift the zone of 
maximum density back towards the tip of the sampling cone.
A compromise of operating conditions (RF power, nebuliser gas flow-rate and 
sampling depth) Is required for simultaneous multi-element determinations. 
Because the optimum operating conditions are nearly the same for all 
elements, near optimum results can be obtained under these compromised 
conditions [Vandecasteele & Block, 1993]. The operating conditions used 
are stated in Table 26.
Table 26. Finnigan MAT SOLA iCP-MS operating conditions
Operating conditions
Incident power; 1400 kW Reflected Power: < 5 W Nebuliser pressure: 26 bar
Coolant flow: 15 Lmin'^ Intermediate flow: 1 
cm^ min"^
Nebuliser flow: 0.95 Lmin’”*
Spray chamber temp: 2 ®C Cooling water temp: 2 ®C Pump speed: 15 rpm
Resolution: 34 Y Steer: 5.81 Y Deflection: 4.78
X Deflection: 6.59 Extraction: 2.40 Focus: 5.01
Match: 4.50 Pole bias: 4.50 Filter: 10.00
Interspace: 10.00 Discriminator: 0.1 Multiplier voltage: 5.00
Vacuum 1:1.0x10"^ mbar Vacuum 2: 3.1 x 10'® mbar Vacuum 3: 3.6 x 10'® mbar
2.2.6 Summary
For the following analytes ®^Mg'*', "^ Ca"", ^^ Cr"^ , ^Mn^, ^^ Fe^ , ^Co"", ^NF, ^Cu*, 
^Zn*, ^^ C^d"" and °^®Pb’^ , calibration standards of 5, 10, 20, 50, 100 and
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200 pg/L were used for the CEM detector with a 50 pg/L indium internal 
standard solution. Calibration standards of 0.5, 1 .0 , 2.0. 5.0 and 10.0 mg/L 
for ^^ Mg"", "^ Ca"", ^Mn'", ^Cu"  ^and ^Zn"" were used for the Faraday Cup
detector measurements with a 2.5 mg/L indium internal standard solution.
2.3 FAAS Analysis Conditions
A PE5000 FAAS instrument was used for the determination of five analytes. 
Instrument conditions were chosen for the attainment of high sensitivity for 
each analyte. An air / acetylene gas mixture was used for all measurements. 
This fuel mixture was chosen for its minimal interferences with the analytes, 
but primarily for its comparative safety. Determinations of the analytes were 
carried out using the primary wavelength of each analyte, which corresponds 
to the 1 ®‘ transition from ground state to the excited state in a neutral atom. 
The highest appropriate applied current was used for each hollow cathode 
lamp. Single element cathode lamps were used as they are considered to be 
more sensitive than multi-element cathode lamps. The wavelengths and 
applied currents used for each analyte are shown in Table 27.
Table 27. Analyte wavelengths and applied currents
Analyte Wavelength (nm) Applied current (mA)
Iron 248.3 15
Magnesium 285.2 6
Manganese 279.5 1 2
Zinc 213.9 1 0
The number of analytes has been reduced for FAAS analysis, this is 
discussed in section 2 .8 , but briefly the analytes were chosen principally 
because of their high concentrations in CRMs and dietary supplements.
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2.3.1 Interferences
There are four types of interferences associated with FAAS. These 
interferences are background absorption, spectral line, vaporisation and 
ionisation interferences.
2.3.1.1 Background absorption
Analytes and other species absorb radiation emitted from a hollow cathode 
lamp in the flame. Some species, for example metal oxides, hydrogen 
molecules, hydroxyl radicals and portions of fragmented solvent molecules 
are capable of broad band absorption. Consequently, this absorption 
contributes to background absorption and results in the direct enhancement of 
the analyte signal and hence a corresponding error in the analytical result. 
Background absorption is corrected for by the use of a matrix blank, the use 
of a broad band continuous source in conjunction with a hollow cathode lamp 
and by the Zeeman effect.
2.3.1.2 Spectral line interference
Spectral line interference occurs when the analytes line overlaps with another 
element’s line and the two lines can not be easily resolved. This type of 
interference is more severe in flame atomic emission spectroscopy (FAES) 
than in FAAS. In FAAS the line overlap between a line of interest and another 
element line is usually negligible.
2.3.1.3 Vaporisation interference
The vaporisation rate of salt particles containing the analyte can be altered by 
other components in the sample matrix. These components can arise from 
chemical reactions. An example of this is the formation of monoxides from 
alkaline-earth metals.
2.3.1.4 Ionisation interferences
This type of interference is also called vapour-phase interferences and cation 
enhancement. Atoms with low ionisation potential are easily ionised at 
elevated temperatures in the flame. The ionisation of the atoms reduces the
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population of both the ground state and excited state of neutral free atoms. 
Consequently, the analyte signal is depressed and sensitivity of determination 
is lowered.
For the five chosen analytes there are little interferences inherent with an air / 
acetylene fuel mixture [Willard et al., 1988; Ebdon, 1998]. Manganese 
experiences some interference when the flame is of the reducing type, but not 
the oxidising type as used in this research. Citric acid is known to interfere 
with iron, though not at the levels reported in dietary supplements. There are 
chemical interferences associated with zinc at the wavelength 213.9 nm. 
These interferences can be corrected for by non-atomic absorption using a 
hydrogen cohtinuum lamp [Parker, 1972].
2.3.2 Limits of detection
Determination limits for FAAS were calculated using Equation 7 (section 
2.2.3). The results from these calculations are stated in Table 28. In general 
FAAS provides detection limits higher than ICP-MS due to is lower sensitivity.
Table 28. Detection limit for FAAS
Analyte Iron Magnesium Manganese Zinc
À 248.3 285.2 279.5 213.9
DL (mg/L) 0.09 0.03 0.01 0.70
2.3.3 Calibration
A series of standards with known concentrations was used to produce a 
calibration line. Single element standards were produced for each analyte. 
The concentration range of the standards was chosen so that the unknown 
sample concentration was encompassed. The calibration standards for each 
analyte are stated in Table 29. These concentration ranges were used in all 
of the FAAS measurements.
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Table 29. FAAS calibration standards
Standards Fe, Mn, Zn (mg/L) Mg (mg/L)
1 0.2 0.1
2 0.5 0.2
3 1.0 0.5
4 2.0 1.0
5 5.0 2.0
6 10.0 2.5
2.4 Sample Preparation
Sampling is'the act of securing material for subsequent laboratory analysis. 
Serious errors can be introduced during collection, manipulation, containment, 
storage and preparation of the sample [Versleck & Cornelius, 1989]. 
Sample contamination, element losses and changes in sample composition 
can all invalidate trace element determinations. Contamination of samples 
can occur from dust, powdered gloves and unclean equipment. Loss of an 
element can be caused by adsorption on container surfaces or by 
volatilisation (e.g. during drying or ashing) resulting in severe systematic 
errors. Changes in sample composition can occur from the loss of water of a 
fresh sample; absorption of water by dried samples and heterogeneous 
samples that are not pre-mixed before sub-sampling.
ICP-MS and FAAS require the sample to be of a solution form. Therefore, a 
solid sample of known weight has to undergo a process of dissolution or 
digestion. Dietary supplements are provided in tablet, capsule and powder 
form. To obtain a solid homogenous sample of known weight, tablets were 
crushed with a pestle and mortar, capsules were broken open and all resulting 
powders were dried in an oven. All samples were dried to a constant weight 
(40°C for 12 hr) before sample preparation for ICP-MS and FAAS 
determinations. An effective digestion should remove in-homogeneities, 
eliminate analytical interferences and provide full dissolution [Jackwerth &
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Gomlscek, 1984]. Reagents used in the digestion procedure should not 
interfere with the subsequent analysis, should be of high purity; and vessels 
(digestion and volumetric) should be inert to attack from such reagents or 
sample matrix [Hares, 2000]. Three types of digestion procedures were 
investigated utilising the elemental analysis of certified reference materials, 
namely open vessel wet digestion, dry ashing digestion and microwave 
digestion. The popularity of microwave digestion has risen in the sample 
preparation of food or biological samples [Mizushima et al., 1996; Barnes, 
1998].
2.4.1 Open vessel wet digestion
Open vessel wet digestion involves the use of mineral acids In conjunction 
with open vessel heating apparatus. Soluble salts are formed from the metal 
ions of interest and the mineral acids used. The most commonly used mineral 
acids are nitric or hydrochloric acid. Wet decomposition by mineral acids is 
effective on both inorganic and organic materials. Organic matter is often 
destroyed in wet digestion; thus the sample matrix is also destroyed. The 
advantage of destroying the sample matrix is that it eliminates potential 
interferences associated with it. There are a number of disadvantages 
associated with open vessel wet digestion procedures, these are: -
(a) contamination from reagents and container material,
(b) loss of elements by absorption onto the surface of the digestion vessel 
or by reacting with the digestion vessel material; and
(c) loss of elements by volatilisation.
By using high purity grade reagents, inert digestion vessels and a thorough 
cleaning procedure of all vessels involved in the digestion procedure, the first 
two disadvantages can be overcome. The loss of elements by volatilisation 
can lessened by the shape of the digestion vessels. For example, modified 
Kjeldahl tubes that are tall and narrow, act as condensers thereby minimising 
the loss of volatile elements [Knapp, 1991].
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Mineral acids used for wet digestion include nitric, hydrochloric, hydrofluoric, 
perchloric and phosphoric acid. For sample analysis by ICP-MS, 
concentrated nitric acid was used. Concentrated nitric acid forms an 
azeotropic mixture at 67% with a boiling point of 121°C. It has both strong 
acidic and oxidising properties with the ability to oxidise all metals with the 
exception of the PGE’s. Nitric acid is considered to be the best acid medium 
for ICP-MS as the elements H, N, and 0  are already present in air entrained 
by the plasma [Gray, 1986]. Therefore, no contamination by additional 
elements from mineral acid reagent occurs that can cause analytical error in 
ICP-MS. Hydrogen peroxide is often used in conjunction with a mineral acid 
as it has a strong oxidising power that increases in acidic solutions [Bock, 
1979]. It is often employed as the final ‘clean-up’ reagent in sample digestion.
2.4.2 Dry ashing digestion
Dry ashing is the process of heating a sample to 400-800®C in a muffle 
furnace. The procedure facilitates the combustion of organic material and 
leaves an involatile inorganic ash. The presence of air in the muffle furnace 
means that oxygen acts as an oxidising agent and the ash consists primarily 
of metal oxides, sulphates, nitrates, chlorides and silicates [Williams, 1996]. 
Since no reagents are Involved in dry ashing it is relatively free from 
contamination and is considered a simple digestion. However, there are 
several disadvantages including [Tolg, 1972; Bock, 1979]: -
(1) loss of volatile elements which can include Ca, Cd, Cr, Cu, Fe, Pb, Zn;
(2) loss of elements due to reactions with the crucible;
(3) contamination from dust particles (arising from other vessels and 
furnace walls) and the release of boron from fire clay of the furnace at 
temperatures >460°C.
2.4.3 Microwave digestion
Microwave digestion provides higher temperatures and pressures compared 
to open vessel digestion procedures, where the maximum sample
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temperature is limited by the boiling point of the mineral acid used. This 
elevation of maximum sample temperature and pressure is a great advantage 
as mineral acids digest materials more effectively at these higher conditions 
[Jackwerth & Gomiscek, 1984]. In a commercial microwave digestion unit a 
magnetron produces microwave energy, which is propagated down to a 
microwave cavity by a wave guide. At the microwave cavity a mode stirrer 
distributes the incoming energy in various directions, causing the microwaves 
to reflect off the cavity walls and in doing so pass through the samples. The 
sample absorbs the microwave energy until no energy remains in a given 
wave. A turntable upon which sample vessels are placed is used to prevent 
non-uniformity of heating. The CEM® MARS-5® digestion system provided by 
CEM for this research uses sample vessels made from Teflon PFA (poly 
tetrafiuroethylene) [CEM Users Manual, 1996]. Teflon PFA is the perfect 
material for digestion vessels as it is resistant to all acids, including HF, and 
has a melting point of 306°C. Nitric acid behaves ideally under microwave 
energy and in closed system it can reach 176°C for 5 atmospheric pressures 
[Jackwerth & Gomiscek, 1984].
2.5 Reagents and Equipment
Throughout the course of this work the following reagents and instruments 
have been used.
2.6.1 Reagents
Acid digestions were performed with nitric acid (Aristar grade. 69%, BDH 
Laboratory Supplies, Poole) and hydrogen peroxide (Aristar grade, 30%, 
BDH). Dilutions were accomplished using doubly distilled deionized water 
(DDW) with a resistively of 18 MH cm"\ The water was obtained from an 
Elgastat UHQ Water Dispenser (Elga Ltd. High Wycombe).
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2.5.2 Analytical standards
Individual standards of the elements (Bi. Ca, Cd, Co, Cr, Cu, Fe, Ge, In, Mg, 
Mn, Mo, Ni, Pb, Zn) were supplied as 1000 pg ml'^  solutions (Aristar, Plasma 
Emission Standards, BDH). All glassware, polypropylene bottles and flasks 
were soaked overnight in 5% HNO3  (Analar) then rinsed with DDW. Digestion 
vessels were cleaned after each sample run using Decon™ solution and 
rinsed with DDW. Sample solutions and stock standard solutions were stored 
in polypropylene bottles at <4°C (in a refrigerator).
2.5.3 Instrumentation
Open vessel digests took place in modified Kjeldahl tubes in an electrical 
heating block. The electrical heating block was a Tecator 2012 Digester 
(Perstop Analytical, England). Dry ashing digests took place in a muffle 
furnace, which was supplied by Gallenkamp (Germany). Microwave 
digestions were achieved using a CEM MARS 5 (Microwave Accelerated 
Reaction System) microwave digestion unit (CEM Corporation, USA). The 
ICP-MS used was the Finnigan MAT SOLA ICP-MS (Finnigan Corporation, 
Bremen, Germany) fitted with a V-groove nebuliser. The machine was 
designed, built and manufactured by Patrick Turner of Turner Scientific prior 
to being purchased by Finnigan. Hence, other models are known as TS 
SOLA. The FAAS used was a PE 5000 FAAS (Perkin Elmer, Connecticut, 
USA) fitted with a pneumatic nebuliser and a Premix design burner.
2.6 Specific digestion procedures
Three digestion procedures were investigated for the analysis of CRMs, and 
ultimately for the analysis of dietary supplements. The proposed digestion 
procedures were wet open vessel, dry ashing and microwave digestion. The 
conditions for each procedure are stated in the next sections.
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2.6.1 Wet open vessel digestion procedure
(1) An aliquot of sample is pre-dried in an oven at 60°C for 3 hours,
(2) 0.50 ± 0.01 g is weighed into modified Kjeldahl tubes, 5.0 ml of 
concentrated HNO3 (67%) added.
(3) The Kjeldahl tubes are then left overnight in a fume cupboard.
(4) The tubes are placed into the heating block and the following heating 
programme is run: -
Ramp to 160°C in 5 min.
Held at 160®C for 2.5 hours
Ramp down to room temperature in 15 min.
(5) At 2 hours into the heating program 0.5 ml of H2O2 (30%) is added.
(6) Digestion solution is diluted to 100 ml with deionized water (18 mQ)
(7) Solutions are stored in polypropylene bottles in a refrigerator (<4®C) 
until analysis.
2.6.2 Dry ashing digestion procedure
(1 ) An aliquot of sample is pre-dried in an oven at 60°C for 3 hours.
(2) 0.50 g ± 0.01 g is weighed into pre-acid-washed borosilicate beakers 
that are then placed into a muffle furnace.
(3) Temperature of muffle furnace is increased to 250®C and held for 2 
hours then increased to 500°C and held for 24 hours.
(4) After cooling the sample is transferred to modified Kjedhal tubes and 5 
mis of concentrated nitric acid (67%) is added.
(5) The heating programme in step D of wet open vessel digestion is 
followed, including the addition of hydrogen peroxide (30%, 0.5 ml) 
after 2 hours.
(6) Digestion solution is diluted to 100 ml with deionized water (18 mQ).
(7) Solutions are stored in polypropylene bottle in a refrigerator (<4°C) until 
analysis.
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2.6.3 Microwave digestion procedure
(1 ) An aliquot of sample is pre-dried in an oven at 60°C for 3 hours,
(2) 0.50 g ± 0.01 g of sample is weighed into Teflon digestion vessels.
(3) 10 ml of concentrated nitric acid (67%) and 0.5 ml of hydrogen 
peroxide (30%) was added to the Teflon vessels and they were left to 
stand in a fume cupboard for 30 min.
(4) Tefion vessels were transferred to the microwave turntable and the 
following heating programme was used: -
Step 1. Ramp (5 min) to 50 psi,
Step 2 Hold (5 min),
Step 3 Ramp (5min) to 150 psi,
Step 4 Hold (5 min).
Step 5 Cool (20 min) to RMT
(5) Digestion solutions were diluted to 100 ml with deionized water (18 
mQ).
(6) Solutions were stored in polypropylene bottles in a refrigerator (<4°C) 
until analysis.
2.7 Evaluation of Microwave Digestion Procedure
Microwave digestion is currently the most popular choice for the sample 
preparation of food and biological samples. It is also the preferred method of 
digestion for dietary supplements, due to the advantages stated previously. 
This section evaluates microwave digestion and ICP-MS analysis with the use 
of certified reference materials (CRMs). CRMs are used to provide validation 
of experimental procedures. Validation of analytical results is extremely 
important and is related to the accuracy of results. Due to the lack of 
comparable commercially available CRMs, reference materials (RM) were 
also used. A definition for each material is given below: -
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A certified reference material is a reference material that one or more 
properties are certified by a technically valid procedure, and which is 
accompanied by a traceable certificate or other documentation issued by a 
governing body [ISO Guide 35,1989].
A reference material is a material or substance having one or more properties 
which are sufficiently well established to be used for the calibration of an 
apparatus, the assessment of a measurement method or for assigning values 
to materials [Vandercasteele & Block, 1993].
The CRMs used were the National Institute for Environmental Studies (NIES) 
Rice Flour (no. 10-b) and the Institute of Geophysical and Geochemical 
Exploration’^ s (IGGE) Tea (GBW 07605). NIES Rice Flour was chosen as it is 
found in tablets and capsules as a base material. However, NIES Rice Flour 
contains the twelve analytes at relatively low concentrations compared to the 
dietary supplements. Upon dilution some of the analytes would be 
undetectable, therefore an additional CRM was suggested. Although tea is 
only a component in six dietary supplements, IGGE Tea was chosen as it 
contained the twelve analytes at relatively higher levels compared to NIES 
Rice Flour. In general, the two CRMs do not share the same basic chemical 
or physical components with the dietary supplements. To overcome this lack 
of similarity between certified reference materials with the dietary 
supplements an ‘in-house’ reference material was chosen from the dietary 
supplements that would represent a large majority of them. Biocal™ is a 
multi-element nutritional supplement that is provided as a tablet. A seaweed 
called Liththamnion Caicareum, harvested from the West Coast of Ireland, is 
the main constituent of Biocal™. As Biocal™ is a tablet it is a good 
comparison to other tablet-form dietary supplements because of the similar 
levels of base materials. Additionally, due to the main constituent being an 
organic component, it also has similar properties to a capsule-form dietary 
supplement.
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2.7.1 Results
The results for each material are presented in Tables 31, 32 and 33. The 
CRM values are also stated in each table. CRM values with no standard 
deviations are not certified and as such are only noted as reference values.
Table 30 presents the experimental results for NIES Rice Flour. The standard 
deviations of the experimental results can be observed as less than or equal 
to the standard deviations of the certified values. This trend is repeated in 
Tables 31 and 32 with the comparison between the experimental and certified 
standard deviations of IGGE Tea and Biocal.
Relative standard deviation (RSD) values are often used to describe the 
precision of successive determinations of solutions obtained by identical 
methods and conditions. A relative standard deviation value of 10% is 
typically considered of “adequate precision”, a value of 5% is considered of 
“good precision” [Iyengar, 1989].
2.7.2 Discussion of results
From tables 30-32 it is observed that the majority of the experimental RSD 
values are for NIES Rice Flour, IGGE Tea and Biocal™ are below ± 10%. 
The exceptions to this are the RSD values for zinc (± 9%) and iron (± 6%) for 
NIES Rice Flour and the molybdenum RSD value for Biocal™ (± 7%). It 
should also be noted that the majority of the experimental RSD values in 
tables 30-32 are lower than the certified RSD values, with the exception of 
experimental RSD value for manganese in IGGE Tea (± 5%) which is greater 
than the certified value (±3%). These observations provide evidence that the 
suggested microwave digestion with ICP-MS analysis produces good 
precision results.
The precision of this method can be statistically evaluated by the use of a 
Paired t-test that compares experimental results against a known value. The t- 
experimental results for this comparison are shown in Table 33.
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The null hypothesis for this comparison of the experimental data and the 
known values states that there is no significant difference between the two 
sets of data. The statistical equation used for these tests is stated in 
Appendix 1 and the t-experimental values are presented in Table 33. At 99% 
and 95% confidence limits the t-critical values at 4 degrees of freedom are 
4.604 and 2.776, respectively.
From Table 33 it is observed that at the 99% confidence limit there is no 
significant difference between the certified and experimental values for all 
three materials. So, at a 99% confidence limit the null hypothesis is accepted. 
At the 95% confidence limit there is no significant difference between the 
certified and experimental values for the analytes in NIES Rice Flour and 
IGGE Tea.' However, at the 95% confidence limit there is a significant 
difference between the certified values of copper, molybdenum, nickel and 
zinc and the experimental values of the same analytes, for Biocal™.
Table 33. T-experimental values for comparison of the experimental
results and CRM values
Analyte NIES Rice Flour IGGE Tea Biocal
Cadmium Nv Nv Nv
Calcium 2.0 2.0 0.0
Chromium Nv 2.0 0.0
Cobalt Nv Nv 0.0
Copper 2.0 0.9 4.0
Iron 0.5 0.5 0.0
Lead Nv 0.9 Nv
Magnesium 1.5 0.0 2.7
Manganese 2.0 0.3 2.0
Molybdenum Nv Nv 4.0
Nickel Nv 1.2 4.0
Zinc 0.0 0.8 4.0
*Key; Nv = no value
**Paired t-test t-critical values (n=4) for 99% and 95% confidence limits are 4.602 and 2.774.
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2.7.3 Conclusion
From the three sets of data (standard deviations, RSDs and paired t-test with 
known value) it can be said that the microwave digestion and subsequent 
analysis by ICP-MS provided precise and accurate results of the CRMs and 
‘in-house' reference material.
2.8 Evaluation of an Alternative Digestion Procedure
The microwave digestion procedure is the preferred method for the sample 
preparation of dietary supplements but due to its limited availability an 
alternative method of digestion is required. The two proposed alternative 
digestion methods are open vessel and dry ashing. Both methods are widely 
available in the laboratory. NIES Rice Flour and Biocal™ were used to 
compare the two alternative methods against the microwave digestion 
method. At the time of this experiment IGGE Tea was not unavailable. The 
null hypothesis for this comparison is "open vessel or dry ashing digestion 
yields results significantly different to the results obtained by microwave 
digestion”; for instance there is a difference between the respective digestion 
methods.
2.8.1 Results
The results for evaluation of the separate digestion methods are presented in 
Tables 34 and 35. The two tables state the statistical data for the comparison 
of wet open vessel (W) with microwave (M) digestion and dry ashing (A) with 
microwave (M) digestion. The statistical data consists of a t-experimental 
value calculated using the Paired t-test for the comparison of two sets results 
illustrated in Appendix 1. The t-critical value for 99% and 95% confidence 
limits at 4 degrees of freedom are 4.602 and 2.774, respectively. The null 
hypothesis for the comparison states that there is no difference between the 
two sets of data.
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2.8.2 Discussion
In the comparison of the open vessel and microwave digestion results for 
NIES Rice Flour the null hypothesis is accepted. At 99% and 95% confidence 
limits there is no significant difference between the two sets of results 
obtained by the different digestion methods. For Biocal, the null hypothesis is 
accepted at the 99% confidence limit, but is rejected at the 95% confidence 
limit for comparison of the iron measurements. The iron t-experimental value 
for the comparison of open vessel and microwave digestion Is just greater 
than the t-critical value (t-expti 2.795> t-crit 2.774). The small number of the 
degrees of freedom would possibly explain this significant difference. 
However, in general it can be surmised that there is a good comparison 
between the results obtained by open vessel and microwave digestion in the 
case of both materials.
The null hypothesis is rejected in the comparison of the results obtained from 
the dry ashing and microwave digestion procedures. At both 99% and 95% 
confidence limits there is a significant difference between the two digestion 
methods that can be observed in the majority results.
2.8.3 Conclusion
In conclusion, the open vessel digestion method is accepted as the alternative 
digestion method; the dry ashing digestion method is rejected as the 
alternative digestion method for dietary supplements.
2.9 Analysis of CRMs by FAAS
For further validation of the CRM results obtained by microwave digestion and 
ICP-MS analysis, the same solutions were measured by FAAS. This provides 
an inter-comparison of two different analytical techniques. Since FAAS has a 
lower sensitivity and hence higher detection limits, fewer analytes were 
chosen for FAAS determination. The analytes found at detectable
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concentrations in the CRMs and ‘in-house’ reference material (Biocal™) are 
iron, magnesium, manganese and zinc.
2.9.1 FAAS results
The results of the FAAS analysis of the CRMs and Biocal™ are presented in 
Tables 36, 37 and 38. The respective ICP-MS results and calculated t- 
experimental values from the comparison of the results obtained by the two 
techniques using a Paired t-test are also illustrated. At four degrees of 
freedom the 99% and 95% confidence limits (t-critical values) are 4.602 and 
2.774, respectively. The null hypothesis states that ‘there is no significant 
difference between the results obtained by ICP-MS and FAAS analysis’.
Table 36. NIES Rice Flour results
Element ICP-MS 
X  ± SD (RSD%)
FAAS
x±SD(RSD% )
t-experimental
value
Zinc (pg/g) 22.7 ± 0.5 (2%) 22.4 ± 0.7 (3%) 0.532
"Key: X ± SD (RSD%) = mean value ± standard deviation (relative standard deviation %) 
"*Paired t-test t-critical values (n=4) for 99% and 95% confidence limits are 4.602 and 2,774
Table 37. IGGE Tea results
Element ICP-MS 
X  ± SD (RSD%)
FAAS 
x ± S D  (RSD%)
t-experimental
value
Mg (mg/g) 0.17 ±0.01 (3) 0.16 ±0.005 (3%) 0.846
Mn (pg/g) 1245 ± 33 (3%) 1283 ±22 (2%) 1.591
Fe (pg/g) 264 ± 7 (3%) 254 ±3(1% ) 2.403
Zn (pg/g) 25.9 ± 1 (4%) 26.2 ± 1 (2%) 1.148
"Key: X ± SD (RSD%) = mean value ± standard deviation (relative standard deviation %) 
"*Paired t-test t-critical values (n=4) for 99% and 95% confidence limits are 4.602 and 2.774
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Table 38. Biocal Results
Element ICP-MS 
x ± SD (RSD%)
FAAS 
X ± SD (RSD%)
t-experimental
value
Mg (mg/g) 26.4 ±0.4 (2%) 26.4 ±0.3(1% ) 0.375
Mn (pg/g) 53.8 ±0.7 (1%) 53.4 ±0.4 (1%) 1.060
Fe (pg/g) 1150 ± 2  (0.1%) 1154 ±2.5(1% ) 2.462
Zn (pg/g) 10.6 1.8(1%) 10.4 ±0.1(1%) 1.732
"Key: X ± SD (RSD%) = mean value ± standard deviation (relative standard deviation %) 
"^Paired t-test t-critical values (n=4) for 99% and 95% confidence limits are 4.602 and 2.774
2.9.2 Discussion
The null hypothesis is accepted; there is no significant difference between the 
two sets of results. The illustrated t-experimental values in all three tables are 
lower than the t-critical values for the 99% and 95% confidence limits at 4 
degrees of freedom. This statistical test provides further evidence that the 
results obtained by both FAAS and ICP-MS are in good agreement and that 
the results obtained by the latter are accurate and precise (calculated RSD’s 
<5%).
2.10 Analysis of Dietary Supplements
All seventy-four dietary supplements were analysed as part of an investigation 
into the quality assessment of the production and labelling of dietary 
supplements. Overall, the elemental content of different dietary supplements 
varies greatly, between levels of pg/g, mg/g to percentage. Therefore, in most 
cases sample solutions were diluted a number of times for ICP-MS analysis to 
ensure that the analyte signal was within the optimum calibration range. The 
dietary supplements with known essential element content will be used as 
assessment of the digestion and analysis procedures as well as the 
assessment of the production and labelling of dietary supplement.
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2.10.1 Methodology
All dietary supplements were digested in duplicate by the microwave digestion 
procedure (section 2.4.4) and analysed by ICP-MS. The dietary supplements 
with essential elements as active ingredients were digested a further two 
times, hence quadruplet The small number of replicates was due to time 
constraints caused by the availability of the microwave digestion system. The 
calibration standards and internal standard solutions used were identical to 
ones stated in sections 2.3.4 and 2.3.2. The ICP-MS conditions of analysis 
have been tabulated in section 2:3.5.
2.10.2 Elemental composition of dietary supplements: Results
The elemental composition of the dietary supplements is reported in Table 39 
for the macro essential elements, namely, calcium, magnesium and iron. 
Table 40 presents the trace essential elements, chromium, cobalt, copper, 
manganese, molybdenum, nickel and zinc. The non-essential elements, 
namely, cadmium and lead are reported in Table 41.
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Table 39. Macro element results for the dietary supplements
Dietary
Supplement
Calcium (mg/g) 
x ±  SD (RSD%)
Magnesium (mg/g) 
x ± S D  (RSD%)
Iron (mg/g)
"x + SD (RSD%)
Acidobifidus 0.6 ± 0.05 (9%) 0.013 ±0.001 (10%) 0.1 ± 0.003 (4%)
Aces 108.8 ±4 .7  (4%) 3.5 ± 0.1 (2%) 1.1 ±0.04(4% )
B-Vltal 131.6 ±4 .2  (3%) 1.3 ±0.01 (1%) 3.6 ± 0.1 (2%)
Betacarotene 64.8 ±0.1 (1%) 0.6 ±0.009 (1%) 1.9 ±0.025 (0.1%)
Biobifidus 0.1 ± 0.08 (5%) 1.0 ±0.008 (0.8%) 0.4 ±0.005 (1%)
Blominerais 531.2 ±14.4 (3%) 69.0 ± 2.3 (4%) 7.1 ± 0.2 (2%)
Boswellia 0.3 ±0.005 (1%) 0.1 ± 0.001 (2%) 0.1 ± 0.001 (2%)
Brain Food 85.2 ±0.05 (1%) 3.6 ± 0.02 (0.5%) 1.1 ±0.007 (1%)
Calcium Ascorbate 10.2 ±1.1 (1%) 0.2 ± 0.04 (7%) 2.5 ± 0.2 (6%)
Cal”M 94.1 ± 2.6 (3%) 5.2 ± 0.5 (9%) 2.7 ± 0.3 (9%)
Calma 22.1 ±0 .3  (1%) 23.4 ±2,2  (10%) 0.9 ± 0.04 (0.005%)
Candi Clear 102.6 ±1 .9  (2%) 21.9 ±0.2  (1%) 2.0 ± 0.03 (0.002%)
Cats Claw cone 6.1 ±0.1 (1%) 0.3 ± 0.002 (0.7%) 0.2 ± 0.03 (3%)
Cats Claw rainforest 8.7 ±0.04 (1%) 0.5 ±0.003 (1%) 0.4 ±0.01 (4%)
Cats Claw tea 4.2 ±0.004 (1%) 0.1 ± 0.01 (0.3%) 0.2 ± 0.009 (0.4%)
Cats Claw rainforest 3.2 ±0.01 (1%) 1.1 ±0.003 (1%) 0.4 ± 0.007 (2%)
CC and Aloe Vera 24.9 ± 0.5 (2%) 2.8 ± 0.01 (0.3%) 0.9 ± 0.02 (2%)
Chlorella 1.3 ±0.03 (2%) 2.5 ± 0.1 (6%) 1.3 ±0.04 (3%)
CGF , 37.1 ±0.1 (1%) 5.1 ± 0.2 (3%) 0.9 ± 0.002 (0.3%)
Cr as Polynicotinate 109.2 ±4 .9  (7%) 0.2 ± 0.0001 
(0.0002%)
3.1 ± 0.1 (2%)
CItricidal 57.5 ±0 .4  (1%) 1.3 ±0.03 (2%) 1.7 ±0.01 (0.7%)
Citri-Lean 1606.0 ±8 .9  (1%) 2.2 ± 0.03 (2%) 6.1 ±0.1 (1%)
Citri-lmmune 1.7 ±0.1 (3%) 0.9 ± 0.1 (6%) 0.003 ± 0.0001 (3%)
Co-enzyme Q10 180.4 ±2 .3  (1%) 0.5 ± 0.008 (0.4%) 4.9 ± 0.03 (0.6%)
Coloclear 15.4 ±0.02 (1%) 2.2 ± 0.02 (1%) 1.1 ± 0.04 (4%)
Colofibre 13.0 ±1 .8  (15%) 1.2 ±0.02 (1%) 0.3 ± 0.02 (6%)
Colofibre 22.4 ±1.4  (6%) 1.0 ±0.02 (2%) 0.4 ± 0.009 (2%)
DIno Chews 35.5 ±1.5  (4%) 15.3 ±0.04 (0.3%) 2.6 ± 0.1 (4%)
Doiamite 281.8 ±3 .4  (1%) 86.2 ± 2.6 (3%) 2.6 ± 0.2 (6%)
Easy Fe 37.8 ±1 .8  (5%) 5.0 ± 0.005 (0.09%) 30.0 ± 0.9 (3%)
Easy Mg 32.4 ± 2.2 (7%) 53.0 ±1 .4  (3%) 16.4 ± 0.7 (4%)
E400 212.1 ± 12.9 (6%) 1.7 ±0.03 (2%) 1.6 ±0.02 (2%)
Easigest 16.2 ±0.03 (1%) 0.9 ± 0.01 (2%) 1.1 ±0.003 (0.2%)
Folacin 281.0 ±0 .3  (1%) 1.6 ±0.1 (4%) 6.7 ± 0.01 (0.2%)
Ginkgo 236.1 ±0 .2  (1%) 1.8 ±0.03 (1%) 2.9 ± 0.060 (0.2%)
Ginseng 69.4 ± 0.04 (1%) 0.7 ± 0.001 (0.2%) 3.0 ± 0.02 (0.8%)
Glucosammine Plus 162.1 ±0 .9  (1%) 4.8 ± 0.1 (2%) 0.7 ± 0.1 (7%)
L-Glutammine 12.1 ±0.1 (1%) 0.01 ± 0.004 (3%) 0.2 ± 0.0007 (0.4%)
Herbal Clear 8.7 ±0.1 (1%) 1.2 ±0.003 (0.2%) 0.8 ± 0.004 (0.5%)
Immune Prevention 5.2 ±0.01 (1%) 0.7 ± 0.002 (0.3%) 2.9 ± 0.1 (2%)
Lecithin 1.2 ±0.1 (4%) 1.4 ±0.04 (3%) 0.2 ± 0.01 (5%)
Maxi Co-Q 4.8 ± 0.3 (6%) 2.9 ± 0.1 (5%) 0.4 ± 0.003 (0.7%)
Maxi Multi 62.6 ±0 .8  (1%) 6.1 ±0.1 (1%) 8.1 ± 0.03 (0.3%)
Menophase 33.1 ±0.003 (0.01%) 43.6 ±4 .7  (11%) 0.003 ± 0.0001 (3%)
Mexican Yam 7.1 ±0.1 (1%) 5.3 ± 0.004 (0.08%) 0.8 ± 0.008 (0.9%)
Niacin 138.7 ±0 .6  (1%) 0.5 ± 0.007 (2%) 5.2 ± 0.002 (0.03%)
Optimum Nutrition 76.0 ± 2.1 (3%) 39.6 ±1.1 (3%) 5.7 ± 0.3 (6%)
Ocean Kelp 146.2 ±0 .5  (1%) 4.2 ±0.04 (1%) 4.1 ± 0.1 (2%)
Organic Feverfew 7.7 ±0.1 (1%) 1.8 ±0.1 (6%) 0.5 ±0.006 (1%)
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Table 39. Macro element results for the dietary supplements cont.
Dietary
Supplement
Calcium (mg/g) 
"x± SD (RSD%)
Magnesium (mg/g) 
X ± SD (RSD%)
Iron (mg/g) 
x± SD (RSD%)
Organic Linseeds 1.5 ±0.1 (5%) 2.8 ± 0.1 (4%) 0.4 ± 0.005 (2%)
Osteo Food 126.9 ±0 .6  (1%) 59.3 ± 2.7 (5%) 4.2 ± 0.02 (0.5%)
Pantothenic Acid 71.0 0.8(1%) 0.6 ± 0.004 (0.6%) 2.1 ± 0.1 (3%)
Paraciens 1.5 ±0.007 (0.5%) 1.1 ±0.02(2% ) 0.2 ± 0.007 (3%)
Positive Nutrition 71.4 ±3.1 (4%) 2.7 ± 0.1 (2%) 1.9 ±0.007 (0.4%)
Pre-Mens 1.5 ±0.004 (0.3%) 76.0 ±1 .2  (2%) 0.5 ± 0.01 (2%)
Probiogest 0.1 ± 0.003 (3%) 1.4 ±0.1 (4%) <dl
X Proustaflorum 4.8 ± 0.3 (5%) 1.2 ± 0.1 (9%) 0.3 ±0.02 (11%)
Rosehips 22.5 ±0.01 (1%) 2.2 ± 0.1 (3%) 0.8 ± 0.02 (2%)
Se 200 111.6 ±0 .7  (1%) 1.9 ±0.02 (1%) 2.8 ± 0.1 (3%)
Spirocal 256.4 ± 6.1 (2%) 20.8 ±0.3 (1%) 6.1 ± 0.2 (3%)
Superantioxidant 73.5 ±1 .0  (1%) 1.3 ±0.1 (9%) 2.8 ± 0.2 (8%)
Super B Complex 79.0 ± 0.04 (0.04%) 3.2 ± 0.1 (2%) 1.3 ± 0.04 (3%)
Supergar 33.2 ±0 .4  (1%) 1.1 ±0.04(4% ) 0.1 ± 0.009 (9%)
Supernutrition 67.1 ±0 .9  (1%) 11.0 ±0 .2  (1%) 2.9 ± 0.1 (4%)
True Food C 24.9 ± 2.0 (8%) 1.7 ±0.0003 (0.02%) 0.3 ± 0.002 (0.07%)
Ultra C+ 28.1 ± 0 .2  (1%) 17.3 ±0 .4  (2%) 1.1 ±0.004 (0.4%)
Vitamin B6 234.5 ±0 .6  (1%) 6.2 ±0.1 (1%) 3.4 ±0.03 (1%)
Vitamin B12 4.0 ± 0.02 (0.4%) 0.5 ± 0.02 (3%) 4.2 ± 0.04 (1%)
Yang Drive 15.5 ± 0.5 (3%) 1.1 ±0.01(0.9%) 0.8 ± 0.04 (5%)
Zinc with Copper 68.2 ± 4.7 (7%) 1.8 ±0.04 (2%) 2.6 ± 0.02 (0.6%)
Zinc Citrate 19.7 ± 1.7 (9%) 3.9 ± 0.008 (1%) 0.1 ± 0.003 (4%)
*Key: X ± SD (RSD%) = mean value ± standard deviation (relative standard deviation %)
**AII values reported on a dry weight basis, n=2 for all dietary supplements except ones 
containing essential elements as active ingredients, then n=4.
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Table 41. Non-essential element results for dietary supplements
Dietary Supplement -Cadmium (pg/g) 
x ± S D  (RSD%)
— Lead (pg/g) 
x ± S D  (RSD%)
Acidobifidus <dl <dl
Aces <dl 0.6 ± 0.01 (2%)
B-Vital <d! <dl
Betacarotene <dl 0.4 ±0.04 (10%)
Biobifidus <dl 0.4 ± 0.01 (3%)
Blominerais <d! <dl
Boswellia <dl <dl
Brain Food <dl 0.6 ±0.06 (11%)
Calcium Ascorbate <dl 0.5 ± 0.01 (2%)
Cai-M <di 6.0 ±0 .6  (11%)
Calma <dl 0.5 ± 0.01 (2%)
Candi Clear <dl <dl
Cats Claw cone 0.8 ± 0.06 (7%) 0.4 ±0.04 (10%)
Cats Claw rainforest <dl <dl
Cats Claw tea <dl 0.4 ± 0.02 (6%)
Cats Claw rainforest 13.7 ±2.1 (16%) 2.2 ± 0.1 (3%)
CC and Aloe Vera <dl 0.6 ±0.1 (13%)
Chlbrella <dl <dl
CGF <dl 0.4 ± 0.03 (7%)
Cr as Polynicotinate <dl 1.2 ±0.1 (6%)
CItricidal <di 0.4 ±0.04 (10%)
Citri-Lean <dl <dl
Citri-lmmune <dl 0.4 ± 0.04 (10%)
Conenzyme Q10 <dl 0.7 ± 0.08 (12%)
Coloclear <dl 1.0 ±0.1 (12%)
Colofibre <d! 0.7 ±0.08 (12%)
Colofibre <dl 0.7 ±0.08 (12%)
Dino Chews <dl 0.5 ± 0.01 (2%)
Doiamite 0.9 ± 0.06 (8%) 1.3 ±0.01 (0.8%)
Easy Fe 2.2 ±0 .2  (10%) 0.8 ±0.01 (1%)
Easy Mg <dl <dl
-E400 <dl 0.3 ± 0.02 (0.9%)
Easigest <dl <dl
Folacin <dl <dl
Ginkgo <dl <dl
Ginseng <dl <dl
Glucosammine Plus <dl 0.8 ±0.01 (1%)
L-Glutammine <dl 0.3 ± 0.01 (3%)
Herbal Clear <dl <di
Immune Prevention <d! <dl
Lecithin <di <dl
Maxi Co-Q <dl <dl
Maxi Multi <dl <dl
Menophase <dl <dl
Mexican Yam <dl <dl
Niacin <dl <dl
Optimum Nutrition <dl <di
Ocean Kelp <dl <di
Organic Feverfew <dl <dl
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Table 41. Non-essential element results for dietary supplements
Dietary Supplement -Cadmium (pg/g) 
x ± S D  (RSD%)
-  Lead (pg/g)
X  ± SD (RSD%)
Organic Linseeds <dl 0.6 ± 0.1 (24%)
Osteo Food <dl 1.3 ± 0 . 3  (2%)
Pantothenic Acid <dl 0.4 ± 0 . 4  (10%)
Paraciens <dl 0.5 ±0 .5 (11% )
Positive Nutrition 1.0 ± 0 . 5  (6%) 4.8 ±0.0 (1%)
Pre-Mens 0.7 ± 0.04 (5%) 13.2 ±1.3 (10%)
Probiogest <dl <dl
Proustaflorum 1.3 ±0.2 (14%) 0.6 ± 0.02 (3%)
Rosehips <dl 0.6 ±0.6 (116%)
Se 200 2.0 ± 0.1 (4%) <dl
Spirocal <dl 1.7 ±0.1 (3%)
Superantioxidant 3.9 ± 0.01 (0.2%) 2.9 ± 0.06 (2%)
Super B Complex <dl 0.5 ±0.05 (11%)
Supergar <dl 0.9 ±0.1 (13%)
Supernutrition <dl 0.8 ±0.01 (1%)
True Food 0 <dl <dl
Ultra 0+ <dl <dl
Vitariiin B6 <dl <dl
Vitamin B12 <dl <dl
Yang Drive 0.8 ±0.01 (1%) 0.8 ± 0.1 (14%)
Zinc with Copper <dl <di
Zinc Citrate 2.2 ± 0.1 (3%) <di
*Key: X ± SD (RSD%) = mean value ± standard deviation (relative 
**AII values reported on a dry weight basis, n=2 for all dietary 
containing essential elements as active ingredients, then n=4.
standard deviation %) 
supplements except ones
2.10.3 Comparison of elemental data between commercial values and 
experimental values
Twenty-four dietary supplements contain essential elements as active 
ingredients. The concentration of an essential element from the respective 
active ingredient is stated on the label of a dietary supplement. A comparison 
can be made between the concentration stated by the label (label value) and 
the concentration found by ICP-MS analysis (expti value). For the 
comparison to be relevant the experimental results have to be converted from 
pg/g or mg/g to pg/tablet or mg/tablet. This is carried out by the multiplication 
of the experimental value by the weight of the dietary supplement. The 
weights of the dietary supplements are provided in Appendix 2 with the label 
values for each dietary supplement involved in the comparison. The results 
are illustrated in Tables 42-49 according to each essential element.
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Table 42 reports the comparison of calcium values between the product labels 
and the experimental levels. The majority of the calcium experimental values 
are slightly lower than the stated label values in the dietary supplements. This 
deviance away from the expected (label) value can be expressed as a ratio; 
the experimental values are 0.7 ± 0.02 lower than the label values. This trend 
cannot be accounted for by the variation in sample weight (3-4 RSD%). Large 
dilutions took place for the calcium measurements in these dietary 
supplements; large dilutions have systematic errors associated with them.
Table 42. Comparison of calcium values
Dietary Supplement Label Value Exptl. Value Trend
Biocal (mg) 150 150.9 ±0.2
Calcium Ascorbate (mg) 175 102.6 ±1.1 4/
Gal-M (mg)' 164 94.1 ±16.5 4/
Calma (mg) 28.5 22.2 ± 0.3 4/
Maxi Multi (mg) 151 134.4 ±2.0 4/
Optimum Nutrition (mg) 167 106.0 ±3.0 4/
Osteo Food (mg) 133.3 126.9 ±14.8
Ultra C Plus (mg) 74 64.7 ± 0.5 4/
Spirocal (mg) 612 128.2 ±27.0 4/
Supernutrition Plus (mg) 33 60.4 ± 0.8 4"
In Table 43 the comparison of chromium experimental values and the 
appropriate label values presents a different trend. All of the chromium 
experimental values are higher than the label values with the exception of 
Spirocal. Experimental values higher than the label values can be explained 
by the possible chromium content found in the active ingredients used for 
other essential elements and base materials that is not represented in the 
label value.
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Table 43. Comparison of chromium values
Dietary Supplement Label Value Exptl. Value Trend
Biominerals (pg) 25 28.2 ±0.8
Dino Chews (pg) 5 7.3 ±0.09 'h
Maxi Multi (pg) 8.5 9.7 ±0.1 4^
Optimum Nutrition (pg) 10 17.6 ±0.7 4"
Spirocal (pg) 7.4 2.3 ± 0.008 4/
Supernutrition Plus (pg) 33 51.3 ±0.7 4^
The majority of the copper experimental values shown in Table 44 are greater 
than or equal to the label values for the respective dietary supplement. Two 
supplements are observed as having experimental values lower than the label 
values, these supplements are Spriocal and Zinc with Copper. Zinc with 
Copper is a small tablet-based dietary supplement that has a visible 
heterogeneous nature. To accomplish the digest weight of 0.5g at least three 
tablets have to be crushed and mixed. In the case of this supplement the 
process of mixing may have been inadequate, resulting in irreproducible 
results. The content of essential elements in Spirocal is based upon the 
content of the essential elements in the seaweed.
Table 44. Comparison of copper values
Dietary Supplement Label Value Exptl. Value Trend
Biocal (pg) 1 9.2 ± 0.3 4^
Biominerals (pg) 1.5 1.0 ±0.2 4^
Optimum Nutrition (pg) 36 184 ±3.2 4^
Spirocal (pg) 36 1.8 ±0.0002 4/
Superantioxidant (pg) 300 433.4 ±2.1 4^
Supernutrition Plus (mg) 0.33 0.33 ± 0.003 =
Zinc with Copper (pg) 1.25 0.7 ± 0.05 4/
All of the iron experimental results illustrated in Table 45 are higher than the 
relevant label values. In some cases there is a large difference between the
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two, as illustrated by the Maxi Multi. Again, the larger values can be 
accounted for by the iron content in the other active ingredients and base 
materials that are not included in the label value.
Table 45. Comparison of iron values
Dietary Supplement Label Value Exptl. Value Trend
Biocal (mg) 0.3 0.6 + 0.001 i '
Biominerais (mg) 4 7 ±0.2 4^
Dino Chews (mg) 2 3.4 ±0.1 4^
Easy iron (mg) 5 6.0 ±0.2 4"
Maxi Multi (mg) 2 17.0 ±0.06
Optimum Nutrition (mg) 5 8.0 ±0.5 4^
Spirocal (mg) 1.32 3.1 ±0.6 4^
Superantioxidant *mg) 1 2.0 ±0.1 4^
Supernutrition Plus (mg) 1.66 2.6 ±0.1 4^
Tables 46 and 47 illustrate the comparison of magnesium and manganese 
values. The main observation from Table 46 is that approximately half of the 
magnesium experimental results are slightly lower than the label values. 
Magnesium is found in dietary supplements at similar levels to calcium. This 
may explain the systematic error ratio of 0.6 for the comparison of the 
experimental values to the label values.
In contrast, the majority of manganese experimental values are equal to the 
label values, presenting a good comparison between the two sets of results. 
Only two dietary supplements have experimental values lower than the label 
values, these are Optimum Nutrition and Superantioxidant.
Table 46 illustrates the comparison of the molybdenum values. The majority 
of the experimental values are lower than the label value. This’ can be 
possibly explained by the low concentration of molybdenum stated in dietary 
supplements. When dilution factors are also taken into account the
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molybdenum concentration is very small and as such is susceptible to a wide 
variance according to the Horowitz curve [Iyengar, 1989].
Table 46. Comparison of magnesium values
Dietary Supplement Label Value Exptl. Value Trend
Biocal (mg) 6.7 13.2 ±0.2
Biominerals (mg) 83 69.0 ±2.3 4/
Calma (mg) 28.5 23.4 ± 2.2 4/
Easy Magnesium (mg) 50 59.2 ± 4.6 4^
Dino Chews (mg) 20 19.9 ±0.05
Maxi Multi (mg) 24 12.7 ±0.1 4/
Menophase (mg) 22 19.9 ±2.8
Optimum Nutrition (mg) 75 55.5 ±1.6 4/
Osteo Food (mg) 67 59.3 ± 2.7 4/
Positive Nutrition (mg) 20 4.0 ± 0.04 4/
Pre-Mens (mg) 45 45.6 ± 0.7
Ultra C plus (mg) 43 39.7 ± 0.9 4/
Spirocal (mg) 17.5 10.4 ±0.14 4^
Supernutrition Plus (mg) 10 9.9 ±0.14
Table 47. Comparison of manganese values
Dietary Supplement Label Value Exptl. Value Trend
Biominerals (mg) 3 3.1 ±0.08
Dino Chews (mg) 0.5 0.54 ± 0.003 ss
Maxi Multi (pg) 340 350 ±31.3
Optimum Nutrition (mg) 1.5 0.89 ± 0.04 4/
Spirocal (pg) 7.8 24.2 ±1.5 4"
Superantioxidant (mg) 2 1.9 ±0.03 4/
Supernutrition Plus (mg) 0.66 0.67 ± 0.03
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Table 48. Comparison of molybdenum values
Dietary Supplement Label Value Exptl. Value Trend
Biocal (pg) 1 0,6 ± 0.05 4/
Supernutrition Plus (pg) 83,3 92.2 ±0.1
Spirocal (pg) 3 0.65 ± 0.03 4/
Biominerals (pg) 5 3.7 ± 0.07 4/
Table 49 illustrates the comparison of the zinc values. The majority of the 
zinc experimental values are greater than or equal to the label value. The two 
dietary supplements with experimental values lower than zinc label values are 
Spriocal and Zinc with Copper. This observation was first seen in Table 44, 
where the copper experimental values for these supplements was lower than 
the label values. The same explanations stated for copper can also be used 
for zinc.
Table 49. Comparison of zinc values
Dietary Supplement Label Value Exptl. Value Trend
Biocal (mg) 2.3 5.3 ± 0.3 4^
Biominerals (mg) 5 4.9 ± 0.2
Dino Chews (mg) 2 6.8 ±1.47 4"
Maxi Multi (mg) 2 4.0 ± 0.2 4"
Menophase (mg) 5 9.9 ±1.4 4^
Optimum Nutrition (mg) 5 17.5 ±1.8 4^
Positive Nutrition (mg) 3 0.8 ± 0.05 4/
Pre-mens (mg) 5 6.3 ± 0.03 4^
Proustaflorum (mg) 6 7.1 ±0.6 4^
Spirocal (mg) 0.24 0.02 ± 0.01 4/
Superantioxidant (mg) 4 2.9 ±0.3 4/
Supernutrition Plus (mg) 3.33 3.9 ± 0.003 4"
Yang Drive (mg) 4.5 5.2 ± 0.2 4^
Zinc with Copper (mg) 20 11.6±0.8 4/
Zinc Citrate (mg) 15 15.2 ±0.8 4^
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So far comparisons have been carried out according to individual essential 
elements, but the values can be illustrated according to a particular dietary 
supplement. Yeast-based dietary supplements illustrate a good comparison 
between the two sets of results. This observation is seen in both single and 
multi-component yeast-based dietary supplements, which are shown in 
Tables 5 0 -5 2 .
Table 50. Easy Iron
Element Label Value Exptl. Value Trend
Iron (mg) 5 6.0 ±0.1
Table 51. Easy Magnesium
Element Label Value Exptl. Value Trend
Magnesium (mg) 50 59.2 ± 4.6
Table 52. Supernutrition Plus
Element Label value Exptl. Value Trend
Calcium (mg) 33 60.4 ± 0.8 4^
Chromium (pg) 33 51 ± 0.7 4^
Copper (mg) 0.33 0.33 ± 0.003 =
Iron (mg) 1.66 2.6 ±0.1 4>
Magnesium (mg) 10 9.9 ±0.1
Manganese (mg) 0.66 0.67 ±0.003 4"
Molybdenum (pg) 83.3 92.2 ±0.1 4^
Zinc (mg) 3.33 3.9 ± 0.003 4^
In tablet-based dietary supplements there is typically a good comparison 
between the two sets of values for trace elements (Cr, Cu, Mn, Mo, Ni and 
Zn). This trend is observed in the values for the macro element, iron. 
However, for the other two macro elements, magnesium and calcium the 
majority of the experimental results are lower than the label values. This was
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not predicted, but can possibly be explained by the large dilution factors 
involved with both of these elements. Another possible explanation for this 
variance is that the experimental results are based upon a ‘dry weight' 
whereas the label content is based upon the specifications of that dietary 
supplement. The two trends associated with the macro and trace element 
values can be observed in Tables 53 and 54.
Table 53. Optimum Nutrition
Element Label Value Exptl. Value Trend
Calcium (mg) 166 106.0 ±3.0 4/
Chromium (pg) 2.66 17.6 ±0.7
Copper (pg) 2.5 184 ±3.2 4^
Iron (mg) 5 8.0 ±0.5 4^
Magnesium (mg) 75 55.5 ±1.6 4/
Manganese (mg) 1.5 0.9 ± 0.04 4/
Zinc (mg) 5 17.5 ±1.8 4^
Table 54. Dino Chews
Element Label Value Exptl. Value Trend
Calcium (mg) 2.5 46 ± 2.0 4/
Chromium (pg) 5pg 7.3 ± 0.09 4^
Iron (mg) 2 3.4 ±0.1 4^
Magnesium (mg) 20 19.9 ±0.05 4"
Manganese (mg) 0.5 0.54 ± 0.03
Zinc (mg) 2 6.8 ±1.4 4"
One dietary supplement repeatedly yields experimental values lower than 
label values, this dietary supplement is Spirocal. The analyte comparisons for 
Spriocal are shown in Table 55. The label value is based on the seaweed 
content and not the addition of the essential elements as active ingredients.
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Table 65. Spirocal
Element Label Value Exptl. Value Trend
Calcium (mg) 612 128.2 ±27.0 4/
Chromium (pg) 7.4 2.25 ± 0.08 4/
Copper (pg) 36 1.8 ±0.0002 4/
Iron (mg) 1.32 3.1 ±0.6 /h
Magnesium (mg) 17.5 10.4 ±0.1 4/
Manganese (pg) 7.8 24.2 ±1.5 4^
Molybdenum (pg) 3 0.7 ± 0.03 4/
Zinc (mg) 0.24 0.02 ± 0,01 4/
As a result of the slight variations reported below it was considered important 
to investigate the elemental composition of the various base materials used in 
the preparation of the various dietary supplements.
2.11 Analysis of Base Materials
Base materials are the inactive ingredients found in dietary supplements. The 
function of base materials is to bind active ingredients together to form a 
tablet or to act as bulk ingredients in a capsule. There are twelve different 
manufacturers producing the seventy-four dietary supplements. The different 
manufacturers and their products are listed in Table 56.
Base materials were obtained for analysis from G&G, Ryder, Seaford and 
LUPO manufacturers. Three of these manufacturers, G&G, Ryder and 
Seaford produce the majority of the dietary supplements that contain essential 
elements as active ingredients. . In total these three manufacturers produce 
over half of the nutritional supplements involved in the study, this is illustrated 
in Figure 26. The base materials obtained by the four manufacturers are 
stated in Table 57.
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Table 56. Dietary supplements categorised by manufacturer
Biofoods Ltd Easy Iron, Easy Magnesium, Maxi Coenzyme 010, Super Nutrition Plus, True Food C
Bioshell Biocal, Spirocal
G&G
AcidoBifidus, Biobifidus, Boswellia, Calma, Cal-M, 
Cat's Claw concentrate, Citri-immune, Coloclear, 
Colofibre, Easigest, Feverfew, Herbal Clear, 
Immune Prevention, Menophase, Mexican Yam, 
Pre-mens, Probiogest, Proustaflorum, Zinc Citrate, 
Supergar, Yang Drive
Hambleden Herbs Linseeds
LUPO Dino Chews
Nutritionelle Beta-Carotene
Opalbond L-Glutamine
Peruvian Imports Ltd Cat’s Claw and Aloe Vera
Peruvian Botanicals Cat’s Claw
Ryder
Antioxidant, Biominerals, Brain Food, Coenzyme 
010, Cr as Polynicotinate, Ginkgo, Glucosammine 
Plus, Ginseng, Super B Complex, Zinc with Copper
Seaford
Vitamin B5, Vitamin B6, B-vital, Vitamin C l00, 
Doiamite with A & D, Ginseng, Maxi Multi, Osteo 
Food, Se 2000, Superantioxidant, Ultra C plus. 
Vitamin E
Tishcon Corp. Dino Chews
Figure 26. Base material manufacturers
□  Biofoods Ltd
■  Bioshell
□  G&G
□  Hambleden Herbs
■  LUPO
B Nutritionelle
■  Opalbond
□  Peruvian Imports Ltd
■  Peruvian Botanicals
■  Ryder
□  Seaford 
BTishon Corp
119
Table 57. Base materials according to manufacturer
Manufacturer Base Material
G & G Maltodextran, Rice flour. Sublingual base,
LUPO Acacia, Calcium hydrogen phosphate, Cellulose, Magnesium stearate, Rice bran flour, Silica,
Ryder Avicel, Dibasic calcium phosphate, Magnesium stearate, Silica, Stearic acid
Seaford
Acacia, Avicel, Dibasic calcium phosphate. 
Magnesium stearate, Starch, Talc, Tribasic calcium 
phosphate
From Table 57, it is observed that the most commonly used base materials 
are dibasic calcium phosphate and magnesium stearate. G&G manufacturers 
also use these two base materials in dietary supplement formulations but 
were not provided for analysis. Obviously, there will be a high amount of 
calcium and magnesium in these base materials. This point provides the 
consensus that the level of essential elements in base materials should be 
quantified so that their contribution to the active ingredient concentration can 
be calculated.
2.11.1 Methodology
The wet open vessel digestion procedure was used for the dissolution of base 
materials. This was due to the microwave digestion equipment being 
unavailable at the time of analysis. The procedure used was identical to the 
one stated in section 2.4.4. Since the base materials were expected to have 
high levels of calcium, magnesium, iron and zinc, the dilution factors were 
calculated for measurement on the Faraday Cup detector. Consequently the 
CEM detector was used for the analysis of the remaining trace elements. The 
calibration standard concentrations and the internal standard concentrations 
were identical to the ones stated in section 2.2.6.
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2.11.2 Results
The results from the analysis of the base materials are in Tables 58-61, 
expressed according to each manufacturer. Each result is presented as an 
arithmetic mean plus or minus the standard deviation (X or pg/g or mg/g ± 
SD) with the percentage relative standard deviation (RSD %) given in 
brackets. These terms are defined in Appendix 1. When no measurement 
was obtained due to the analyte signal being less than the detection limit <dl 
stated on Tables 58-61.
2.11.3 Discussion
The base material results present potential problems in the analysis of 
nutritional supplements. A number of individual results have high relative 
standard deviations, for example the magnesium value for Seaford's tribasic 
calcium phosphate has 18% (RSD). The equivalent value for Ryder’s tribasic 
calcium phosphate material has a 21% (RSD). The base material silica used 
by Ryder manufacturers contains a number of essential elements, (Ca, Cr, 
Cu, Fe, Mg, Mn, Mo and Ni). The values obtained for these essential 
elements have relative standard deviations over the range of 25 - 65%. So in 
general it can be concluded that base materials from Seaford, G & G  and 
Ryder appear to be very heterogeneous. The LÜPO base materials are 
considered to be less heterogeneous than the other manufacturers base 
materials. A variation in the concentration of essential elements in a typical 
base material will cause an error in the calculation of the base materials 
contribution to the overall essential elemental content per tablet or capsule. If 
essential elements found in base materials are not part of the in t^ a l 
structure they should be considered ‘additives’ to the total ‘nutrient dose' per 
supplement.
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It was planned that for each manufacturer a dietary supplement was chosen 
to calculate, from their specifications, the contribution from the base materials 
to the overall essential elemental concentration. Unfortunately, the 
, manufacturers G&G only supplied three of their base materials. Therefore, a 
calculation from one of their specifications would be inaccurate and as such 
will not be carried out. The LUPO manufacturers have supplied a number of 
base materials but they only formulate one dietary supplement, Dino Chews. 
No specification was provided for this dietary supplement. Therefore, the 
base material contribution cannot be calculated for LUPO base materials. 
However, they can be used for alternative calculations of other samples due 
to the low concentration of essential elements found in them. Seaford and 
Ryder manufacturers provided a number of dietary supplement specifications 
utilising the'majority of the base materials listed in Table 57.
Doiamite is a vitamin and mineral formula supplied in tablet form by Seaford. 
The two essential element active ingredients listed on the label are calcium 
and magnesium. The specifications provided by Seaford state that the 
following base materials are added to a single dietary supplement: - avicel 
0.045g, acacia 0.03g, starch 0.05g, stearic acid 0.05g, magnesium stearate 
0.01 g and talc O.OSg. The results obtained by the relevant base materials 
have been used to calculate the base materials contributions are shown in 
Table 62.
In Table 62, the total base material contribution is compared to the 
experimental value obtained by the digestion of the dietary supplement. Also 
stated is the concentration of the essential element active ingredient stated on 
the label of the dietary supplements. The calculated calcium and magnesium 
contributions of the base materials are 840 pg/g and 347 pg/g respectively. 
These contributions would at the most cause a 0.5% increase in the label 
value. The calculated calcium contribution does not account for the .elevated 
calcium experimental value compared to the label value. The magnesium 
experimental result is lower that the label value. From Table 62 it is also 
observed that the total base material contribution is greater than the
126
experimental value in the case of Cr, Cu, Fe, Mn, Mo, Ni and Zn. This 
deviance could be explained if the base materials underwent a washing or 
purification step prior to use or that a different batch was used for dietary 
supplement formulations.
Table 62. Seaford - Doiamite base material contributions
Element Avicel
(gg/g)
Acacia
(gg/g)
Starch
(gg/g)
Stearic 
Acid (gg/g)
Mg Stearate
(gg/g)
Talc (gg/g)
Ca 1 221 5 5 610
Cr 5 9 9 45
Cu 31
Fe 3570 10 2714 857 23
Mg 52 105 191
Mn 23 274 29 2912 1
Mo 2 3 1
Ni 7
Zn ; 23 9 35
Element Total Base Material 
Contribution (gg/g)
Experimental value
(gg/g)
Label value (gg/g)
Ca 840 281800 170000
Cr 68 3.6
Cu 31 8.8
Fe 7175 2600
Mg 347 86200 100000
Mn 339 28.2
Mo 10 0.5
NI 7 <dl
Zn 176 <dl
Biominerals is a mineral and herbal formula with citrate minerals for easy 
absorption in the small intestine. Ryder produces Biominerals in the form of a 
tablet with the following base materials included in the formulation: - acacia 
O.OSg, dicalcium phosphate 0.25g, magnesium stearate 0.02g, starch O.OSg 
and stearic acid 0.01 g. Biominerals contains more active ingredients than 
Doiamite, namely calcium, iron, magnesium, zinc, manganese, copper, 
chromium and molybdenum. The contribution from the base materials to the 
overall concentration of these elements is presented in Table 63.
There is a similar inconsistency for Biominerals between the calculated base 
material total contribution compared to the experimental value, as previously 
shown for Doiamite supplements. The calculated magnesium and zinc base
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material contribution is less than the experimental value of the dietary 
supplement. The other essential element contributions have been calculated 
to be greater than the actual experimental value. Table 63 also shows that 
the base material concentration plus the active ingredient concentration of an 
essential element do not equal the experimental value of that essential 
element in the respective nutritional supplement.
Table 63. Ryder - Biominerais base materials contribution
S'Element
>£ .
Acacia (gg/g) Dicalcium
phosphate
'(gg/g)
Magnesium 
Stearate 
(gg/g) ' -
Starch (gg/g) Stearlc^cid
..(wp/g)
Ca 222 60994 22 3'.
Or 9 c 782 44 89 23
Co 115
Cu 31 52
Fe 10 1633 1862 . . 2714 428
Mg 52 42 732
Mn 274 2196 74  ^ 29 6
Mo 2 108 1 3 1
NI 64 7 3
Zn 23 227 41 9 17
Element Total Base Material 
Contribution (gg/g)
Experimental Value 
(gg/g)
Label Value (gg/g)
Ca 61241 <dl <dl
Cr 947 28 25 -
Co 115 <dl <dl
Cu 83 1 0.5
Fe 6647 7000 4000
Mg ' 826 69000 83000
Mn 2579 3128 3000
Mo 115 4 5
Ni 75 <dl <dl
Zn 317 4900 5000
The evidence so far suggests that the base materials could potentially make a 
significant contribution to the ‘total' essential elemental content of the 
supplement. This additional contribution could be viewed as an overestimate 
of the ‘nutrient dose’. Each essential element level varies greatly in sub­
samples of base materials and also by manufacturer. Therefore, it is possible 
that different batches of base materials will contain different concentrations of 
the essential element resulting in varied ‘additions' to the total tablet dose. 
Comparing the results of Ryder or Seaford’s dibasic calcium phosphate with
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the results of the LUPO calcium phosphate illustrates the variation of the 
essential element contamination for the same base material between 
manufacturers. The LUPO calcium phosphate contains far less essential 
element contaminants than those in Ryder of Seaford dibasic calcium 
phosphate. A similar trend is seen between the LUPO magnesium stearate 
base material and the Ryder and Seaford magnesium stearate. To fully 
illustrate this variation Tables 64 and 65 are presented.
Table 64. Ryder - Brain Food base material contribution
Elements Dicalcium
phosphate
(MQ/g)
Mg
Stearate
(MQ/g)
Starch
(pg/g)
Stearic 
Acid (pg/g)
Total Base 
Material 
Contribution
(pg/g)
ExptI
Value
(pg/g)
Ca(pg/g) 158585 9 3 158597 127500
Cr ((pg/g) 2032 18 4 27 2080 2
Co (pg/g) 298 4 301 3
Cu (pg/g) . 135 135 2
Fe (pg/g) 4247 745 1085 514 6591 1650
Mg (pg/g) 109 293 402 5400
Mn (pg/g) 5710 30 12 7 5759 7
Mo (pg/g) 279 1 1 1 282 1
Ni (pg/g) 166 3 169 <dl
Zn (pg/g) 588 16 4 208 816 523
Table 65. LUPO & Ryder - Brain Food base material contribution
Elements Dicalcium
phosphate
(pg/g)
Mg
Stearate
(pg/g)
Starch
(pg/g)
Stearic 
Acid (pg/g)
Total Base 
Material 
Contribution 
(pg/g)
ExptI
Value
(pg/g)
Ca 143000 3 143003 127500
Cr 1 4 27 32 2
Co 0.1 4 4 3
Cu 2
Fe 1473 1085 514 3072 1650
Mg 179 264 443 5400
Mn 0.1 12 7 19 7
Mo 1 1 2 1
Ni 1 1 <dl
Zn 0.7 4 208 213 523
Table 64 consists of the calculated base material contribution for Brain Food 
using Ryder base material results. Table 65 presents the calculated base 
material contribution for Brain Food using the LUPO results for magnesium 
stearate and calcium phosphate. The other base material contributions were 
calculated using the results from the Ryder manufacturers. The amounts of
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base materials added to the Brain Food formulation are discalcium phosphate 
0.65g, magnesium stearate 0.008g, starch 0.02g and stearic acid 0.012g.
The total base material contribution from Ryder base materials yields much 
higher concentrations across the spectrum of analytes. The LUPO total base 
material contribution is much lower and in the case of copper is non-existent.
2.11.4 Conclusion
When the experimental value for a dietary supplement is greater than the 
calculated base material contribution, the unaccounted active ingredients 
could explain the difference. When the calculated base material contribution 
is greater than the experimental value for a nutritional supplement, the large 
variation of essential element concentration in base materials may account for 
this difference. Other explanations could include an unaccounted for clean-up 
procedure used for the base materials prior to use and the large dilution factor 
involved in the digestion and analysis of the base materials and nutritional 
supplements.
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Chapter 3 Fat-Soluble Vitamins Analysis
3.1 Introduction
Fat-soluble vitamins have the potential to be analysed simultaneously by high 
performance liquid chromatography (HPLC). This study investigates the use 
of HPLC in the determination of vitamins A, D, E and K in dietary 
supplements.
3.1.1 Vitamins in Dietary Suppiements
In the last three decades, vitamins have become closely associated with 
dietary supplements. In 1970 Linus Pauling published a book titled “Vitamin 0  
and the common cold", which suggested taking daily doses of vitamin C to 
prevent colds. This suggestion led to a great deal of controversy that resulted 
in a number of discussions on the merits of recommending large doses of 
vitamins for the treatment or prevention of chronic diseases [Basu & 
Dickerson, 1996]. Today, the most common types of dietary supplements 
taken by adults are multivitamin preparations with and without iron [Gregory 
et al., 1990]. The current social trend of taking vitamin supplements has lead 
to a number of food types to be enriched with vitamins. Typical food types 
fortified with vitamins include breakfast cereals, soft drinks, margarine and 
frozen vegetables. Folic acid is a prime example of a vitamin that is regularly 
added to breakfast cereals and soft drinks. This widespread enrichment of 
folic acid is due to folic acids role in reducing the risk of a pregnant woman 
producing a baby with a neural tube defect, particularly spina bifida [Schorah 
& Smithells, 1991]. Typically, water-soluble vitamins (e.g. thiamine, 
riboflavin, niacin, vitamin B6 and folic acid) are regularly added to types of 
breakfast cereal; and fat-soluble vitamins (A, D and E) are regularly added to 
types of margarine [van den Berg, 1997].
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Both water-soluble and fat-soluble vitamins are found in dietary supplements. 
Water-soluble vitamins, especially the B group, are traditionally grouped 
together and formulated in specific dietary supplements (e.g. Super B 
Complex, Higher Nature). Fat-soluble vitamins are more typically found in 
multi-vitamin dietary supplements or formulations for a specific condition (e.g. 
Menophase, Higher Nature) instead of a dietary supplement based on their 
content.
There is a range of vitamin or vitamer compounds available for addition to 
dietary supplements. The vitamin compound is typically chosen for its various 
properties that include toxicity, solubility and most importantly, potency. The 
choice of vitamin compounds is increased when considering both synthetic 
and natural'vitamin compounds. At a molecular level both forms are equally 
effective but there are inherent disadvantages with using synthetic forms of 
vitamins A and K [Kirschmann & KIrschmann, 1996]. Synthetic vitamin A is 
not as biologically effective as synthetic vitamin A as it does not bind as tightly 
to cellular structures. In large doses vitamin K can be toxic; the toxicity results 
from the combination of synthetic menadione (K3) with sulfhydryl groups 
causing the oxidation of phospholipids in cell membranes [Groff et al., 1995]. 
The most popular vitamin compound that is added to a dietary supplement is 
usually the most active vitamer of the vitamin group or the most stable, often a 
derivative. a-Tocopherol acetate is routinely found in dietary supplements, as 
it is the most stable derivative of the most biologically active vitamer in the 
vitamin A group, i.e. tocopherol [Cohn, 1997].
3.1.2 Vitamin Stability
All vitamins show deterioration in content over a period of time [Ottaway, 
1993] The rate of reduction in vitamin content is influenced by a number of 
factors: -
(1) temperature;
(2) moisture;
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(3) oxygen;
(4) light;
(5) pH;
(6 ) oxidising and reducing agents;
(7) presence of metallic ions (e.g. Cu, Fe);
(8 ) presence of other vitamins;
(9) other components of food such as sulphur dioxide; and
(1 0 ) combinations of the above.
These factors are known to affect vitamin compounds in dietary supplements 
[Hashmi, 1993]. The factors that cause the most instability are heat, 
moisture, oxygen, pH and light. Consequently, storage conditions are of 
importance'when analysing for vitamin compounds in dietary supplements. 
Although, synthetic and naturally occurring vitamins are affected identically by 
the degradation factors, vitamins are a heterogeneous group of compounds 
with no common structure. Therefore, the stability of an vitamin compound 
varies widely from the relatively stable to the relatively unstable.
3.1.2.1 Vitamin A
In general, vitamin A is relatively stable in alkaline solutions and during food 
processing involving heat, but becomes unstable when exposed to 
atmospheric pressure. Vitamin A suffers from complete loss of activity upon 
oxidation from high temperatures [Lambert et al., 1985]. The presence of 
double bonds in vitamin As structure makes it the subject of isomerization, 
particularly in conditions of acid pH in an aqueous medium [Ottaway, 1993]. 
The ester forms of vitamin A are relatively more stable than the alcohol forms, 
especially in the presence of oxygen. However, both forms are inactivated in 
the presence of ultra-violet light.
3.1.2.2 Vitamin D
Vitamins D2 (ergocalciferol) and D3 (cholecalciferol) are the two forms of 
vitamin D found in dietary supplements. Both forms are sensitive to light and 
acids. Vitamin D2 is more oxygen sensitive compared to vitamin D3. possibly
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as vitamin D2 contains one more double bond. In solution, both vitamers 
exhibit isomerization due to the presence of double bonds in their structures. 
Vitamin D3  undergoes isomerization resulting in a time dependent equilibrium 
between D2 and precalciferol. The ratio of products is temperature 
dependent. In solid the solid state, thermal isomerization of vitamin D does 
not occur [Ball, 1998]. However, in powders vitamin D2 undergoes 
isomerization that is catalysed by the surface acids of calcium sulphate, 
calcium phosphate, talc and trisilicate [De Ritter, 1982]
3.1.2.3 Vitamin E
The naturally occurring forms of vitamin E, the tocopherols, are readily 
oxidised py air, heat (in the presence of air), light, alkaline pH conditions, the 
presence of metal ion and the processing and storage of foods [Nells et al., 
1985]. In comparison, the tocopherol esters are relatively more stable due to 
the removal of the free phenolic hydroxy group upon estérification. 
Tocopherol esters (e.g. tocopherol acetate) are relatively stable to light and 
air, but are hydrolysed by moisture in the presence of alkalis or strong acids to 
free tocopherols.
3.1.2.4 Vitamin K
The degradation of vitamin K occurs by UV radiation, alkali conditions, strong 
acids and reducing agents. Vitamin Ki (phytomenodione) is the form typically 
added to dietary supplements as oxygen and heat only slowly affects its 
structure and potency. Isomerization between the c/s and trans isomers of 
vitamin Ki can occur. If it does, it is important to note that only the naturally 
occurring trans isomer is biologically active.
3.2 Fat-soluble Vitamin Analysis Methods
The determination of fat-soluble vitamins was first carried out by biological 
assays (bioassays). Over time microbiological assays and more recently high 
performance liquid chromatography (HPLC) and gas chromatography (GO)
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techniques have replaced these tests. Because the term ‘fat-soluble vitamins’ 
encompasses four vitamin groups, a simultaneous method is difficult to find. 
In this section, the different types of vitamin analysis are discussed with 
particular preference placed on the HPLC methods.
3.2.1 High performance liquid chromatography
In recent years, HPLC method, development for fat-soluble vitamin 
determination has increased [Rizzolo & Polesello, 1992]. This is because 
HPLC has the ability to analyse low concentrations of volatile compounds, 
uses organic solvents sparingly and involves less sample pre-treatment, 
particularly derivatisation steps than other chromatographic methods [Nells et 
al., 1985; Blanco et al., 1995]. Vitamin stability problems are also overcome 
by HPLC conditions that often include low, ambient temperatures and no 
contact between the sample solution and direct light during analysis [Lefevere 
et al., 1973]. For the simultaneous analysis of fat-soluble vitamins, both 
normal phase (NP) and reverse phase (RP) HPLC can be used. However, 
routine determinations by NP-HPLC is considered a more complicated 
procedure due to the use of gradient elution or isocratic mode with multi- 
column chromatography [Denisova et al., 1994; Ake et al., 1998]. NP-HPLC 
is also unable to separate the vitamin D vitamers (D2 and D3) unlike RP- 
HPLC, For these reasons RP-HPLC is often the chosen method for fat- 
soluble vitamin determination. The separation of fat-soluble vitamins by RP- 
HPLC is based on the partition of the non-polar vitamin molecules between 
the polar mobile phase and a non-polar stationary phase [WIelinskI & 
Olszanowski, 1999].
Most of the RP-HPLC published methods for the separation of fat-soluble 
vitamins utilises totally porous microparticulate silica-based packings, in which 
the non-polar stationary phase, usually octadecylsilane (CDS), is chemically 
bonded to the silica surface through a siloxane bridge. Other stationary 
phases used for vitamin determination are phenyl and cyano-bonded phases. 
The typical mobile phase used in RP-HPLC is based on the traditional water 
and acetonitrile mixture. However, a number of fat-soluble vitamin analysis
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methods have used non-aqueous reversed phase (NARP) chromatography 
instead. NARP chromatography is the solution to the problem of the solubility 
between the relatively non-polar fat-soluble vitamins and the water / organic 
mobile phase. A typical NARP mobile phase consists of a polar solvent (e.g. 
acetonitrile), a modifier of lower polarity (e.g. dichloromethane) to act as a 
solubliser and to control retention and occasionally a small amount of a third 
solvent with hydrogen bonding capacity (e.g. methanol) to optimise selectivity 
[Ball, 1998].
The most commonly used mode of detection for the analysis of fat-soluble 
vitamins is spectrophotometric. A spectrophotometric detector is often 
considered the workhorse of a modern chromatography laboratory [Willard et 
al., 1988  ^ Both fluorescence and electrochemical detection are also available 
and offer greater sensitivity, but they are unable to detect all of the fat-soluble 
vitamin compounds [Blanco et al., 2000]. Vitamin D can not be directly 
measured by fluorescence, instead it requires a derivatisation step [Hashmi, 
1973]. Ultra-violet (UV) absorbance and not electrochemical detection can 
only carry out the analysis of vitamin K by NARP chromatography. However, 
there is a small drop in sensitivity inherent with the detection of vitamin A by 
spectrophotometric detectors.
When measuring the four fat-soluble vitamins by spectrophotometric detection 
a compromised wavelength has to be chosen. The respective wavelength 
values for each vitamin’s absorbance maxima are shown in Table 66. 
Wavelengths 254 nm and 280 nm are typically used for the simultaneous 
determination of fat-soluble vitamins [Lambert et al., 1985]
Table 66. The maximum absorbance wavelength values of the fat-
soluble vitamins.
Vitamin A D E K
m^ax (nm) 325 294 264 240-270
‘Source: Lefevere et al., 1973; Ball, 1998.
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There are a number of papers concerning the simultaneous analysis of fat- 
soluble vitamins. However, most papers concentrate on two or three fat- 
soluble vitamins, typically vitamins A, D and E. Only a small number of 
papers present methods for the analysis of all four fat-soluble vitamins. 
Application notes from chromatographic column manufacturers were more 
useful in this respect. Table 67 gives a representation of the literature on 
simultaneous fat-soluble vitamin analysis. References were restricted by a 
criterion that the methods were developed for pharmaceutical preparations, 
then for food matrices. Three chromatographic conditions are included in 
Table 67; these are mode of detection, mobile phase and stationary phase 
used. As mentioned previously spectrophotometric detection is observed as 
the most popular mode of detection. The majority of the references use 
NARP chromatography, with only four papers involving a conventional water- 
based mobile phase.
In vitamin analysis, sample extraction is considered to be the rate-limiting step 
of the experimental method. This is because extraction and clean-up 
procedures have to be optimised for (a) vitamin degradation evaluation; (b) for 
specific food matrices; and (c) maximum recovery of added vitamins [Rizzolo 
& Polesello, 1992]. A typical extraction procedure for vitamins in food 
matrices usually involves saponification followed by solvent extraction or 
direct extraction. Saponification is the alkaline hydrolysis of an ester to an 
alcohol and the alkali-metal salt of a carboxylic acid [Sharp, 1990]
The extraction of vitamins in dietary supplements or pharmaceutical 
preparations should be comparatively simple as the vitamin is often found in 
its parent form and will have been added as a stabilised preparation. Also, 
fat-soluble vitamins have similar solubility properties and isoprenoid related 
structures [Lambert & Scott, 1990]. Table 68 states the solubility of fat- 
soluble vitamins in different solvents.
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Table 68. Solubility of fat-soluble vitamins
Solvent A D E K
H2O X X X X
Acetone y y y X
Alcohol* y y y y
Benzene X y X X
Chloroform y y y y
Diethyl Ether y y y y
Fats & Oils y y y y
*Alcohols or mixture of alcohols (70-90% alcohol)
**Source: Hashmi, 1973
A number of papers exist that suggest an extraction procedure for fat-soluble 
vitamin in dietary supplements or pharmaceutical preparations [Blanco et al., 
1995; Ôttles, 1999; Wielinski & Olszanowski, 1999]. The use of hexane as 
an extraction solvent with agitation of solution by mechanical means are 
mentioned in papers by Blanco et al., 1996 and Wielinski and Olszanowski, 
1999. All of the literature concerning vitamin extraction and subsequent 
analysis states that the following conditions should be incorporated: - subdued 
lighting, amber flasks and occasionally the use of an inert atmosphere. These 
conditions are suggested for the prevention of vitamin degradation under 
normal laboratory conditions.
3.2.2 Other Methods
There are three main ‘alternative’ methods for the analysis of fat-soluble 
vitamins, which are bioassays, microbiological and physiochemical assays 
and gas chromatography.
Bioassays are a direct measurement of a vitamin’s biological activity and are 
based upon a vitamin’s biological function. Measurement of biological 
function depends upon a series of sequential physiological events. These 
events are intestinal absorption, plasma transport, tissue uptake, metabolism 
and ultimately function at target cells [Ball, 1998]. By measuring biological
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function, bioassays are the only method of vitamin analysis that can measure 
the potency of a vitamin or it’s derivatives. Fat-soluble vitamin bioassays are 
also carried out for compliance to food specifications, possible degradation by 
processing of food and food composition tables [Lambert & Scott, 1996]. It 
should be noted that although bioassays provide a measure of the 
bioavailability of a vitamin, the results could not be extrapolated to human 
nutrition. This is because bioassays are extensively carried out on animal 
models, mainly chicks and rats.
There are two types of bioassay methods, curative and prophylactic. In 
prophylactic bioassays the animals receive the test sample and standard 
vitamin preparation at the beginning of the assay, and their ability to prevent 
the deficiency disorder is compared. Curative bioassays are based on the 
depletion of the vitamin then the re-introduction of the vitamin to the diet. An 
example of a curative bioassay is the vitamin A growth response assay. Four 
groups of young rats are fed a vitamin A deficient diet for 3-4 weeks until all 
body stores of vitamin A are depleted. Then for four weeks, two of the groups 
are fed diets containing vitamin A at different known concentrations. The 
results from these two groups act as standards. The other two groups are fed 
a diet of the analyte (new vitamin A derivative) or a diet of unknown vitamin A 
concentration. The gain of body weight during the four-week treatment period 
is a linear function of the logarithm of the dose. Hence, the potency of the 
unknown diet can be calculated by comparison to the standard diets [Ball, 
1998]. The other vitamins are also tested by curative bioassay methods. 
Vitamin D determination is carried out by the ratline test; determination of 
vitamin E is accomplished by liver storage assay and vitamin K is determined 
by the chick bioassay. Until the advent of HPLC vitamin methods, the chick 
bioassay was the predominant test for vitamin K content and potency 
[Lefevere et al., 1973].
In summary, bioassays are difficult to conduct, time-consuming, expensive 
and ultimately cannot be extrapolated to human nutrition. Due to these
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disadvantages most vitamin determinations of this type are now carried out by 
microbiolpgicai assay and physiochemical methods of analysis.
Microbiological assays measure the combined response of the active 
substances and take into account utilisation at the cellular level. However, 
microbiological assays do not account for the physiological processes of 
digestion and absorption. Physiochemical assays permit the quantification of 
the principal substances that are responsible for biological activity. But, in 
many cases, physiochemical assays do not account for all of the active 
substances [Ball, 1998].
Gas chromatography (GC) has been widely used for the analysis of vitamin E 
and its analogues [Nells at al., 1985] Although, analysis of vitamin E by GC 
is successful, the required analysis conditions are in some cases, impractical 
[Bell & Christie, 1973]. Typical GO conditions for vitamin E analysis are a 
high temperature, a long analysis time and the inclusion of a derivatisation 
step that often does not separate (3- and y-tocopherols [Lumley et al., 1993; 
Llebler et al., 1996]. Due to the high temperatures needed under these 
conditions, the analysis of vitamins A, D and K by GC is hampered, as all 
three are unstable at high temperatures. This instability can lead to on-line 
column absorption, dehydration and thermal rearrangements of the vitamin 
compounds. Furthermore, the derivatisation of vitamin A is prone to partial 
reaction resulting in analytical error. In summary, the use of capillary columns 
facilitates the separation of the trimethyl silyl ethers of all eight vitamin E 
isomers and enables the tocopherols and the major plant sterols in margarine 
to be determined simultaneously [Slover et al., 1985]. However, there is no 
ideal method for the simultaneous analysis of the fat-soluble vitamins by GC.
3.3 Reagents and Equipment
The following reagents and equipment were used in the determination 
experiments of fat-soluble vitamins.
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3.3.1 Reagents
The extraction of fat-soluble vitamins was carried out using n-hexane (BDH, 
Laboratory supplies, Poole) and methanol (HPLC grade, BDH). The mobile 
phase of in the NARP chromatography consisted of acetonitrile (HPLC grade, 
Fisher Ch)emicals, Loughborough) and methanol (HPLC grade, BDH).
3.3.2 Analytical standards
The following compounds were obtained for vitamin standards: - all-trans­
retinol apetate (Sigma, St Louis, USA); retinol palmitate (SUPELCO, 
Bellefonte USA); Ergocalciferol (vitamin D2) (SUPELCO); Cholecalciferol 
(vitamin D3) (SUPELCO); D, L-a-tocopherol (SUPELCO); (+)-a-tocopherol 
acetate (Sigma); Phylloquinone (SUPELCO).
Stock solutions of 1g/l were accomplished for each compound, using 
methanol (HPLC grade, BDH). The stock solutions were stored in covered 
Durans™ at 4®C to prevent vitamin degradation. Calibration standards were 
made-up daily from these stock solutions with a n-hexane/methanol (1/9 ratio) 
solution. The concentrations of the standards were 2.0, 4.0, 8.0 and 10.0 
mg/L. All glassware was washed with DECON™ and rinsed with distilled 
water, then DDW prior to use and covered with tin foil.
3.3.3 Equipment
The agitation of the vitamin sample solutions was accomplished by the use of 
an ultrasonic heated water bath, supplied by Camlab, West Germany, and the 
clean-up procedure was accomplished by using 10ml Plastipak® sterile 
syringes (Becton Dickenson, Madrid) and Minisart® single use filter units 
(Sactorius, Madrid). The chromatography system consisted of an absorbance 
detector, Waters 490E programmable multi-wavelength detector (Waters Ltd, 
Hertfordshire) and an integrator, Waters 745b Data Module (Waters Ltd, 
Hertfordshire). A column heater was used for the heating of a Genesis Cl 8 
(150 X 4.6 mm id) 3 pm particle size (Jones Chromatography, Mid Glamorgan) 
to 30 X .
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3.4 Experimental and Analysis Procedures
In this section the procedures used for the extraction and determination of fat- 
soluble vitamins are stated. A simple direct extraction method has been 
chosen with simultaneous HPLC analysis of vitamins A, D, E and K. The 
theory and instrumentation of HPLC has not been discussed in this chapter as 
the technique is universally known and as such there are a number of well 
written books that explain the principals of HPLC. Two books with particularly 
good explanations of HPLC are ‘Practical High Performance Liquid 
Chromatography’ 3"^  ^edition by V.R. Meyer (1998, Chichester, PA: Wiley) and 
‘Environmental Analytical Chemistry’ 2"*^  edition edited by F.W. Fifield and P.J. 
Haines (2000, Oxford, PA: Blackwell Science Ltd).
3.4.1 Extraction procedure
The extraction procedure used was based on the method stated in Wielinski 
and Olszanowski, 1999. The method is considered a simple direct solvent 
extraction, which was accomplished as follows: -
(1) the tablet-based dietary supplements were crushed and 
homogenised with a pestle and mortar;
(2) a 1.0 ± 1.1 g aliquot of the crushed dietary supplement was 
dissolved in 10 ml of n-hexane (10 ml) in a covered flask, then 
diluted to 100 ml with methanol;
(3) the sample solution was then transferred to a water bath and 
sonicated for 15 minutes at a temperature of 30°C; at this time the 
solution were under a nitrogen atmosphere;
(4) prior to injection the sample solution was filtered using Plastipak® 
syringes (Becton Dickenson) and Minisart® filters (Sactorius); and
(5) in some cases the sample solutions were diluted to the appropriate 
concentration range using a solution of n-hexane/methanol (1/9 
ratio).
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3.4.2 Chromatography analysis conditions
The HPLC method was based upon the application notes provided by Jones 
Chromatography [Jones Chromatography, 2000] with the purchase of the 
analytical column. Two chromatography conditions were investigated for 
optimum performance. These were the mobile phase solvents and the 
analytical wavelength used.
3.4.2.1 Mobile phase
Acetonitrile and methanol both have a UV cut-off of 190 nm; therefore they 
are appropriate choices for use with UV detection, as they exhibit no 
interferences in the analytical wavelength range of 240-330 nm. Three 
different solvent ratios were investigated, which were 95/5, 60/40 and 30/70 
acetonitrile/methanol. The 95/5 solvent ratio provided a chromatogram where 
the solvent peaks interfered with the retinol acetate peak and did not separate 
the two vitamin D vitamers. The 60/40 solvent ratio provided the best 
chromatogram where the retinol acetate peak was free from interference and 
the analysis time was approximately 20 minutes. However, the peaks for 
vitamins Da and Ds were not completely resolved. The final solvent ratio of 
30/70 caused the band broadening in the chromatogram and increased the 
analysis time to an unreasonable 40 minutes.
Of the three solvent ratios investigated the acetonitrile/methanol 60/40 mixture 
was chosen for the mobile phase in this study. The incomplete separation of 
the vitamin D2 and D3 peaks was not seen as an obstacle as the dietary 
supplements under investigation did not contain both types of vitamin D.
3.4.2 2 Analytical wavelength
Two wavelengths have been stated by in the literature to be useful for the 
simultaneous analysis of fat-soluble vitamins, these are 280 nm and 285 nm 
[Ôttles, 1999; Wielinski & Olszanowski, 1999]. A multi-solution of fat- 
soluble vitamins and individual fat-soluble vitamin solutions were injected and 
detected at both wavelengths. At the 285 nm wavelength the peaks for 
tocopherol, tocopherol acetate and phylloquinone were not observed. All of
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the fat-soluble vitamins were observed at the wavelength of 280 nm (Figures 
27 and 28).
3.4,2.3 Summary of chromatography conditions
Under the conditions stated below, typical retention times for the fat-soluble 
vitamin standards can be given and are shown in Table 69.
Chromatoaraohv conditions
Stationary phase: Genesis Cis @ 30°C
Mobile phase
Wavelength
Flow-rate
Acetonitrile / Methanol (60/40) 
280 nm 
1 ml/min
Table 69. Retention times of fat-soluble vitamins
Fat-soluble vitamin Retention time (mins)
-Retinol acetate 4.3
Ergocalciferol 10.1
Cholecalciferol 10.8
Tocopherol acetate 13.0
Tocopherol 15.7
Phylloquinone 19.8
Figures 27 and 28 illustrate chromatograms of the two sets of fat-soluble 
vitamin standard solutions. Figure 27 is a chromatogram of a 2 mg/L solution 
of ergocalciferol. Figure 28 is a chromatogram of a 4 mg/L solution of retinol 
acetate, cholecalciferol, tocopherol acetate, tocopherol and phylloquinone.
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Figure 27. Chromatogram of a 2 mg/L ergocalciferol solution
Figure 28. Chromatogram of a 4 mg/L multi-fat-soluble vitamin solution
936
fe «=;7 a. ss i. 86
4 . 55
10 . 80
13. 03
15. 79
19 . 67
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3.4.3 Spike recoveries
Spike recoveries where used to validate the extraction procedure and method 
of analysis. This was due to the lack of CRM’s with a similar sample matrix to 
the dietary supplements. Two sets of spike recovery experiments were 
carried out. The first experiment involved the spiking of matrix blanks and the 
second with the spiking of actual dietary supplements.
Tablet-based matrix blanks were made-up from the base materials obtained 
by the manufacturer Ryder and spiked with the fat-soluble vitamin stock 
solution. The proportion of each base material in the matrix blank was 
determined by the typical proportion of that base material found in typical 
tablet-based dietary supplement. The four base materials and their specific 
proportions to produce a 1 g matrix blank are shown in Table 70.
Table 70. Constituents of matrix blank
Base material Weight in matrix blank (g)
Dibasic calcium hydrogen.phosphate 0.5
Magnesium phosphate 0.2
Cellulose 0.1
Silica 0.1
Four matrix blanks were spiked with a 0.5 g/L solution of each fat-soluble 
vitamin. A further two matrix blanks were weighed and used as reagent 
blanks arid as such were not spiked. After the extraction and measurement of 
the fat-soluble vitamin spikes, the subsequent results were calculated as 
percentage recoveries. These results are shown in Table 74 in section 3.6.1
Although the matrix blanks represent a typical tablet-based dietary 
supplement matrix they do not include the active components present in some 
of the dietary supplements. Since it is known that fat-soluble vitarhins can 
interact with elements such as iron, calcium and copper in dietary 
supplements, spike recoveries were carried out on each dietary supplement
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under analysis, namely Calma, Dino Chews, Dolamite, Maxi Multi, Optimum 
Nutrition and Supernutrition Plus. The concentration of the spike was 2 g/L, 
as it was expected that a concentration of this level would be above the 
content of the respective fat-soluble vitamin. The results of these spike 
recoveries are shown with the calculated experimental concentration results in 
the appropriate table for the respective dietary supplement (Tables 75-78). 
Good recoveries (>90%) were made for all vitamin compounds under 
investigation.
3.5 Analytical Parameters
Two analytical parameters are presented in this section, namely the limit of 
detection and the reproducibility of sample injection.
3.5.1 Limit of detection
The detection limit is typically stated as ‘the concentration of the analyte that 
gives a signal significantly different from the “blank" or “background signal”’ 
[Willard et al., 1988] and is calculated using equation 7.
Xl = Xb + ksB eqn (7)
where X l  = smallest measurable signal, Xb = mean of blank measurements, k 
= a numerical constant typically 3 and sb  = standard deviation of blank 
measurements.
Due to the nature of a chromatographic reagent blank there was no 
measurable signal above the baseline. The same value would also be stated 
for the determination limit, where the numerical constant is equal to 6. So, the 
lowest measurable signals for the fat-soluble vitamins were calculated from a 
series of multi-vitamin solutions with decreasing concentrations. The 
calculated lowest measurable signals for each fat-soluble vitamin are listed in 
Table 71.
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Table 71. Lowest measurable signal for fat-soluble vitamins
Vitamin Concentration (mg/L)
Retinol acetate 0.1
Cholecalciferol 0.1
Ergocalciferol 0.1
Tocopherol 0.5
Tocopherol acetate 0.5
Phylloquinone 0.5
These results can also be expressed as pg per tablet; the concentration units 
used for the vitamin content in the dietary supplement labels. These values 
are listed in Table 72. If the dietary supplement typically weighs only 1 g then 
the determination values in Table 72 should be halved. This is significant for 
the nutritipnal supplement Dolamite, which weight 1 g.
Table 72. Lowest measurable signal of fat-soluble vitamins in a typical
0.5 g dietary supplement
Fat-soluble vitamin Concentration (ug per tablet)
Retinol acetate 20
Cholecalciferol 20
Ergocalciferol 20
Tocopherol 100
Tocopherol acetate 100
Phylloquinone 100
3.5.2 Precision
For each fat-soluble vitamin a solution of 2 mg/L was run consecutively for ten 
determinations. The mean, standard deviation and relative standard 
deviations (RSDs) were calculated for each fat-soluble vitamin and are shown 
in Table 73.
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Table 73. Precision results
Vitamin Mean (mg/L) Std. Dev. (mg/L) RSD %
Retinol acetate 11106 464 4
Cholecalciferol 26233 327 2
Ergocalciferol 16007 496 3
Tocopherol 1631 69 4
Tocopherol ace. 1682 72 4
Phylloquinone 2708 496 3
‘n = 10
All of the RSD values are below 5%, therefore there is good precision 
between different injections of the same solution and there is no variation in 
analysis conditions over a period of 3-4 hours.
3.6 Fat-soluble vitamin results
This section presents the results from the spiked matrix blanks and the fat- 
soluble vitamin analysis of dietary supplements.
3.6.1 Matrix blank results
Table 74 illustrates the spike recovery results of the fat-soluble vitamins 
added to the matrix blanks. The percentage recoveries are in the range of 96- 
113%.
Table 74. Matrix blanks
Vitamin analyte Recovery % ± Std Dev (RSD %)
Retinol acetate 97 ± 1 (2%)
Ergocalciferol (D2) 105 ± 3  (2%)
Cholecalciferol (D3) 102 ± 3  (3%)
Tocopherol (E) 113 ±15 (13%) '
' Tocopherol acetate 108 ± 4  (4%)
: Phylloquinone (Ki) 96 ± 8  (8%)
‘n = 3
150
Figures 29 and 30 are chromatograms of different matrix blank solutions. 
Figure 29 is a chromatogram of a matrix blank that was spiked with 2 mg/L of 
retinol acetate and ergocalciferol. Figure 30 is a chromatogram of a matrix 
blank that was spike with 2 mg/L of cholecalciferol, tocopherol acetate, 
tocopherol and phylloquinone.
Figure 29. Chromatogram of a matrix blank spiked with retinol acetate
and ergocalciferol
'.£ 1
Figure 30. Chromatogram of a matrix blank spiked with cholecalciferol, 
tocopherol acetate, tocopherol and phylloquinone
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3.6.2 Dietary supplement results
The results from the analysis of fat-soluble vitamins in dietary supplements 
are presented as the concentration of the analyte in the tablet (pg/tab). This 
enables a comparison between experimental results and labelled values. All 
results including percentage spike recoveries are shown as an arithmetic 
mean ± the standard deviation and the relative standard deviation (RSD). 
The mathematical definitions of these terms are stated in Appendix 1. When 
concentrations of the fat-soluble vitamin in the dietary supplement were below 
the detection limit and no value was obtained from analysis, the term nv is 
given in the tables 75-78.
No comparable peaks for analyte vitamins were found for Optimum Nutrition 
and Supernutrition Plus.
Table 75. Calma results
Vitamin Recovery % Cone, (pg/g) Actual conc.
Ds 98.±6(6% ) <dl 0.36 pg/g
^Key; <dl = signal below detection limit, (n=4)
Table 76. Dino Chews results
Vitamin Recovery % Gone, (mg/tab) Actual conc.
D2 100 + 8 (8%) <dl 3.75. pg/tab
E 96 ± 4  (0%) <dl 8.3 mg/tab
E acetate 91±17(19% ) 7.8 ±2.2 (28%) Nv
*Key: <dl = signal below detection limit, (n=4), Nv = no value stated, (n=4)
Table 77. Dolamite results
Vitamin Recovery % Gone, (pg/tab) Actual conc.
Retinol acetate 109 + 1 (0%) 1108 + 6.3(2%) 1125 pg/tab
Ds 111+2 (2%) 12 ±0.1 (0%) 9.4 pg/tab
%n=4)
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Table 78. Maxi Multi results
Vitamin Recovery % Conc. (pg/tab) Actual conc.
Retinol acetate 110±10(9) 1088 ±18(1%) 1500 pg/tab
D3 110 + 3(2%) <dl 5 pg/tab
*^ Key: <dl = signal below detection limit, (n=4)
3.7 Discussion
The matrix blanks represent the components of a tablet before active 
components were added. A decrease in the spike recovery value would 
specifically represent interactions between fat-soluble vitamins and the base 
materials of a tablet. These interactions could result in a loss of fat-soluble 
vitamins. The percentage spike recovery results for the matrix blanks range 
from 96-113% for all fat-soluble vitamin analytes. Therefore, it can be said 
that no interactions between the tablet base materials and the spiked vitamins 
occurred.
The spike recoveries for each of the dietary supplements (except Optimum 
Nutrition and Supernutrition Plus) followed the same trend as the matrix blank 
spikes. The percentage spike recovery results were all in the region of 91- 
111%. Sjnce the results are all greater 90% it can be stated that the method 
of extraction was appropriate for the sample matrix and that good recovery 
was made for each fat-soluble vitamin analyte (retinol acetate, cholecalciferol, 
ergocalciferol, tocopherol, tocopherol acetate and phylloquinone). Spike 
recovery results greater than 100% can be potentially explained by possible 
memory effects, sensitivity of detector, the dilution factor (typically 100-1000), 
response time and finally the use of an integrator and not a computer system.
Results for analysis of retinol acetate in Maxi Multi and Dolamite were 
relatively close to the actual concentrations found in the dietary supplements. 
Multi is a multi-vitamin and multi-mineral supplement; Dolamite contains only 
vitamin A, vitamin K, calcium and magnesium. The retinol acetate result for
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Maxi Multi is a third lower than the actual concentration stated on the label. 
Possible interactions between retinol acetate and active ingredients could 
explain the low result. This trend was not expected to be observed in the 
Dolamite results due to the lower number of active and Inactive ingredients in 
the Dolamite specifications. This trend Is reflected in the good agreement 
between the experimental result and the actual concentration for retinol 
acetate in Dolamite.
The Dino Chews label stated that there is 8.3 mg/tab of tocopherol present, 
however no tocopherol was detected by this method of analysis. Instead 1.8 
mg/tab of tocopherol acetate was detected. Due to the good spike recovery 
results of tocopherol and tocopherol acetate, it is unlikely that during the 
extraction procedure tocopherol underwent an estérification reaction to 
tocopherol acetate. Therefore, the most obvious explanation is that the 
labelling is incorrect.
For three of the dietary supplements (Calma, Dino Chews and Maxi Multi) the 
vitamin D signal (D2 and D3) was below the detection limit of the extraction 
and analysis procedures. No results were obtained by the determination of 
Optimum Nutrition and Supernutrition Plus. This is illustrated in Figures 1 and 
2 in Appendix 2; chromatograms of the dietary supplements which show that 
there are no comparable experimental peaks to the vitamin standard peaks. 
Unexplainable peaks were expected for Supernutrition Plus due to the nature 
of the dietary supplement, namely it is yeast-based and consequently the fat- 
soluble vitamins are incorporated into the nutrient media and as such could 
have undergone an alteration in structure. Optimum nutrition contains the fat- 
soluble vitamins as compounds attached to an antioxidant preparation, 
(tocopherol acetate). This attachment could explain the apparent lack of 
retinol and cholecalciferol peak at the expected retention times.
The extraction procedure of Wielinski and Olszanowski (1999) provides a 
simple, direct solvent extraction for the analysis of fat-soluble vitamins in 
nutritional supplements. Due to the relative simple sample matrix of these
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supplements this extraction method was ideally suited. Advantages of this 
method are mainly its speed and small amount of apparatus required. The 
main disadvantage of the extraction method is the high dilution factor (100-f) 
causing the inability to measure low concentrations, specifically vitamin D. 
This relatively large dilution factor also leads to a large amount of solvents 
going to waste.
The nitrogen gas atmosphere adds significantly more glassware and the 
requirement of more fume cupboard space. A small number of extractions 
were carried out without the nitrogen gas atmosphere. Instead the glass flask 
was fitted loosely with a stopper. The results from these experiments showed 
no deviation from the results obtained under a nitrogen gas atmosphere. 
However, more extensive experiments would need to be carried out before 
the use of nitrogen gas atmosphere ceased. The nitrogen gas atmosphere is 
a preliminary measure in the prevention fat-soluble vitamin oxidation.
There is a lack of appropriate certified reference materials (CRMs) for the 
analysis of fat-soluble vitamins in dietary supplements. The closest CRM to 
the dietary supplement matrix would be a pharmaceutical preparation. 
Unfortunately, these CRM's are unavailable, only food based matrices are 
commercially available (e.g. margarine, flour and milk powder). There is also 
a general lack of a singular method for the analysis of fat-soluble vitamins in 
CRM’s [Finglas et al., 1996]. Due to the unavailability of relevant CRM’s the 
good agreement between the experimental results and the stated values has 
great importance. This comparison of results combined with the spike 
recovery results validates the extraction method and analysis method.
Further work should include the addition of more fat-soluble vitamins to the 
extraction method. Retinol, tocopherol acid succinate, menadione are also 
added to dietary supplement. It would be convenient if these vitamins could 
be extracted and analysed by the methods mentioned in this chapter.
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Chapter 4 Bioavailability Study
4.1 Introduction
Dietary supplements are traditionally produced as tablets with inactive 
ingredients. In recent years new products have come on to the health food 
market that are advertised as delivering essential elements in a more 
bioavailaiple form. One of the current trends is the use of food-based inactive 
ingredients, typically yeast. The aim of this study is to establish whether there 
is a difference in the bioavailability of iron and zinc between yeast-based and 
traditional tablet-based dietary supplements.
Bioavailability is the “fraction of the ingested nutrient that is utilised for normal 
physiological functions or storage” and is discussed in greater detail in section
4.2 [Jackson, 1997].
Food Form™ supplements are currently being marketed by Higher Nature as 
supplements that contain nutrients in a form that is “more effectively absorbed 
compared to isolated or chelated minerals” [Higher Nature, 2001]. This 
increase^ bioavailability of the nutrients is due to their absorption “over a 
longer stretch of the small intestine” which directly relates to their chemical 
structure. Food Form™ supplements are produced from a culture of 
saccharomyces cerevisiae [Higher Nature, 2000] Yeast-based supplements 
are typically made from Brewer’s yeast and are grown in a nutrient media 
containing the inorganic salt of the essential element [Vinson et al., 1989]. 
Food Form™ supplements consist of a yeast culture grown in a nutrient 
media that are pre-digested with papaya and pineapple enzymes for easier 
absorpticjn prior to tabletting.
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In traditiqnal tablet-based dietary supplements a number of forms of essential 
elements are used; these include inorganic salts, organic salts and amino acid 
chelates. In the United States there are a number of iron and zinc 
compounds that are listed as “generally considered safe” (GCS) for food 
fortificaticjn. These compounds are listed in Table 79.
Table 79. Generally considered safe (GCS) iron and zinc compounds
GCS Iron compounds GCS Zinc compounds
Elemental Iron . Zinc sulphate
Ferrous ascorbate, Ferrous carbonate Zinc chloride
Ferrous citrate. Ferrous fumarate Zinc gluconate
Ferrous lactate. Ferrous sulphate Zinc oxide
Ferric ammonium citrate Zinc stearate
Ferric chloride. Ferric pyrophosphate
Ferric sulphate
*Source: Whitaker, 1998
The iron and zinc compounds listed in Table 79 can also be categorised 
according to their bioavailability. Examples of iron compounds with high 
bioavailability are ferrous sulphate and fumarate. Elemental iron and ferric 
pyrophosphate are examples of iron compounds with low bioavailability 
[Johnson et al., 1998]. Even though elemental iron is less bioavailable than 
ferrous sylphate it is more widely used. This is because ferrous sulphate is 
more expensive to produce and can catalyse the oxidation of fat and produce 
organolef^tic problems in cereals during storage [Whitaker, 1998]. Zinc 
compounds with high bioavailability are zinc acetate, chloride and sulphate 
[Prasad pt al., 1993]. Examples of zinc compounds with low bioavailability 
are zinc oxide and carbonate. Both of these zinc compounds are virtually 
insoluble [Allen, 1998].
4.1.1 Bioavailability ^
Bioavailability is the proportion of the nutrient that is digested, absorbed and 
metabolized in normal pathways. By defining bioavailability of a nutrient in
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this, manner a number of similarities can be seen with the definition of the 
bioavailability of a drug. This latter definition is expressed as the amount of 
the substance that reaches the circulation intact and the rate at which thisI
occurs. The rate depends upon particle size, chemical form of drug and 
absorptiop (if taken orally). The extent of a drug’s bioavailability depends 
upon the rate of absorption and the extent of metabolism before it reaches 
target organs [Bender, 1989].
Rate conditions affecting a drug's bioavailability are the dietary factors that 
affect the absorption of a nutrient. A nutrient is a substance that has been 
defined as having nutritive value, i.e., it participates in metabolism or is used 
to build structures [Zeisei, 1999]. Dietary factors affecting a nutrient’s 
bioavailability include the chemical form of the nutrient that is presented to the 
intestinal mucosa cell, the oxidation state of the nutrient compound and the 
binding strength of the ligands in the lumen of the gastrointestinal tract 
[Falrwea|:her-Tait, 1999]
Digestion is a biological process carried out in the digestive system that 
comprises of the alimentary canal and associated digestive glands [Hale at 
al., 1995]. Because digestion is a natural process, physiological factors are 
also knovyn to affect nutrient absorption. The physiological factors affecting 
nutrient bioavailability [Jackson, 1997] are the: ~
(1 ) efficiency of digestion;
(2) previous intake of nutrient;
(3) body ^tatus of nutrient;
(4) gut transmit time;
(5) presence of gastrointestinal disorders or disease;
(6) other pbsorbed food stuffs at the same time; and
(7) prior-treatment (cooking or processing) of the product.
The main' areas of activity in the digestive system occur in the mouth cavity, 
stomach and small intestine [Hale et al., 1995]. The main site for nutrient
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absorption and digestion is the small intestine; essential elements and 
vitamins are generally absorbed in the duodenum and jejunum sections of the 
small intestine [Groff et al. 1995]. In general, essential elements can be 
grouped jnto those that are well absorbed, moderately absorbed and least 
well absorbed [Fairweather-Tait, 1999]. In this categorisation the two 
analytes, namely iron and zinc, fall into the following groups; iron is least well- 
absorbed (15%) and zinc is moderately absorbed (50%). The difference in 
efficiency of absorption between iron and zinc can be partly attributed to the 
fact that zinc is less affected by dietary factors, particularly inhibitors when 
comparecj to iron.
4.1.2 Iron and zinc
Iron and zinc were chosen as analytes due to the worldwide prevalence of 
their deficiencies. Iron deficiency is the most common nutritional deficiency in 
the World; zinc deficiency is associated with poor growth and development 
and impaired immune response and can also be found in the population of 
Developed Countries [Whitaker, 1998; Hambrldge, 2000].
Four population groups have a frequently inadequate iron intake, these are: 
(1) infants and young children; (2) adolescents; (3) females of childbearing 
years; anpl (4) pregnant women [Herbert, 1987]. Some of these groups are 
represented in the data presented by Dr Bruno de Benoist from the 
International Nutritional Anaemia Consultative Group [Beard, 2000] The data 
states that: -
(1) 46% of the World’s 5-14 year olds are anaemic;
(2) 48% of the World’s pregnant women are anaemic; and
(3) in the Developing World 56% of pregnant women are anaemic.
In India the number of pregnant women who are anaemic is increased to 86% 
[Singlar et al., 1997]
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The. increase of iron requirement in newborns and small children is due to the 
low iron content of milk and other preferred food, rapid growth rate and their 
low body reserve of iron, which is insufficient to meet the body’s needs 
beyond 6 months. During puberty, the average iron requirement increases in 
both boys and girls from 0.7 - 0.9 mg Fe/day to 2.2 mg Fe/day [Beard, 2000]. 
This increase is a result of the expansion of the total blood volume, an 
increase |n body mass and the onset of menstruation in young girls. Females 
during childbearing years are included in the risk groups due to menstrual iron 
losses; p/egnant women are included due to their expanding blood volume, 
demands of the foetus and placenta, plus blood losses to be incurred in 
childbirth [Groff et al,, 1995]. There is particular concern for pregnant 
adolescent girls who fall into two risk groups, adolescence and pregnancy 
[Beard, 2000].
Studies on the supplementation of iron has been focused on pregnant women 
as maternal anaemia is associated with the risk of pre-term delivery, low birth 
weight and prenatal mortality [Singla et al., 1997; Scholl & Reilly, 2000]. 
However, the supplementation of pregnant women is surrounded in 
controversy. There are two opposing sides; one which is for routine 
supplementation and the other for specific supplementation [Roodenburg, 
1995]. Routine supplementation enables every pregnant woman to be given 
iron supplements. This course of action has been proposed as it would 
eliminate anaemia across the spectrum and does not require the assessment 
of iron status in the patient. However, specific supplementation has a greater 
record of compliance, which is significant as gastrointestinal complaints and 
nausea a|re known side effects of iron supplementation [Sjôstedt et al., 1977; 
Roodenburg, 1995].
The main risk groups for zinc deficiency are newborns, children, pregnant 
women, Ipctating women and old people [Krebs, 2000]. Conditions affecting 
zinc requirement include alcoholism, chronic illness, stress, trauma, surgery, 
malabsorption and lacto-vegetarians [Pennington et al., 1986]. Zinc 
deficiency is known to affect the whole population, but especially elderly
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women [j^algueiro et al., 2000]. Severe zinc deficiency has been identified in 
Developed Countries and zinc supplementation studies have proven that zinc
deficiency is a Worldwide problem [Hambrldge, 2000].
I
The most commonly known essential role of zinc in the human body is its 
participation in wound healing [Mason, 1995]. The involvement of zinc in the 
metabolic events that follow injury have a profound effect on the final 
outcome. There is good experimental and clinical evidence for the 
supplementation of zinc to improve healing [Van Rij, 1988]. Nutritional 
support in hospitalised patients has become an aggressive discipline that has 
emphasised nutritional assessment as a predictor of surgical outcome as well 
as an indicator for nutritional needs.
4.2 Biopvaiiability Methods
The dietary intake of essential macro and trace elements can not be 
evaluatecj from the total essential content of a meal. Physiological and dietary 
factors affect the degree of intestinal absorption, so that for most elements 
only a fraction of dietary intake is absorbed and utilised for body functions 
[Sandstrom et al., 1993]. There are two types of bioavailability techniques 
used for plemental absorption studies. These two techniques are in vivo and 
in vitro. Physiological and or dietary factors to be taken into consideration 
depends ppon the bioavailability technique to be used.
Iron is the only inorganic nutrient for which it is possible to obtain a direct 
measurement of bioavailability. This is accomplished by the use an in vivo 
method. Radio- or stable isotopes of iron are used to label “food iron" in a 
meal so fhat its utilisation in the body can be traced. Since most newly 
absorbed iron is incorporated into the haemoglobin of reticulocytes within 10 
to 14 dap, haemoglobin incorporation of isotopically labelled iron can be 
used to quantify bioavailability [Fairweather-Talt, 1996].
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There is no optimum method to assess zinc bioavailability at a reasonable 
cost. Thy use of radioisotopes in zinc bioavailability studies is restricted due 
to the limited access of human whole body counters. Stable isotopes with 
faecal monitoring are an alternative to the use of radioisotopes but within this 
method there is a large in-built error due to the many separate steps involved 
in the sar^ple collection and handling [Sandstrôm, 1997]. Zinc bioavailability 
of foodstuffs is preliminary analysed using an in vitro technique and then 
further analysis is carried out using an in vivo procedure, such as the double 
isotope ratio method [Lowe et al., 2000].
4.2.1 In vivo digestioit
In vivo techniques for the assessment of nutrient availability [Jackson, 1997] 
include t^e: -
(1) reversal of a deficiency symptom or the growth rate in animals;
(2) response of a physiological variable (e.g. haemoglobin repletion test 
for iron); assessment of body retention (balance studies, mass or 
isotopÿ);
(3) blood (or urine) response or the uptake of the nutrient by tissues; and
(4) measurements of the rates of absorption (radioactive or stable 
isotope).
The use of radioisotopes and stable isotopes is predominant with in vivo 
techniques. This is because a radio- or stable isotope of the essential 
element in a meal or body fluid is more easily identified in the final sample 
matrix. The basic principal of isotope studies is that an added isotope of the 
element of interest exchanges with and behaves in an identical way to the 
native element of interest. Radioisotopes are authentic tracers; they are 
relatively cheap and do not require sample pre-treatment before analysis. 
However, the disadvantage of using radioisotopes is the expensive* cost of 
counting equipment and more importantly the restrictions on using such 
radioactiye sources in certain risk groups (e.g. newborns and pregnant 
women) due to the type of administered dose of the radioactive material.
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Radioactive decay in collected and stored samples can lead to an error in the 
results. Due to these restrictions and inherent errors associated with 
radioisotqpes the use of stable isotopes in supplementation studies has risen.
Unlike radioisotopes, stable isotopes are universally present in body tissues. 
Stable isotopes are relatively more expensive and require sample pre­
treatment in order to remove organic materials and any interfering substance. 
Due to their automatic presence in body tissues, the basic requirement of a 
stable isotope study is to achieve a sufficient isotope enrichment in the body 
tissue or fluid of interest so that added tracers can be quantified with the 
necessary degree of precision [Sandstrom, 1987]. The amount of stable 
isotope added to the sample depends upon the following factors: -
(1) the amount of expected absorbance and retention;
(2) the rejative distribution between different body tissues and fluids 
(e.g. 60% of the body's 2 - 3 g of zinc in the human body is in the 
muscle, only 0.1 % is in found in the blood plasma; 60% of 4 g of 
body iron is in haemoglobin);
(3) the natural abundance of the isotope administered, (higher the 
abundance, higher the enrichment);and
(4) the degree of stable isotope enrichment required for detection, 
(dependent upon precision of the instrument).
To overcpme the factors mentioned above a large dose of the enriched 
isotope is often calculated. Large doses of a nutrient are unacceptable as 
they may exceed the normal daily Intake of the nutrient and consequently 
produce unrepresentative results [Mellon & Fairweather-Tait, 1997].
There ary two types of methods for labelling food samples with radio- or 
stable isotopes, namely, extrinsic and intrinsic labelling. Both methods work 
on the basic principle of isotope studies (that an added isotope of an element 
exchanges with and behaves in an identical manner to the native element). 
Extrinsic labelling is where the isotope is mixed with the foodstuff or meal.
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Intrinsic labelling involves the biological incorporation of the isotope into food, 
typically plant and animal tissue. Extrinsic labelling is the more common 
method.
In summary, human in vivo techniques are time-consuming, expensive, rather 
complicated to perform and sometimes yield variable results which are 
susceptible to large error [Shen et al., 1994]. In vivo animal studies are 
limited by uncertainties about the differences in human and animal iron 
metabolism [Miller et al., 1981]. However, only human in vivo methods take 
into account all physiological, factors influencing bioavailability of a nutrient.
4.2.2 In  v i t r o  digestion
There are two types of in vitro techniques available for the assessment of 
nutrient bjoavailability [Miller et al., 1981], these are: -
(^)in vitro solubility or dialysability test; and
(2) the uptake of a nutrient by isolated tissue or cultured cells.
In vitro techniques are relatively simple and rapid inexpensive methods, which 
usually involve the stimulation of gastric digestion followed by a measurement 
of soluble or dialyzable iron [Jackson, 1997]. The in vitro technique is often 
used to pj^ edict the direction of the absorptive response but not the magnitude 
in man [Murrell, 1997] Since in vitro techniques are often used as 
preliminaijy tests before in vivo analysis the main aim is to rank individual 
foods in order of available iron content and to predict correctly the effects of 
enhancers and inhibitors in vivo (i.e. human digestion) [Valdez et al., 1992].
The first in vitro methods were based on the release of ionizable iron from 
foods subjected to treatment with pepsin-HCI at pH 1.35 and subsequent 
adjustment of pH to 7.5. These methods stimulated in vivo conditions in the 
stomach and intestine, respectively [Narasinga & PrabhavathI, 1978, 
Schricker et al., 1981]. Other methods published at the same time period 
included the addition of an enzymolysis step at the beginning of the pepsin
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and pancreatine incubation [Crewes et al., 1983]. In these early methods, 
the change in environments from the stomach (acidic) to the small intestine 
(alkaline) occurred only through an adjustment of the pH level. However, 
these in y/fro methods were able to distinguish between the availability of iron 
in different complex mixtures and the respective results did resemble those 
found froryi human in vivo studies [Schricker et al., 1981].
In 1981, Miller et al. suggested an in vitro method that stimulated 
gastrointestinal digestion and measured soluble, low molecular weight iron 
[Miller et al., 1981]. This method was different to the other in vitro digestion 
methods in two ways; (1) it included a gradual and reproducible pH 
adjustment; and (2) soluble low molecular weight iron was used to estimate 
the amount of available iron.
Any pH adjustment is crucial in an attempt to stimulate gastrointestinal 
digestion. The pH of the stomach and duodenum can have a major effect on 
iron absorption and digestive enzyme activity [Benjamin et al., 1967; 
Bezwody et al., 1978] In the Miller et al. (1981) method the gradual pH 
adjustment following the movement of the chyme from the stomach to the 
small intestine is brought about by the use of a sodium bicarbonate solution 
inside a length of dialysis tubing [Hazell & Johnson, 1987]. The dialysis 
tubing provides a physical representation of the small intestine. This is 
important as both iron and zinc are predominantly absorbed at the proximal 
end of thp small intestine and not the stomach [Narasinga & PrabhavathI, 
1978]. However, it should be understood that the selection of pH and 
incubation times for in vitro digestion is entirely arbitrary since it is impossible 
to duplicate the in vivo mechanisms controlling the pH and rates of passage in 
the biological digestion process [Miller et al., 1981].
Soluble low molecular weight iron was chosen to provide bioavailability 
measurements as iron bound to high molecular weight peptides are unable to 
cross the mucosal mucus layer in the proximal small intestine where iron 
absorption is the most efficient [Miller & Berner, 1989]. Thus the inclusion of
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high molecular weight iron peptides would result in the overestimation of iron 
bioavailability [Valdez et al., 1992].
In 1991, Kapsokefalou and Miller modified the Miller et al. (1981) in vitro 
method. Instead of using sodium bicarbonate and a titration step to provide 
the alkaline conditions of the small intestine a solution of PIPES (piperazine- 
N,N’-bis[2-ethane-sulfonic acid]) as a disodium salt was suggested 
[Kapsokefalou & Miller, 1991]. The advantage of using PIPES was that the 
cumbersome titration step for each sample was no longer necessary.
The great advantage of the Miller et al. (1981) method and any later modified 
methods is that it can be used for the bioavailability assessment of any 
essential élément. This method has been used for the study of calcium, iron 
and zinc bioavailability and the results from these studies show good 
agreement with the in vivo prediction of the respective bioavailability, 
especially for iron and zinc [Schwarz et al., 1982; Zemel, 1984; Garcia, 
1998].
Further advances in the in vitro technique include continuous flow digestion, 
the addition of Caco-2 cell cultures and the use of computer systems. All 
three improvements are based upon the Miller et al. (1981) method or the 
Kapsokefalou and Miller (1991) method and are presented as more 
representative of in vivo conditions. The continuous flow method, involves the 
continual removal of the dialyzable components from the pancreatic digestion 
mixture [Welter et al., 1993] The removal of the dialyzable components 
more closely mimics the conditions in the human gut, as once the nutrients 
are absorbed they do not stay in that vicinity but instead are transported to 
various organs. The disadvantage of the continuous flow method is that it 
cannot be applied to some essential macro and trace elements, where their 
dialysability is susceptible to pH change [Shen et al., 1994].
Caco-2 cell cultures are currently being used as an adjunct on the end of the 
Kapsokefalou and Miller (1991) m vitro method. This method involves the use
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of radioisotopes of the nutrient (e.g. ^Fe). The radioisotopes are extrinsicaliy 
labelled to the meal prior to in vitro digestion. The dialysalate solution is 
removed from the tubing and an aliquot is added to Caco-2 cell monolayers. 
After an incubation of 60 minutes, iron non-specifically bound to the surface of 
the monolayers was removed and the remaining cells were counted.for ^Fe 
activity [Ganloff et al., 1996]. Caco-2 cells are useful as they are of human 
origin, they possess many characteristics of the intestinal epithelium and they 
are capable of taking up non-heme iron. More importantly Caco-2 cells 
exhibit uptake characteristics consistent with in vivo observations in humans 
and animals [Glahn et al., 1997; Glahn et al., 1998].
Computerised advanced digestion methods have been proposed for the 
analysis of iron and phosphorous availability in cereals. Four separate but 
connecting compartments mimic the stomach, duodenum, jejunum and ileum. 
The advantages of this in vitro method are the peristaltic movements and the 
absorbance of the nutrients in the jejunum and ileum compartments [Minekus 
et al., 1995; in Larsson et al., 1997].
4.3 Experimental Procedure
Four sets of dietary supplements were chosen from three companies (Higher 
Nature, ^uperdrug and Nature's Own) to give a good comparison of yeast- 
based with traditional tablet-based dietary supplements. Yeast-based dietary 
supplements were obtained from Nature’s Own and Higher Nature; traditional 
tablet-based dietary supplements were bought from Superdrug and Higher 
Nature. Table 80 presents the dietary supplements for the bioavailability 
study according to the manufacturer. Spike recovery experiments were 
carried out on two types of base material used by Higher Nature. A yeast 
material (yeast culture without nutrient media) was obtained by Higher Nature 
from the manufacturer of true Food Form™ supplements, namely. Grow 
Company. The tablet-base materials provided by Seaford were for the 
traditional dietary supplement matrix.
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Table 80. Dietary supplements for bioavailability study
Higher Nature Nature’s Own
Food Form™ Supernutrition 
Food Form™ Easy Iron 
' Food Form™ Zinc
Food State Multivitamins & Minerals 
Food State Iron 
Food State Zinc
Higher Nature - Superdrug
Optimum Nutrition 
■ Biominerals 
Zinc & Copper
Multivitamins & Minerals 
■Multiminerals
4.3.1 Reagents and equipment
The following reagents and instruments were used during the bioavailability 
study.
4.3.1.1 Dietary Supplements
Three sets of dietary supplements were analysed in the bioavailability study. 
Food Form™ Supernutrition, Food Form™ Easy Iron, Food Form™ Zinc, 
Optimum Nutrition, Biominerals, Zinc and Copper (Higher Nature, Burwash, 
UK) were bought by mail order directly from Higher Nature. Multivitamins and 
Minerals and Multiminerals (Superdrug Stores PLC, Croydon, UK) were 
obtained Jrom the Superdrug store in Guildford High Street and Food State 
Multivitamin and Minerals, Food State Iron, Food State Zinc (Nature’s Own 
Ltd, Worcjestershire, UK) were bought in Cheese World in Guildford.
4.3.1.2 Reagents
The in vitro digestions were performed with pepsin (Sigma, St Lours USA), 
pancreatipe (Sigma), bile extract (Sigma), PIPES (piperazine-A/,A/’-bis-(2- 
ethane-sulfonic acid)) disodium salt (Sigma). Dilutions and in vitro solutions
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were accomplished using distilled, deionized water (DDW) with a resistively of 
18 IVincm'\ The water was obtained from an Elgastat UHQ water dispenser 
(Elga Ltd, High Wycombe).
4.3.1.3 In vitro solutions
The pepsin solution used consisted of 4.0 g of pepsin powder that was 
suspended in 0.01 N hydrochloric acid (Analar grade, 67%, BDH Laboratory 
supplies, Poole, UK) diluted to 100 ml with 0.1 N HCI (Aristar grade, BDH). 
The pancreatine-bile mixture consisted of 0.5g porcine pancreatine and 3.0 g 
of bile extract that was suspended in 0.01 N NaHCOs (BDH) and diluted to 250 
ml with 0.1 N NaHCOs (BDH). The PIPES buffer solution added to the dialysis 
tubing (Spectra/Por® Molecularporous Regenerated Cellulose. Dialysis 
Membrane,'MW cut-off 6000-8000, Fisher BIO-200-040U, UK) consisted of 
0.15N PipES (Sigma) dissolved in DDW and adjusted to pH 6.1 with 
concentrated HCI (Analar grade, BDH).
4.3.1.4 Analytical standards
Individual standard of zinc and iron standards were supplied as 10,000 mg/L 
solutions (Aristar, Plasma Emission Standard, BDH). FAAS calibration 
standards were accomplished by the use 0.15N PIPES solution for matrix- 
matching. All glassware and polypropylene bottles were soaked overnight in 
5% HCI then rinsed with DDW. In vitro digestion bottles were cleaned after 
each digest using Decon™ and rinsed with DDW.
4.3.1.5 Instrumentation
In vitro digests took place in a Grant OLS 200 shaking water bath supplied by 
Grant Instruments Ltd (Royston, UK). Analysis of samples took place on a PE 
5000 FAAS (Perkin Elmer, Connecticut, USA) fitted with a pneumatic 
nebuliser and a Premix design burner.
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4.3.2 Experimental method
The method stated in Kapsokefalou & Miller (1991) was used to digest dietary 
supplements test solutions. Dietary supplement and reagent blank analyses 
were carried out in triplicate. Spike recoveries on yeast and tablet matrices 
were carried out in duplicate. A 1 ml aliquot of 10,000 pg/L of iron and zinc 
Plasma Emission Standards (BDH, Poole) was added as a spike to each 
sample matrix. After dilution the final concentration of the spike was 250 pg/L. 
The base materials used for the tablet matrix were dibasic calcium phosphate 
(0.2 g), magnesium stearate (0.1 g), cellulose (0.1 g) and silica (0.1 g).
Modified Method
A 0.50 g ±0.10 g aliquot of the crushed dietary supplement was transferred to 
a polypropylene bottle (250 ml) and mixed with 20 ml of 0.01 IN HCI. This 
solution was then adjusted to pH 2 using 6M HCI. Pepsin solution (1ml) was 
added to each bottle. The mixture was then incubated at 37®C in a shaking 
water bath for 2 hours. At the end of the pepsin incubation, a dialysis bag 
containing 20 ml of PIPES buffer was added to each bottle. After 30 min of 
incubation 5 ml of pancreatine-bile mixture was added to each bottle, and the 
incubation was continued for another 2 hours. At the end of the pancreatine- 
bile incubation the dialysis bag was removed and rinsed by dipping in 
deionized water (18mQ). The dialysalate solutions were emptied into pre­
weighed polypropylene bottles, weighed, then stored in a refrigerator (4®C) 
until analysis.
4.3.3 Analysis procedure
The dialysalate solution determinations were carried-out using flame atomic 
absorption spectroscopy (FAAS). Single element cathode lamps were used 
for the iron and zinc analysis. The lamps were heated for one hour prior to 
the commencement of sample analysis. The FAAS analysis conditions are 
stated in Table 81.
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Table 81 FAAS conditions for in vitro analysis
FAAS Conditions Iron Zinc
Wavelength (nm) . - 248.3 . . 213.9
Applied current (mA) 10 5
Energy 50 52
Slit width (nm) 0.7 0.7
The calibpation standards were prepared using Plasma Emission Standards 
(BDH) and PIPES solution for matrix-matching. Table 82 states the set of 
calibration standards used for each analysis. To prevent the PIPES from 
falling out of solution during analysis, caused by the low pH of the Plasma 
Emission Standards (BDH), the first stock solution was made-up using only 
deionized water (18mO). All subsequent dilutions were made using the 
PIPES solution.
Table 82. Calibration standards for in vitro samples by FAAS
Standard Iron, Zinc (mg/L)
1 1
2 2
3 4
4 8
4.4 Bioavailability Test Results
All bioavailability test results for iron and zinc are expressed as a percentage 
of the dietary supplement content that was dlalysed. Dialyzability percentage 
is expressed in Equation 8.
% = (D / T) X 100 eqn (8)
171
where D = nutrient content (mg/g) in the dialysalate and T = the nutrient 
content in the nutritional supplement stated on the label [Garcia et al., 1998].
To calculate the nutrient content (mg/g) of the dialysalate solution (D) the 
absorbance data was converted to a concentration by the linear regression 
data obtained from the respective calibration graph and then a) multiplied by 
the volume of the dialysalate solution (and any dilutions) and b) divided by the 
weight of the dietary supplement.
Tables 83, 84 and 85 presents the bioavailability results for iron and zinc 
according to manufacturer. The relative standard deviation for the majority of 
the results is less than or equal to ± 10%. The exceptions to this finding are 
Higher Natures Food Form™ Easy Iron and Superdrug’s Multivitamin and 
Mineral dietary supplement. The heterogeneous nature of Superdrug’s 
Multivitanfiin and Mineral dietary supplement could easily explain the larger 
variance from the mean value. For Higher Nature’s Food Form™ Easy Iron 
dietary supplement the variance away from the mean is less and closer to the 
ideal (± 10%), however large dilution factors and the possible heterogeneous 
nature could account for the larger relative standard deviation and the 
Horowitz factor. The Horowitz factor states that as the concentration of an 
analyte decrease the degree of variance increases [Iyengar, 1989]
Table 83. Bioavailability results for Higher Nature Supplements
Dietary supplement Iron (%)
X ± SD (RSD%)
Zinc (%)
X ± SD (RSD%)
Food Form Easy Iron 3.83 ±0.41 (11%) <dl
Food Form Zinc <dl 34.54 ±1.87 (5%)
Supe;nutrition Plus 14.62 ±1.31 (9%) 31.28 ±1.41 (5%)
Optimum Nutrition 12.68 ±0.68 (5%) 6.57 ±0.54 (8%)
Biominerals 0.64 ± 0.05 (9%) 3.06 ± 0.27 (9%)
Zinc and Copper <dl 2.43 ± 0.21 (9%)
*Key: X ± SD (RSD%) = mean ± standard deviation (relative standard deviation %), <dl 
signal below detection limit.
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Table 84. Bioavailability results for Nature’s Own supplements
Dietary supplement Iron (%)
X ± SD (RSD%)
Zinc (%) 
X ± S D  (RSD%)
Food State Iron 0.26 ±0.03 (10%) <dl
Food State Zinc <dl 29.52 ±0.43 (1%)
FS Multivitamins & min. 34.45 ± 2.76 (8%) 23.26 ±1.83 (8%)
*Key: X ± SD (RSD%) = mean ± standard deviation (relative standard deviation %), <dl 
signal below detection limit.
Table 85. Bioavailability results for superdrug supplements
Dietary Supplement Iron (%)
X ± SD (RSD%)
Zinc (%)
X ± SD (RSD%)
Multivitamins and minerals 0.58 ±0.06 (11%) 8.86 ±1.14 (13%)
Multiminerals 0.12 ±0.01 (9%) 0.24 ± 0.02 (8%)
*Key: X ± SD (RSD%) = mean ± standard deviation (relative standard deviation %).
Two trends are identified in the dietary supplement bioavailability results from 
Tables 83-85, namely, the vitamin C enhancement of iron availability and the 
increase in zinc availability in yeast-based compared to traditional tablet- 
based supplements.
To establish whether the sample matrix (yeast or traditional tablet-based 
materials) caused any inhibition or enhancement of iron and zinc 
bioavailability spike recovery experiments were carried out and the results are 
shown in Table 86. The immediate interpretation of the results is the 
difference in availability between iron and zinc. Iron bioavailability is 
significantly lower than that for zinc. This observation reflects the fact that 
iron is not readily absorbed in the human body when compared to zinc which 
is moderately absorbed [Fairweather-Tait, 1999]. Iron bioavailability of the 
spiked samples decreases with a tablet-based matrix. In contrast, zinc 
bioavailability of the spiked samples does not significantly differ between the 
two types of matrix. These observations are in contradiction to the trends
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observed in Tables 83-85. It should be noted that the spiked samples 
consisted of adding iron nitrate and zinc nitrate in a 2% nitric acid solution.
Table 86. Spike recovery results for sample matrices
Sample matrix Iron (%) 
X±SD(RSD%)
Zinc (%) 
X ± S D  (RSD%)
Food State Iron 6.70 ± 0.57 (8%) 38.25 ± 0.21 (0.6%)
Food State Zinc 6.15 ±0.21 (3%) 39.00 ± 2.26 (6%)
Tablet 1.51 ±0.01 (0.5%) 36.95 ±1.34 (4%)
"Key: X ± SD (RSD%) = mean ± standard deviation (relative standard deviation %).
4.5 Discussion
The statistical evaluation of bioavailability data for dietary supplements was 
carried-out using a Paired t-test. The equations for this statistical test are 
stated in Appendix 1 [Farrant, 1997]. The t-critical values (n=3) at the 99% 
and 95% confidence limits are 5.841 and 3.182, respectively.
The primary aim of this study was to find out if there was a significant 
difference between the bioavailability of iron and zinc in yeast-based dietary 
supplements compared to tablet-based dietary supplements. Table 87 
presents the comparison of two Higher Nature dietary supplements, 
Supernutrition plus (yeast-based) and Optimum Nutrition (tablet-based). For 
iron bioavailability there is no significant difference between the two dietary 
supplements at 95% and 99% confidence limits. Both of the multi-component 
dietary supplements contain vitamin C. In the case of zinc there is a 
significant difference at a 95% and 99% confidence limits. Therefore, the 
multi-component yeast-based dietary supplements provide zinc in a 
significantly more bioavailable form than the equivalent tablet-based 
supplements.
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Table 87. Comparison of Supernutrition plus (Food Form™ supplement)
with Optimum nutrition using a Paired t-test
, Element Iron bioavailabi ity (%) Zinc bioavailabi ity (%)
Sample no. 1 2 3 1 2 3
Supernutrition Plus 13.11 15.25 15.00 32.36 31.80 29.69
Optimum Nutrition 12.28 13.47 12.29 6.00 6.65 7.08
Bioavailability difference 0.83 1.78 3.21 26.36 25.15 22.61
Mean 1.92 24.71
Standard Deviation 1.20 1.91
t-experimental 2.81 22.37
*Paired t-test t-critical values (n=3) for 99% and 95% confidence limits are 5.841 and 3.182.
Table 88 compares Higher Nature's Supernutrition plus (yeast-based) dietary 
supplement. with Higher Nature’s Biominerals (tablet-based) dietary 
supplement, that does not contain any vitamins, particularly vitamin 0 and 
reports a significant difference between the two iron bioavailability results for 
both confidence limits. This result supports the evidence that the difference in 
bioavailability is firstly due to the vitamin 0  content in the dietary supplements. 
The zinc bioavailability results for the yeast-based (Supernutrition Plus), is 
significantly greater than for the tablet-based, (Biominerals) dietary 
supplement.
Table 88. Comparison of Supernutrition plus (Food Form ™ supplement) 
with Biominerals using a Paired t-test.
Element Iron bioavailabi ity (%) Zinc bioavailabi ity(%)
Sample no. 1 2 3 1 2 3
Supernutrition Plus 13.11 15.25 15.00 32.36 31.80 29.69
Biominerals 0.66 0.68 0.58 3.32 3.07 2.78
Bioavailability difference 12.45 14.57 14.92 29.04 28.72 26.91
Mean 13.98 28.23
Standard Deviation 1.34 1.15
t-experimental 18.13 42.60
Paired t-test t-critical values (n=3) for 99% and 95% confidence iimits are 5.841 and 3.182
The products considered so far have been multi and not "single"' mineral 
dietary supplements. Higher Nature produces one dietary supplement 
containing zinc as the “single” mineral, namely. Zinc and Copper (tablet- 
based). By comparing Zinc and Copper with Biominerals it would be possible
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to establish the relative enhancement or inhibition of the other active 
ingredients in a multi dietary supplement. The results of this comparison are 
presented in Table 89.
Table 89. Comparison of Biominerals with Zinc and Copper using a
Paired t-test
Element Zinc bioavailability %)
Sample no. 1 2 3
Biominerals 3.32 3.07 2.78
Zinc & Copper 2.66 2.40 2.24
Bioavailability difference 0.66 0.67 0.54
Mean 0.63
Standard deviation 0.08
t-experimental 14.16
Paired t-test t-critical values (n=3) for 99% and 95% confidence iimits are 5.841 and 3.182.
There is a significant difference in the zinc bioavailability results of Zinc and 
Copper compared to Biominerals as t-experimental (14.16) is greater than 
both t-critical values for 99% (5.841) and 95% (3.182) confidence limits. This 
provides further evidence that multi-component products provide zinc in a 
more available form than single mineral supplements.
So far the statistical evaluation has been based on dietary supplements from 
one manufacturer, Higher Nature. The comparison of Higher Nature’s Food 
Form™ Supernutrition with SuperDrug’s dietary supplements provides further 
evidence of the trends identified with the comparison of Higher Nature 
products i.e. iron bioavailability is enhanced by vitamin C, zinc bioavailability 
is enhanced by yeast or multi-component dietary supplements. This 
comparison is illustrated in Table 90.
Table 90 illustrates that both iron and zinc’s bioavailability in Supernutrition 
Plus is significantly greater than the iron and zinc bioavailability in 
Superdrug’s Multivitamin and Minerals. The 0.58% value for iron 
bioavailability in Superdrug’s Multivitamin and Minerals is relatively low, 
considering that it contains vitamin C.
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Table 90. Comparison of Supernutrition plus with Superdrug’s
Multivitamins & Minerals using a Paired t-test
Element Iron bioavailabi ity (%) Zinc bioavailabi ity(%)
Sample no. 1 2 3 1 2 3
Supernutrition Plus 13.11 15.25 15.00 32.36 31.80 29.69
Multivitamin & Minerals 0.54 0.65 0.55 8.18 8.17 8.23
Bioavailability difference 12.57 14.60 14.95 24.18 23.63 21.46
Mean 14.04 23.09
Standard deviation 1.29  ^ 1.44
t-experimental 18.92 27.82
^Paired t-test t-critical values (n=3) for 99% and 95% confidence limits are 5.841 and 3.182.
Table 91 provides further evidence that zinc bioavailability is significantly 
greater in yeast-based supplements such as Supernutrition Plus compared to 
tablet-based dietary supplements like Superdrug’s Multiminerals.
Table 91. Comparison of Supernutrition Plus with Superdrug’s 
Multiminerals using a Paired t-test
Element Iron bioavailabi ity (%) Zinc bioavailabi ity(%)
Sample no. 1 2 3 1 2 3
Supernutrition Plus 13.11 15.25 15.00 32.36 31.80 29.69
Multiminerals 0.11 0.12 0.13 0.22 0.24 0.26
Bioavailability difference 13.00 15.13 16.37 32.14 31.56 29.43
Mean 14.50 31.04
Standard deviation 1.31 1.43
t-experimental 19.24 37.70
*Paired t-test t-criticai values (n=3) for 99% and 95% confidence limits are 5.841 and 3.182.
However, when SuperDrug’s Multivitamin and Minerals is compared against 
SuperDrug’s Multimineral dietary supplements there is a significant difference 
between the two sets of results at both the 95% and 99% confidence levels 
(Fe t-expti 12.01 and Zn t-expti 7.50 > t-critical at 99%: 5.841 & 95%: 3.182). 
This comparison is presented in Table 92. There is a significant increase in 
the iron bioavailability of Superdrug’s Multivitamin and Minerals compared to 
Superdrug’s Multimineral tablet. This difference is due to the presence of 
vitamin 0 in the Multivitamin and Mineral tablet. This trend is also seen when 
comparing two of Higher Nature’s tablet-based dietary supplements, namely. 
Optimum Nutrition and Biominerals (Table 93). Iron bioavailability is
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significantly different between Optimum Nutrition and Biominerals at the 95% 
and 99% confidence limits. The same result is seen in the comparison of zinc 
bioavailability results. Overall, zinc bioavailability is greater in the multivitamin 
and mineral tablets compared to multimineral dietary supplements.
Table 92. Comparison of Superdrug Multivitamins & Minerals with 
Superdrug Multiminerals using a Paired t-test
, Element Iron bioavailabi ity(%) Zinc bioavailabi ity (%)
Sample no. 1 2 3 1 2 3
Multivitamin & Minerals 0.54 0.65 0.55 8.18 8.17 8.23
Multiminerals 0.11 0.12 0.13 0.22 0.24 0.26
Bioavailability difference 0.43 - 0.54 0.42 7.96 7.93 7.97
: Mean 0.46 7.96
Standard deviation 0.07 0.02
t-experimental 12.01 697
''Paired t-test t-critical values (n=3) for 99% and 95% confidence iimits are 5.841 and 3.182.
Table 93. Comparison of Optimum Nutrition with Blomlnerals using a
Paired t-test
Element Iron bioavailabi ity (%) Zinc bioavailabi ity(%)
Sample no. 1 2 3 1 2 3
Optimum Nutrition 12.28 13.47 12.29 6.00 6.65 7.08
Biominerals 0.66 0.68 0.58 3.32 3.07 2.78
Bioavailability difference 11.62 12.79 11.71 26.8 3.57 4.30
Mean 12.04 3.52
Standard deviation 0.65 0.81
t-experimental 32.16 7.50
Paired t-test t-criticai values (n=3) for 99% and 95% confidence iimits are 5.841 and 3.182.
Higher Nature's Food Form™ dietary supplements are based upon a yeast 
matrix; Nature’s Own Food State dietary supplements are also based upon,;a• : I >'.•
yeast based matrix. Both manufacturers state that these forms have greater 
nutrient availability than tablet-based dietary supplements. Tables 94, 95 and 
96 shows the statistical evaluation of the comparison of Higher Nature's Food, 
Form™ Iron, Zinc, Supernutrition Plus with Nature’s Own Food. State 
Iron, Zinc ^  Multivitamin and Minerals, respectively.
\ ,
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Table 94 shows that there is a significant difference between the iron 
bioavailability of Higher Nature’s Food Form™ Easy Iron compared to Natures 
Own Food State Iron. There are two possible explanations for this, firstly 
Higher Nature’s Food Form™ Easy Iron is produced as a vegi-capsule while 
Nature’s Own Food State Iron is produced as a tablet that includes the 
following base materials; dibasic calcium phosphate, magnesium stearate, 
silica and glazing agent. Secondly, the difference in the production of the 
"food” matrix influences the bioavailability of iron. If the difference in the 
production of the “food” matrix causes a significant contribution to elemental 
bioavailability, it would also appear in the zinc bioavailability comparison, and 
this is not seen.
Table 94: Comparison of Food Form™ Easy Iron with Food State Iron
using a Paired t-test
Element Iron bioavailability (%)
Sample no. 1 2 3
Food Form Iron 3.73 3.48 4.27
Food State Iron 0.28 0.27 0.23
Bioavailability difference 3.45 3.21 4.05
Mean 3.57
Standard deviation 0.43
t-experimental 14.43
*Palred t-test t-critical values (n=3) for 99% and 95% confidence limits are 5.841 and 3.182.
From Table 95 it is possible to state that at the 99% confidence limit there is 
no significant difference between the zinc bioavailability in Higher Nature’s 
Food Form™ Zinc compared to Nature’s Own Food State Zinc. However, at 
the 95% confidence limit the zinc bioavailability of Higher Nature's Food 
Form™ Zinc is significantly greater than Nature’s Own Food State Zinc (t- 
exptl 4.82 > t-crit 3.182). This significant difference in zinc bioavailability 
between Higher Nature’s Food Form™ dietary supplements and Nature’s 
Own Food State dietary supplements is evident in the comparison of 
Supernutrition Plus and Multivitamin and Minerals (Table 96).
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Table 95. Comparison of Food Form™ Zinc with Food State Zinc using a
Paired t-test
Element Zinc bioavailability %)
Sample no. 1 2 3
Food Form Zinc 35.96 32.42 35.25
Food State Zinc 29.96 29.48 29.11
Bioavailability difference 5.99 2.94 6.15
Mean 5.03
Standard deviation 1.81
t-experimental 4.82
Paired t-test t-critical values (n=3) for 99% and 95% confidence limits are 5.841 and 3.182.
Table 96. Comparison of Food Form™ Supernutrition plus with Food 
State Multivitamin and minerals using a paired student t-test
, Element Iron Zinc
Sample 1 2 3 1 2 3
Supernutrition plus 12.28 13.47 12.29 32.36 31.80 29.69
NO Multivitamin & min 35.52 31.31 36.51 23.77 24.77 23.23
Difference 23.24 17.85 24.22 8.59 7.03 8.46
Average 21.77 8.03
Standard Deviation 3.43 0.87
T-experimental 10.99 16.06
Table 96 supplies evidence that zinc bioavailability of Supernutrition Plus is 
significantly greater than Multivitamin and Minerals. The comparison of iron 
bioavailability in Table 95 shows that Nature’s Own Food State Multivitamin 
and Minerals is significantly greater than Higher Nature’s Food Form™ 
Supernutrition Plus. This is not due to the differing production processes but 
to the amount of vitamin C present in both supplements. Nature’s Own Food 
State Multivitamin and Minerals contains 100 mg of vitamin G compared to 
only 10 mg found in Higher Nature’s Food Form™ Supernutrition Plus.
4.6 Conclusions
This in vitro study is the first step in investigating the potential bioavailability of 
iron and zinc in yeast-based dietary supplements. This is because in vitro 
techniques are considered to be a form of preliminary screening of nutrient
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availability [Forbes et al., 1989]. Iron and zinc are ideal candidates for in vitro 
techniques for a number of reasons. The human body excretes only a small 
amount pf iron [Hurrell, 2000], therefore bioavailability and absorption are 
synonymous. In theory, all zinc compounds can be absorbed, in some cases 
certain types of diets (e.g. EDTA) can not be utilised as they alter the re­
absorption of endogenous intestinal excreted zinc. With these exceptions 
there are no indications that absorbed zinc is not utilised by the body if 
needed [Sandstrom, 1997]
The two major trends noted in the comparison of bioavailability results for 
different sets of dietary supplements was the enhancement of iron availability 
by vitamin C and the enhancement of zinc availability by yeast-based matrix 
and components of multi-component dietary supplements. These trends are 
presented in Figures 31 and 32.
Figure 31 reports that the three dietary supplements with increased iron 
bioavailability are all multi-component dietary supplements containing vitamin
C. The enhancement of iron availability by vitamin C overcomes the inhibition 
of tablet-based dietary supplements to the extent that Higher Nature’s 
Optimum Nutrition provides iron in a more available form than Higher Nature’s 
Food Form™ Easy Iron. This is also seen with the comparison of 
Superdrug’s Multivitamin and Minerals iron dialysability results, which is 
higher than Nature’s Own Food State Iron. Nature’s Own Food State Iron 
appears at the low end of the chart as it contains no vitamin C and is 
produce^ as a tablet, so potentially inhibiting base materials are included in its 
formulation. The inhibition of iron absorption by base materials is also seen in 
the comparison of Higher Nature’s Food Form™ Supernutrition Plus and 
Higher Nature’s Optimum Nutrition dietary supplements (Figure 31). Optimum 
Nutrition contains ten times more vitamin C than Supernutrition Plus, yet due 
to its formulation it has lower iron bioavailability than Supernutrition Plus.
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Figure 31. Iron bioavailability results
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Figure 32 reports the major trend in the zinc bioavailability results. Firstly, 
“food” matrix products have a significantly greater zinc bioavailability than 
tablet-based dietary supplements. The secondary trend within the tablet- 
based products are that dietary supplements that contain vitamins show a 
greater zinc bioavailability than those not containing vitamins.
Figure 32. Zinc bioavaiiability results
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All the results have been expressed in terms of bioavailability (or dialysability) 
of the supplements under the conditions stated in the experimental procedure. 
As with all in vitro results quantifiable extrapolation to in vivo situation is 
debatable, partly because of the dynamic changes that take place in biological 
systems cannot be easily stimulated [van Dokkum, 1989]. Therefore, in vitro 
measurements of nutrient availability must be relative rather than absolute i.e. 
an indication of bioavaiiability [Miller et al., 1981].
in vivo rat studies have been carried out for the analysis of iron bioavaiiability 
in Food Form™ Easy Iron in comparison with an inorganic iron compound and 
an iron amino acid chelate compound. In the rat blood and liver samples 
there was no significant differences between the three forms of iron 
compounds'[Vinson 1991]. This report appears to back-up the evidence that 
the major influence of iron availability is vitamin C enhancement and not the 
dietary supplement matrix / form of iron.
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Chapter 5 Conclusions and Further Work
5.1 Conclusions
At present dietary supplements are subject to a different efficacy and safety 
standard than are pharmaceuticals and functional foods, even though they 
share the same goal of enhancing health. No evidence of a dietary 
supplements safety for public consumption is required before being sold to the 
general public [Haisted, 2000]. The aim of this research was to provide 
analytical rnethods for the determination of active ingredients in dietary 
supplements. The two active ingredients determined were essential elements 
and fat-soluble vitamins. Non-essential elements were also measured to 
provide information on the possible contamination of lead and cadmium to 
dietary supplements from a number of possible sources.
5.1.1 Elemental analysis
ICP-MS was chosen as the primary analytical technique determination of 
essential and non-essential elements. It was chosen due to its large dynamic 
range and its sequential measurement of the twelve analytes. Two digestion 
methods were developed for the determination of essential and non-essential 
elements in dietary supplements by ICP-MS. Wet open vessel and 
microwave digestion methods provided the answer to the main sample 
preparation problem of the dietary supplements being of solid form and not 
liquid. Bpth methods utilised the oxidising powers of concentrated nitric acid 
and hydrogen peroxide and both methods resulted in sample solutions with a 
low percentage of solids. The digestion procedures and subsequent ICP-MS 
analysis was validated with the use of CRMs (NIES Rice Flour and IGGE Tea) 
and an in-house reference materials (Biocal™). A good comparison was 
found to exist at a 99% confidence limit between the experimental results and 
the stated values of the twelve analytes in the CRMs. All seventy-four dietary
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supplements were digested by microwave and analysed by ICP-MS. Even 
though the number of replicates was small the RSD values were 
predominantly below 15%, so that the precision of the method can be said to 
be adequate. It was important that all 74 dietary supplements were analysed, 
as two th^ irds of the supplements did not have any information on essential 
element content. These dietary supplements were herbal, fruit extracts and 
root based. Only 24 dietary supplements contained essential elements as 
active ingredients. The experimental results from the 24 dietary supplements 
were used in a comparison with the stated essential content on the respective 
labels. Two trends were observed from these comparisons. Firstly, the 
experimental values for calcium and magnesium were consistently lower than 
the values stated on the respective labels of the 24 dietary supplements. 
Secondly, the experimental values for chromium, copper, iron, manganese, 
molybdenum and zinc were typically equal to of higher that the respective 
dietary supplement label values.
Calcium and magnesium are found at varying levels in dietary supplements. 
From Table 39 (p?) it can be observed that the majority of the experimental 
values for calcium and magnesium are in excess of 1 mg/g. Large dilutions 
were regjularly carried out for the measurement of both macro essential 
elements by ICP-MS. Often the dilution factor involved was 1000-fold or 
10,000-fold. Errors can be associated with these types .of dilutions of real 
solutions; these errors could be the cause of the low signals for both 
elements, The experimental levels of the other essential elements are, for the 
majority, equal to or above the stated value on the respective dietary 
supplement’s label. A higher value was expected with most of the essential 
elements (e.g. chromium, iron, manganese and zinc) as they were found in 
base materials at relatively high concentrations. It is known that the 
concentration of essential elements in base materials and active ingredients 
not related to the specific essential element’s active ingredient is not take into 
account by the values given on the label of the dietary supplement. Only the 
content of the essential element in its active compound (i.e. zinc in zinc 
citrate) is stated on the label. Therefore, any results found to be higher th^n
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the,stated label value would be explained by the unaccounted for essential 
elements content in the other active ingredients and base materials.
The content of an essential element in a dietary supplement is usually stated 
on the label as a percentage of the Recommended Dietary Allowance (RDA) 
for that essential element. It is well known that RDA limits are fairly broad 
allowances that take into account the variable bioavaiiability of elements in 
food matrices and more importantly are based on the needs of a population 
and not the needs of an individual [Neve, 1996]. Consequently, an 
exaggeration of the dose often occurs, which can lead to toxicity problems 
and pharmacological interactions. This is the reason why the base materials 
were obtained and analysed for essential elements in this research, to see 
whether thè content of the essential elements in base materials would 
significantly add to the possibly already exaggerated dose of an essential 
element in a dietary supplement. Four manufacturers (G & G, LUPO, Ryder 
and Seaford) provided base materials for the determination of essential and 
non-essential elements. After analysis it was found that that the base 
materials provided by G & G, Ryder and Seaford were very heterogeneous, 
which was represented by the number of essential elements present in the 
base materials and the high RSD values for these results. This variation lead 
to the problems encountered with the calculation of the base material 
contribution when compared against the total essential element content stated 
on the label and the experimental data for that dietary supplement. In general 
the results from calculating the potential essential element contribution from 
the base materials by using the experimental data and the dietary 
supplement’s specification were inconclusive. In some cases the calculated 
base material contribution was greater than the experimental value obtained 
by ICP-MS analysis, in other cases the contribution did not account for the 
difference between the experimental values and the essential element’s 
content stated on the dietary supplement’s label.
In conclusion, the determination of essential elements in base materials 
provided answers and more questions. Yes, base materials do contain
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essential elements and some base materials (e.g. dibasic calcium phosphate, 
magnesium stearate and silica) contain them at relatively high levels that 
could significantly increase the total amount of essential elements present in 
dietary supplements. So, there is a small possibility that an exaggerated high 
dose of an essential element present in a dietary supplement that was taken 
twice or ^hree times daily could cause toxic effects. More likely is that the 
exaggerated dose of an essential element will cause greater interactions with 
other essential elements that would result in the inhibition of the other 
essential elements. This is not to be taken lightly as the optimal function of an 
organism^ , in this case a human being, requires balance among the essential 
nutrients [Mertz, 1993]. If one forces higher activity by giving one element, 
another becomes limiting, and a substantial balance can occur. But why were 
the results so variable? Are the materials washed in a ‘cleaning’ procedure 
prior to formulation? This could account for the difference between the 
calculated high results for the base material contribution and the lower values 
from the experimental results. Should the elemental content of the base 
materials be included in the essential element content stated on the dietary 
supplements label? If so, an investigation into their bioavaiiability would have 
to be accomplished and weighed against the actual among of base material 
added to the formulation of the dietary supplement. Would the amount of 
base material added be so small that the essential elemental content in it 
would be insignificant to the content stated on the label? In summary, by 
measuring elemental content in base materials used as inactive ingredients in 
dietary supplements this research has indicated that the base materials used 
have a heterogeneous nature and contain a number of essential elements 
that are regularly added to dietary supplements.
The determination of non-essential elements in dietary supplements was 
carried put for the purpose of investigating possible contamination of 
seaweed, barks and roots with lead and cadmium. Both of these elements 
were also determined for in base materials. In general, the lead content found 
in dietary supplements was below 2 pg/g and the cadmium content was below
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0.7 pg/g. At these levels not adverse or toxic effects caused by lead and 
cadmium would be expected in human consumption.
In summary, a method for the determination of elemental content in dietary 
supplements by ICP-MS has been developed and validated. This method is 
appropriate for tablet-based, capsule-based, powder-based and yeast-based 
dietary supplements containing a variety of active and inactive ingredients.
5.1.2 Fat-soluble vitamin analysis
For the determination of fatrsoluble vitamin in dietary supplements, a simple 
extraction and a reverse-phase HPLC method was developed and validated. 
A number of papers in the literature have investigated the simultaneous 
analysis of fat-soluble vitamins, mostly in food matrices. However, this 
method was purposefully developed for dietary supplements or 
pharmaceutical preparations. By restricting the method’s usage, the chosen 
extraction procedure had only a small number of steps and involved a simple 
direct solvent extraction of the fat-soluble vitamins. The HPLC conditions 
chosen for the analysis of vitamin A (retinol acetate), vitamin D (ergocalciferol 
and cho(ecalciferol), vitamin E (tocopherol and tocopherol acetate) and 
vitamin K (phylloquinone) resulted in a sample analysis time of approximately 
20 minutes. As such this method lend itself to routine analysis of fat-soluble 
vitamins. It should be noted that the measurement of vitamins D2 and D3 
should be carried out separately as under the HPLC conditions stated in 
Chapter 3 incomplete separation of the vitamer peaks Is observed. This was 
not a prqblem in this research as only one of the vitamers was found in a 
dietary supplement and not both. Good spike recoveries were obtained for 
each vitamin in a blank matrix (95-111 %) and for each dietary supplement 
under analysis (90-110%). However, not all of the dietary supplements 
provided chromatograms with determinable peaks. Fat-soluble vitamins in 
yeast-based dietary supplements cannot be measured by this HPLC method. 
The stançlard peaks did not match with any of the experimental peaks in the 
chromatogram for Supernutrition Plus, a yeast-based dietary supplement. No 
results yvere obtained for Optimum Nutrition, a tablet-based dietary
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supplement. The fat-soluble vitamins A, D, E were added attached to an 
antioxidant preparation, namely dl-a-tocopherol. This attachment caused the 
fat-soluble vitamin compounds to behave differently in their interactions with 
the stationary and mobile phases. As such there were no comparable 
experimental and standard peaks.
In conclusion, the extraction procedure and HPLC method provided a suitable 
method for the routine analysis of vitamins A, D, E and K in dietary 
supplements.
5.1.3 Bioavaiiability study
The iron and zinc bioavaiiability study discussed in Chapter 4 is the first study 
to look at the different bioavaiiability of iron and zinc in differently based 
dietary supplements. The in vitro technique is regularly used in the 
investigation of enhancers and inhibitors of essential elements in different 
food matrices, in this research the Kapsokefalou and Miller 1991 in vitro 
digestion method was used to mimic the human digestion of the dietary 
supplements by three different manufacturers (Higher Nature, Nature’s Own 
and supqrdrug). The two main types of dietary supplements investigated 
were yeast and tablet-based ones. It was expected and hypothesised that the 
yeast-based dietary supplements provided iron and zinc in a more 
bioavailable form than tablet-based dietary supplements. A more bioavailable 
form meant that it was more readily absorbed by the small intestine and 
utilised by the human body. The results obtained from this study illustrated a 
difference between the two dietary supplement bases but it was also 
observed that the enhancers of the iron and zinc bioavaiiability found in the 
dietary supplements played a large and sometimes greater role.
Vitamin C is the most commonly known enhancer of iron, and the inclusion of 
vitamin C in the multi-component dietary supplements greatly enhanced the 
bioavaiiability of iron in both tablet-based and yeast-based dietary 
supplements. Higher Natures Optimum Nutrition, a tablet-based dietary
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supplement, that contains vitamin C was observed to have a greater iron 
bioavaiiability than Higher Natures Food Form™ Easy Iron, a yeast-based 
dietary supplement that does not contain vitamin C. However, when 
comparing two Higher Nature multi-component dietary supplements that 
contain vitamin C, the yeast-based dietary supplement, Supernutrition Plus 
that contains ten times less vitamin C than the tablet-based dietary 
supplement. Optimum Nutrition provided iron in a more bioavailable form. In 
conclusion, a yeast-based dietary supplement that contains vitamin C 
provided iron the most bioavailable form.
Two trends were also observed in the zinc bioavaiiability results. Firstly, the 
yeast-based dietary supplements provided zinc in a more bioavailable form 
(20-35% absorbed zinc) compared to tablet-based dietary supplements (0- 
10% absorbed zinc). The second trend was observed within the tablet-based 
dietary supplements group. Tablet-based dietary supplements with multi­
components that included vitamins, showed greater zinc bioavaiiability (5-10% 
absorbed zinc) than those that only contained essential elements (0-3% 
absorbed zinc).
In conclusion, although the results from any in vitro technique are relative, 
yeast-ba^ed dietary supplements with multi-components provide iron and zinc 
in more bioavailable forms and as such are more easily absorbed and utilised 
by the hufnan body.
5.2 Further Work
Two separate methods for the determination of elemental and fat-soluble 
vitamin content in dietary supplements have been presented in this research. 
However, both methods could be further developed and tested. The use of 
ICP-MS for the determination of calcium and magnesium in dietary 
supplements at high levels is unsuitable due to the consistently obtained low 
results. The technique of FAAS would be considered a suitable alternative
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due to the lower dilution factors inherent with this technique. The HPLC 
method for the analysis of fat-soluble vitamins needs to be extended to 
include determination of tocopherol acid succinate and menadione (vitamin 
K3). Both vitamin compounds are regularly included in dietary supplements. 
Further development of the conditions is required for the complete separation 
of vitamins D2 and D3.
The use of an in vitro technique is the first step in the investigation into the 
bioavaiiability of essential elements in yeast-based dietary supplements.. As 
an in vivo method has previously been carried out on rats for the absorption of 
iron in yeast and tablet-based dietary supplements, the next step would be an 
in vivo assay technique involving human patients.
In conclusion, if new legislation is proposed by the Government concerning 
the efficacy and manufacture of dietary supplements, this research and the 
proposée  ^methods would be one of the first steps toward the required testing 
of dietary supplements.
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APPENDIX 1
Mathematical and Statistical Equations
All equations were taken from “Practical Statistics for the Analytical Scientist” 
by T. Farrant (1997, Cambridge, PA: RSC).
Arithmetic Mean
The average of all observations, where x is the arithmetic mean, xi is the 
observation values and n is the number of observations.
n
Z x i
i=1
X =
n
standard Deviation (sample)
Standard deviation (SD) is the positive square root of the variance that 
measures the extent to which the results differ from one another. The larger 
the variance the greater the spread of data.
S  (xi - X)
i=i
sd =
Relative Standard Deviation (RSD)
This is the measure of the spread of data in comparison to the mean of the 
data.
RSD = s /  X
Paired t“test: Comparison with a known value
A statistical test that compares a set of data values with a stated value. The 
calculated test statistic, t, is compared with the tabulated value with v degrees 
of freedom, at various percentages of confidence level, for either one or two- 
tailed tests. From the test statistic n is the number of data points, ID s  the 
mean value of the data, p is the stated value and sd is the standard deviation 
of the set of data.
^  . (x - p) 
t=  ------------------
sd
Paired t-test: Paired Comparison
A statistical test that compares two sets of data by the differences (d) between 
the sets and not the individual values. From the equation Sd is the standard 
deviation of the differences between the two sets of data.
ld| . >Jn
t=  --------------
Sd
Figure 1. Chromatogram of Supernutrition Pius
iflî'M
Figure 2. Chromatogram of Optimum Nutrition
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APPENDIX 2
Product Weight Variability
Sample Weight 1 Weight 2 Weight 3 Weight 4 Weight 5 Std Dev Mean RDS (%)
Calma 3.3308g (tsp)
Cal-M 1.4684 1.3756 1.4999 (2 level tsp or 4g)
Ca absorbate (ig)
Candi Clear 1.4381 1.4644 1.4361 1.3750 1.4005 0.0351 1.4228 2.5
Cats Claw 
Concentrate
0.5549 0.6105 0.6088 0.6181 0.5989 0.0252 0.5982 4.2
Cats Claw 
Rainforest
0.6810 0.7084 0.7133 0.6821 0.6909 0.0149 0.6951 2.2
Cats Claw & Aloe 
Vera
0.5939 0.6053 0.6246 0.6051 0.6149 0.0116 0.6088 1.9
Chlorella 0.2457 0.2589 0.2586 0.2486 0.2603 0.0067 0.2544 2.7
C.G.F. Chlorella 0.3396 0.3086 0.3392 0.3732 0.3736 0.0273 0.3468 7.9
Citricidal 0.4308 0.4365 0.4292 0.4300 0.4324 0.0029 0.4318 0.7
Citri-lean 1.0017 0.9874 0.9931 0.9923 0.9824 0.0072 0.9914 0.7
Citri immune . 0.5485 0.5608 0.5408 0.5250 0.5441 0.0130 0.5438 2.4
Coenzyme Q10 0.3805 0.3799 0.3952 0.3895 0.3880 0.0065 0.3866 1.7
Coloclear 0.5287 0.6612 0.5572 0.6065 0.5975 0.0318 0.5702 5.6
Colofibre (Tablet) 0.6152 0.5880 0.6088 0.6251 0.5808 0.0186 0.6036 3.1
Colofibre
(Powder)
3.6860 2.9864 (1 rounded tsp or 5g) 3.3362
Cr as
polynicotinate
0.4340 0.4435 0.5085 0.4967 0.4905 0.0336 0.4746 7.1
Ultra C+ 2.2556 2.4056 2.2140 2.2389 2.3983 0.0920 2.3025 4.0
Acidobifidus 1.4440 1.4727 1.3877 (1 level tsp) 1.4348
Antioxidant Aces 0.7298 0.7398 0.6708 0.7267 0.7395 0.0288 0.7213 4.0
B-Vital 0.9092 0.8943 0.9344 0.9152 0.9102 0.0144 0.9127 1.6
Beta-carotene 0.4707 0.4710 0.4739 0.4715 0.4739 0.0016 0.4722 0.3
Bio-bifid us 0.6188 0.6215 0.6305 0.6395 0.6491 0.0126 0.6319 2.0
Biominerals 1.0122 1.0205 1.0318 1.0071 1,0215 0.0095 1.0186 0.9
Boswellia 0.4489 0.4277 0.4397 0.3769 0.4802 0.0377 0.4347 8.7
Brain Food 1.7129 1.6766 1.7129 1.7335 1.6836 0.0234 1.7039 1.4
Dino Chews 1.2613 1.3833 1.3069 1.3829 1.2612 0.0613 1.3191 4.6
Dolomite 0.9809 0.9767 0.9764 0.9902 0.9753 0.0061 0.9799 0.6
E400 1.3346 1.3658 1.3513 1.3822 1.3910 0.0228 1.3650 1.7
Easigest 0.5460 0.6567 0.5578 0.5403 0.5586 0.0082 0.5519 1.5
Folacin 0.3012 0.2997 0.2825 0.3004 0.2753 0.0121 0.2918 4.1
Ginkgo 0.7735 0.7391 0.7545 0.7421 0.7390 0,0148 0.7496 2.0
Ginseng 0.3679 0.3767 0.3813 0.3746 0.3832 0.0060 0.3767 1.6
Glucosammine
Plus
1.6474 1.3212 1.2923 1.3210 1.3623 0.1467 1.3888 10.6
L-Glutammine 5.2053 (1 heaped tsp) 5.2053
Herbal clear 0.5727 0.5985 0.6068 0.5775 0.4836 0.0492 0.5678 8.7
Immune
prevention
0.6668 0.6630 0.6742 0.6728 0.6891 0.0100 0.6732 1.5
Lecithin 3.6696 (1 rounded tsp or 5g) 3.6696
Maxi Multi 2.1510 2.0378 2.1622 2.0260 2.0396 0.0672 2.0833 3.2
Menophase 0.5816 0.5242 0.6200 0.5464 0.5907 0.0377 0.5726 6.6
Mexican Yam 0.5100 0.5407 0.4375 0.6039 0.5140 0.0600 0.5212 11.5
Niacin 0.4331 0.4204 0.4084 0.3995 0.4190 0.0128 0.4161 3.1
TABLE 3. Product Weight Variability
Sample Weight 1 Weight 2 Weight 3 Weight 4 Weight 5 STD AVE RDS
Optimum
Nutrition
1.3601 1.3777 1.3731 1.3231 1.3742 0.0226 1.3616 1.7
Ocean Kelp 0.5638 0.5516 0.5396 0.5358 0.5605 0.0124 0.5503 2.2
Organic Feverfew 0.5575 0.5108 0.5218 0.5538 0.5022 0.0251 0.5292 4.8
Organic Linseeds 3.0111 (1 level tsp or 8g freshly ground 3.0111
Osteo Food 0,9940 1.0532 1.0469 1.0822 1.0251 0.0329 1.0403 3.2
Pantothenic 1.0169 1.0131 1.0246 1.0059 1.0072 0.0076 1.0135 0.8
Paraclens 0.5384 0.5395 0.5481 0.5287 0.5824 0.0207 0.5474 3.8
Positive Nutrition 1.6809 1.5266 1.6063 1.4564 1.4782 0.0932 1.5497 6.0
Pre-mens 0.5909 0.6356 0.6517 0.6447 0.6264 0.0238 0.6299 3.8
Probiogest 0.5979 0.6567 0.6012 0.6128 0.5906 0.0263 0.6118 4.3
Prostaflorum 0.5783 0.6049 0.5295 0.6074 0.5455 0.0349 0.5731 6.1
Rosehips 0100 1.4628 1.4890 1.4792 1.3955 1.4809 0.0381 1.4615 2.6
Se 200 0.2985 0.2930 0.3134 0.2915 0.2875 0.0101 0.2968 3.4
Starflower (50mg) 0.7376 0.7393 0.7410 0.7422 0.7390 0.0018 0.7398 0.2
Starflower
(lOOmg)
1.5083 1.5593 1.5472 1.5313 1.5650 0.0229 1.5422 1.5
Superantioxidant 0.7661 0.7262 0.7604 0.7703 0.7177 0.0244 0.7481 3.3
Super B complex 1.2273 1.2710 1.3322 1.2613 1.2737 0.0379 1.2731 3.0
Supergar 0.5153 0.5527 0.5146 0.5227 0.5232 0.0156 0.5257 3.0
Vitamin B6 with 
Coenzyme
0.2837 0.3122 0.3023 0.3036 0.2825 0.0131 0.2969 4.4
Vitamin B12 0.3925 (1 level measure or 400mg) 0.3925
Yang Drive 0.5289 0.5808 0.6125 0.5125 0.5605 0.0400 0.5590 7.2
Zinc with Copper 0.5985 0.6286 0.5659 0.6182 0.5503 0.0335 0.5923 5.7
Zinc Citrate 0.4999 (1 level measure or 400mg)
Biocai 0.5051 0.4887 0.488 0.5114 0.5114 0.0097 0.5019 1.9
SuperNutrition + 0.9170 0.9008 0.9110 0.9106 0.9160 0.0064 0.9111 0.7
Easy Magnesium 1.0748 1.0940 1.0690 1.0684 1.0578 0.0137 1.0722 1.3
Spiroca! 0.4876 0.4979 0.4998 0.4938 0.4908 0.0050 0.4940 1.0
Easy Iron 0.2338 0.2067 0.1965 0.1943 0.2023 0.0159 0.2067 7.7
Labels of Dietary Supplements Containing Essential Elements
] NUTRITIONAL INFORMATION
I Two tablets typically provide:
MINERALS %RDA'
Calcium ' 403mg SO
(from calcium carbonate 203mg)
(from calcium phosphate 190mg)
(and calcium citrate Wmg)
Iron ffrom iron c/trate> Smg S7
Magnesium 166mg 55
(from magnesium oxide I SSmgJ
(and magnesium citrate lOmg)
Z\r\c (from zinc citrate) lOmg 67
Iodine (from Aefpj 32pg 21
Manganese C/rom manganese c/fra(e) Smg • 
Copper (from copper citrate) 1 mg
Boron img
Selenium 50 pg
Chromium 50 pg
Molybdenum lOpg
HERBS (dried and powdered)
Kelp 40mg
Dandelion root 40mg
Alfalfa 40mg
Horsetail 30mg
•flOAss EC Recommended Û3ily AHowance
B  I o  M IN E R A L S
M I N E R A L A N D  H E R B A L  F O R M U L A
W IT H  CITRATE  
M IN E R A LS FOR EASY  
A BSO RPTIO N
All mineral values are elemental.
No sugar, salt, soy, yeast wheat, dairy, animal 
products, artificial preservatives, flavours or 
colours.
9 0  t a b le ts
BIO MINERALS 90 tablets
Take two tablets a day with meals, as a food 
supplement to help safeguard against mineral 
deficiency In the diet. A daily multivitamin is also 
recommended.
INGREDIENTS: Calcium carbonate, tnbasic calcium I 
phojpnarc , magnesium oxide, microcrystaHine j 
cellulose, maize starch, magnesium citrate, acacia, 
calcium citrate, kelp, dandelion root, alfalfa, steanc 
acid, zinc citrate, iron citrate, horsetail, manganese 
citrate, boron proteinate. magnesium stearate, glazing j 
agent shellac, copper citrate, selenomethionine prep., j 
chromium picolinate, molybdic acid. Herbs dried and ! 
powdered.____________________________  i
Store out of the reach of children.
E G E T A R I A N
$t»r« in J cool, dry p lx«.B«tt B«for« Em* (Se«
HIGHER NATURE
fiurwâsh Common, East Sussex TNJ9 7LX
NUTRITION INFORMATION j
Two 2 gram teaspoons typically j
provide; j
MINERAL % RDA*\
Calcium 328mg 41
*RDA= EC Recommended Daily Allowance
S u g g e s te d  U ses
Athletes after exercise 
Before sleeping 
During convalescence
Seniors as a beverage 
alternative
Teething children
(1/4 teaspoon dally)
E a s ily  a s s im i la b le
C A L -M
C A L C IU M  A N D  
O R G A N IC  CIDER  
V IN E G A R
IN S T A N T  D R IN K  P O W D E R
C A L - M  9 0  g
Take 2 level teaspoons (4g) a day, or as 
your practitioner advises. Stir 2 level 
teaspoons of powder into a cup of 
boiling w ater u ntil dissolved. Add 
water, juice or herb tea to taste. A daily 
multivitamin is also recommended.
INGREDIENTS: Calcium gluconate, magnesium carbonate, organic cider 
vinegar (dried powder).
No sugar, salt, corn, soy, yeast, wheat, 
dairy, animal products, artificial 
preservatives, flavours or 
cotours.Vegan formula.
Store out of the reach of children.
Developed and manufââured by G&G Food Supptiet UA, U.1C
9 0 g
E G E T A R I A N
Store in » refnoerator. B<sc 8«fer« (5oe b-Ai«I
HIGHER NATURE
BurwâsK Common, East Sussex TNt9 7LX
INFORMATION
One teaspoon (3.5 grams) typically provides:
MINERALS
Calcium 
Magnesium 
VITAMINS  
Vitamin C 
Vitamin D (50iu)
lOOmg
lOOmg
%RDA-
12.5
33.3
lOOmg 167 
1.25pg 25
ROA= EC Recommended Daily Allowance
No sugar, salt, corn, soy, yeast, w heat, dairy, 
animal products, artificial preservatives, flavours 
or colours. Vegan formula.
CALCIUM 
AND MAGNESIUM 
WITH VITAMIN C
INSTANT DRINK 
POWDER
CALMA-C160g 
Take 7i -1 teaspoonful up to three times a day, 
put in a cup, add hot water and stir until dissolved. 
Add juice or herb tea to taste. A daily multivitamin 
is also recommended.
Suggested Uses 
Athletes after exercise 
Before sleeping 
During convalescence 
Seniors as a beverage alternative
INGREDIENTS: Calcium Gluconate, Magnesium 
Gluconate, Vitamin C prep., Citric acid. Malic 
acid. Vitamin D3 prep.
Store out of reach of children.
160 g
V E G E T A R IA N
a <00  ^dry place, Beit BekfC Cnd:(See bate)
HIGHER NATURE 
Burwash Common, East Sussex TN19 7LX
NUTRITION INFORMATION
Each 1/4 teaspoon (1 g) typically provides: 
VITAMIN %RDA
Vitam ine S25mg 1375
MINERAL
Calcium 175mg 22
"RDA= BC Recommended DùUy AUo^vance
No sugar, salt, soy, yeast, wheat dairy or animal 
products, artificial preservatives, flavours or 
colours. Vegan formula.
C A L C I U M  A SC O R B A T EP O W D E R  
V IT A M IN  C A N D  C A L C IU M  F O R M U L A
4 5 g
V E G E T A R I A N
C A L C IU M  A S C O R B A TE P o w d e r  4 S g  
Take 1/4 teaspoonful (1g) in water or juice one 
to four times a day, or as your practitioner 
advises. A daily multivitamin/mineral is also 
recommended.
IINORSDIENTS; CalCiutn ascorbate. )
Store in a cool, dry place, out of reach of children. 
Best before end: (See base)
HIGHER n a t u r e  
Burwash Commoo, Bast Sussex TNÏ9 7LX
INGREDIENTS Each tablet typically provides:
Calcium Caprylate 350mg
Magnesium Caprylate 3S0mg
Tribasic calcium phosphate 249mg
Maize starch ISOmg
Pau D'Arco lOOmg
Microcrystalline cellulose 70mg
Acacia Simg
Thyme SOmg
Rosemary SOtng
Lemon Balm 50mg
Stearic acid 20 mg
Magnesium stearate lOmg
Glazing agent shellac lOmg
No sugar, salt, soy, yeast, wheat, daiiy or animal 
products, artificial preservatives, flavours or 
colours.
CANDI CLEAR7 0  0
CALCIUM, 
M A G N E S IU M  
CARRY LATE A N D  
HERBAL F O R M U LA
3 0  ta b le ts
V E G E T A R I A Nim* m * govl. dry p\*cr
CANDI CLEAR 700 30 tablets
Take 1 tablet a day with a meal, or as your 
practitioner advises. Contains dried raw herbs 
of the highest quality, prepared in small batches 
to ensure maximum freshness. A daily  
multivitamin/mineral is also recommended. 
Store out of the reach of children.
HIGHER NATURE 
Biifwaîh Common, EasC Suisax TNI9 1LX
NUTRITIONAL INFORMATION 
One tablet typically provides:
VITAMIN %RDA
Niacin l.Smg 8
MINERAL 
Chromium
(from Polynicotinate) 200pg 
*RDA s fC Recommended Daily Allowance
No sugar, salt, soy. yeast, wheat, dairy, animal 
products, artificial preservatives, flavours or 
colours. Vegan formula.
CHROMIUM 2 0 0 ]jg 
POLYNiœTlNATE
YEAST-FREE
90 tablets
V E G E T A R I A N
store in a cool, dry place. Best Seloie Errd; (lee base)
C H R O M IU M  200pg 90 tab le ts  
Take one tablet a day with a meal A daily 
multivitamin is also recommended.
I INGREDIENTS: Trib.isic cakium  pliospltate.jI Clirotmutn polyniCQtrn.ite, rnicrocrystalline| Cellulose, maire stnrcli. stearic add. mairei protein coating, magnésium stfarate. I
S toreout o f reach o f children.
HIGHER NATURE 
Burwash Common, East Sussex TN19 7LX
IN F O R M A T IO N  3 d inosauM M ptd tabipü typically provide;
VITAMINSVitamin A 136001'u)Vitamin D OSOiu)Vitamin E (30lu)Vitamin C
Thiamine fvitim in B IJ Ribollavin (vtUmin 82) "Niacin fw'faniin 83}Vitamin 06 
Folacin Vitamin 012
Pantothenic acid (vitamin BS)
MÈNERAIS
Calcium
MagnesiumZinciodine (from ke/pj Manganese Chromium Selenium
O n »R  INGREDIENTS
Choline bitartrateinositolSilica
Kelp powder
108Ipg 
3.7Sug 2a.75mg ZaOmg 9mg I2mg 12mg 9mg dSpg 
oug •OaSmg I2mg
88mglOmgSimg
8mg4^mgI l f
9mg9mgSmg
30mg
248400643
50
200 I
Apricot, blackcurrant, cherry, honey and raspberry powders.
DINOCHEW S
C H I L D R E N S
C H E W A B L E
V I T A M I N  A N D  M I N E R A L  F O R M U L A  
W ITH CITRATE MINERALS AND  
N A TU R A L FRUIT FLAVOURS
3 0  ta b le ts
E G E T A R I A N
Store in a <oc). dry B«st Before End: (See betel
DINOCHEWS 30 tablet*
Children S years and over chew 3 tablets daily. 
Younger children chew 1-2 tablets daily.
Not su/tabfe far pregnant women.
j INCKEOIENTS; Fructose, vitamin C preo., dried honey I powder, calcium carbonate, vegetable oil. magnesium I ovide. Vitamin E (as dl-alpha tocopherol), iron citrate.
I k e lp  p o w d e r, a p r ic o t p o w d e r, b la c k c u rra n t p o w d e r, i Cherry powder, raspberry powder, magnesium stearate,I zinc citrate, silica, magnesium citrate, calcium citrate, 
pantothenic acid (as calcium 0 pantothenate), niacin (as niacinamide), v itam in BS (as pyridoxtne I hydrochloride), ribo flav in , thiam in (as th iam in hydrochloride), choline bitartrate, inositol, manganese I citrate, vitamin A (as retinyl palmitate prep.amioaidant:■ d alpha tocopheryl acetate), selenomethionine prep..I chromium picolinate, folacin (as folic acid), biotin. i vitamin D (at ergocalciferol prep.antiondant; d-alpha 
{ tocopheryl acetate), vitamm BIZ (as cyanocobalamin).
No sucrose, salt, soy, yeast, wheat, corn, dairy, 
animal products, artificial preservatives, flavours 
or colours. Store out of the reach of children.
HIGHER NATURE
Burwash Common, East Sussex TN19 21X
NUTRITIONAL INFORMATION
Three tablets typically provide: 
VITAMINS
Vitamin A (3750 iu) retinol 
Vitamin D (375iu)
MINERALS 
Calcium 
Magnesium
•flOAa EC Recommended Oaily Allowance
%RDA
112Sgg 141
9.4gg 1S8
SlOmg 64
300mg 100
All mineral values are elemental.
No sugar, salt, soy, yeast wheat, dairy, animal 
products, artificial preservatives, flavours or colours.
D O L O M I T E
W I T HA & D
VITAMIN AND MINERAL F O R M U L A
1 8 0  ta b le ts
V E G E T A R I A N
$Lorc K\ à cool, cky pixe. 8c« 8«fort End: (S«« bate)
DOLOMITE with A & D 180 tablets
Take three tablets a day with meals, or as your 
practitioner advises. Recommended to be taken in 
combination with a multivitamin/mineral formula.
INGREDIENTS: Dolomite, maize starch, mictocrystalline • cellulose, acacia, talc, stearic acid, magnesium stearate, ■ g lazing agent shellac, vitamin A  (as re tinyl acetate j prep.antioxidant: dl-alpha tocopherol), vitamin 0  (as cholecaiciferol prep.antioxidant: dl-alpha tocopherol) [
Store out of the reach of children.
HIGHER NATURE
Burwash Common, East Sussex TN19 71X
INFORMATION
Each tablet typically provides:
VITAMIN %RDA-
Vitamin C 3 00mg 500
MINERAL
Calcium 144mg 18
OTHER FACTOR
D Glucosamine Sulphate 400mg
•RDAvt EC Recommended Daily Allowance
All mineral values are elemental.
No sugar, salt, soy, yeast, wheat, dairy or 
animal products, artificial preservatives, 
flavours or colours.
GLUCOSAMINE SULPHATE 
VITAMIN C fir CALCIUM PORMUIA
30 tablets
VEGETARIAN
GLUCOSAMINE PLUS 30 tablets 
Take 1 tab le t three times a day fo r one 
month, then 1 tablet a day or as your practi­
tioner advises. A daily multivitamin/mineral 
is also recommended.
t INGREDIENTS; D.glucosamine sulphate. Vitamin C I (ascorbic acid prep.), calcium carbonate, dibasic cal- I cium phosphate, microcrystalline cellulose, maize starch, acacia, glazing agent shellac, stearic acid,I magnesium stearate.__________________________ j
Store in a cool, dry place, out of reach of children. 
Best Before End:(See base)
HIGHER NATURE 
Burwash Common, East Sussex TN19 7LX
INFORMATION Each Vegicapup typically provides: 
VITAMINS %RDA'
Vitamin A fiOOOiuj 901pg 113
(as tetmyt palmitate ItXlCiul 300pg)
(at beta carotene (3.6mg) 60lpg)
Vitamin C (ascorbic acidj 167mg 273MINERAL
Zinc (from n'r.c citrate) 4mg 26*/iDA» EC DiifyAlhwtrxe
HERBS (dried and powdered)
Astragalus EOmg
Ganoderma (Reishi mushroom) SOmg 
Echinacea 33mg
St john's Wort 33mg
No sugar, salt, corn, soy, yeast, wheat, dairy, animal 
products: artificial preservabves. flavours or colours. Vegan 
fo rm u la .
Vegicaps® isa registered trademark of G5. Technologies USA
IMMUNEP R E V E N T I O NV I T A M I N .  M IN E R A L  A N D  H E R B A L  F O R M U L A
W i t h  ASTR A G A LU S, REISHI
a n d  EC H IN A C EA
30  capsules
V E G E T A R I A NSlgre in  a cool, diy ptKc 3 « t terere snd: (See baie)
IM M U N E  P R E V E N T IO N  3 0  c a p s u le s
Take 1 VegtcapB. 3 times a day. or as your practitioner 
advises. A daily multivitam in is also recommended. Includes vitamins and minerals to  help prevent dietary 
deficiency o f nutrients needed to maintain a haa lthy 
im mune system. Highest quality Chinese and Western 
herbs prepared m small batches to ensure maximum freshness.
j INGREDIENTS: Vitamin C prep., Vegicaps® capsule I 1 (hydroxypropylmethyl cellulose, glycerin, water). 1 j astragalus, echinacea, ganoderma, StJohn't wort, beta j 
carotene prep., zinc citrate, vitamin A (as rebnyl palmitate , I prep, entioxidant dl-alpha tocopherol). (Hertn dned and \ I powdered).______________________|_____________ |
Store out of the reach o f children.
HIGHER NATURE
Burwash Common. East Sussex TN19 7LX
INFORMATIONEach sustained release tablet typically provides: 
VITAMINS HftDA-
Vitamin A (5000 luj ISOOpg 187Vitamin D (2(30fu) Spg 10O
Vitamm Ê fiOOiuJ 134mg 1340
Vitamin C 250mg 417
Thiamine (wtamin 81) 7Smg S35SRiboflavin (vitamin B2) 75mg 4638
Niacin fvffimfn 83) 7Smg 417
Vitamin 86 7 Smg 37SO
Folacin 200pg 100Vitamin 812 SOpg SOOO
Biotin 0 .035mg 23
Pantothenic acid (vitamin 85) 7Smg 1250
MINERALS
Calcium (from citrate) 15l.Smg 19
Magnesium (from oxide) 24mg 8
Iron (from citrate) 2mg 14
Zinc (from citrate) 2mg 13
Iodine (from keip) ICOpg 67
Manganese (from citrate) 340pg
Chromium (from picoiinate) B.Spg
Selenium 13pg
OTHER INGREDIENTS Choline dihydrogen citrate 35mg
Inositol 3SmgPA8A 35mg
Rutin 2SmgCitrus bioflavonoids 2Smg
Kelp , 125mg*flfJA= EC Recommended Daily Allowance
All mineral values are elemental.
MAXI MULTI 30 tablets
Take one tablet a day with a main meal.
M A X I  
M U L T I
M U L T IV IT A M IN  A N D  M IN ER A L  F O R M U L A
with
CITRATE MINERALS 
fo r  EASY ABSORPTION
S U S T A I N E D  R E L E A S E
30  t a b le t s
V E G E T A R I A N
Score In e cool, dry piece Seic Sctore End (See bele)
INGREDIENTS: Tnbasic calcium phosphate, vitamm C prep., microcrystalline cellulose .vitamin £ (as d-alpha tocopheryl succinate prep.), kelp powder, corn starch, vitamin 96 (as pyridoxine hydrochloride), thiamin (as thiamin hydrochloride), pantothenic acid (as calcium O pantothenate), niacin (as niacinamide), ritsoflavin, acacia, stearic acid, talc, magnesium oxide, calcium 
citrate, choline dihydrogen citrate, inositol, para aminobenzotc acid, magnesium stearate, rutin, citrus bioflavonoids, glazing agent shellac, vitamin A (as raunyl acetate prep, antioxidant dl-alpha tocopherol), granulating material: shellac, iron citrate, zinc citrate, selenomethionine prep., manganese citrate, vitamin D (as cholecaiciferol prep, antioxidant dl-alpha tocopherol), folacin (as fo lic  acid), chromium picolinate, vitamin 812 (as cyanocobalamin). biotin.
No sugar, salt, soy, yeast, wheat, dairy, animal 
products, artificial preservatives, flavours or 
colours.
Store out of the reach of children.
H IG H E R  N A TU R E
Burwash Common, East Sussex T,N19 7LX
INFORMATION Two Vegicaps® typically provide: VITAMINS %RDA*Vitamin C SOmg 84Vitamin E (ZOOiu) 134mg 1340Niacin (vitamin 83) 20mg 110Vitamin 86 20mg 1000MINERALSMagnesium 44mg IS(from magneaum oxide 33mg)(from magnesium citrate 6mg)Zinc (from zinc titrate) lOmg 67•BOA a EC Recommended Daily Allowance OTHER INGREDIENTS Hesperidin Complex lOOmgHERBS
Mexican Yam extract 10:1 2C0mgDong quai extract 4:1 lOOmgDong quai powder IQOmgWhite Peony Root powder lOOmgSchizandra extract 5:1 SOmgKorean Ginseng powder SOmg
VITAMIN, MINERAL AND HERBAL 
FORMULA CAPSULES 
with Dong Quai 
and Mexican Yam 
30 capsules
V E G E T A R IA N
Slurs in M cuut dry ul««. Zeis Zefore End: (Sue ha«I
MENOPHASE 30 capsules Menopausal women should take 2 Vegicaps® a day w ith a mam meal, or as their practitioner advises.
INGREDIENTS: .Mexican yam extract 10:1, Vegicaps j • capsule (hydroxypropylmethyl cellulose, glycerin. I ; water), vitamin E (as d alpha tocopheryl succinate), [ ; hesperidin complex, dong quai powder, dong quai I extract 4:1, white peony root powder, vitamin C ! I prep., schizandra extract 5:1. Korean ginseng I : powder, magnesium oxide, vitamin 86 (as pyrid- : ! oxine hydrochlonde). niacin (as nicotinamide), zinc I citrate, magnesium citrate.
No sugar, salt. corn, yeast, wheat, dairy products, aitificial preservatives, flavours or colours. Suitable for vegans. Store out of reach o f children.
Vegicaps® is a regstered trademark of GS. Technologies USA
HIGHER NATURE Burwash Common, East Sussex ÎN I9 7LX
INFORMATIONEach three tablets provide on average:VITAMINS %ROA*Vitamin A ffP.OOWu) 3.002ug 375(from retinol 2,252pg) —(from beta carotene (-timg) ZSOpg) —Vitamin 0 (joofti) 7.5pg ISOVitamin E (tSOiu) tOO.Emg 1,006vrtamin C 300mg 500Thiamin (vitamin 31) 37.5mg 2,678Riboflavin (vitamin 82) 37.5mg 2.344Niacin 7Srag 417Vitamin 06 75mg 3.750Folic acid ISOpg 75Vitamin 312 ispg 1,500Biotin 0.075mg 50Pantothenic acid 75mg 1.250MINERALSCildum SOOmg 63Iron ISmg 107Magnesium 225mg 75Zinc ISmg 100Iodine 4Spg 30Copper 7SpgManganese 4.5mg /Chromium 30ug - LSelenium 45pgOTHER NUTRIENTSCholine 30mgInositol 3omg•RÛA» EC Recommended Daily Allowance
Patrick Holford'snr
w ith  citrate minerals 
for easy absorption
30 tablets
V E G E T A R IA N
Stor« in « Cdot dry place. S tit Before End: ($<« bate)
OPTIMUM NUTRITION 30 tablets
Take 3 tablets a day w ith meals.
Childrens-11 years I aday, 11-14 years 2 a day.
Tbit product contains vitamin A  Do not take ifp re g  ■ 
nant or likely to become so except on advice o f your 
doctor or antenatal clinic.
MULTIVITAMIN AND MINERAL
INGREOIEfTTS: Caldum carbonate, tnbasic calcium phos­phate. magnesium oxide, vitamin C prep., maize starch, magnesium citrate, calcium citrate. Vitamin E (as d-elpha tocopheryl succinate), acacia, pantothenic acid (as calci­um O pantbthenate), vitamin 36 (as pyrldoxine Isydrochloride). niacin (as nicotinamide), stearic acid, iron citrate, zinc citrate, beta carotene prep, thiamin (as thi­amin hydrochloride), riboflavin, vitamin A (as retinol acetate prep. Antioxidant dUatpha tocopherol), chcline di hydrogen citrate. Inositol, glazing agent shellaq man­ganese citrate, magnesium stearate, selenomethionine prep, vitamin D (as cholecaiciferol prep. Antloxidant: dl- alpha tocopherol), copper citrate, chromium picolinate, folic acid, biotin, potassium Iodide, vitamin 312 (as cyanocobalamin).
All mineral values are elemental. No sugar, salt, soy. 
yeast. wheaL dairy, preservatives, flavours or colours. 
Store out of the reach o f children.
HIGHER NATURE 
Burwssfi Common, East Sussex TN19 7LX
INFORIMATION
Three tablets typically provide:
VITAIMINS %RDA'
Vitamin C 300mg 500
Vitamin D (SOOiu) 7.Spg 1 SO
MINERALS
Calcium 430mg 54
(from calcium carbonate 304.Smg)
(from caldum citrate 94.Smg)
(from calcium phospha te 31 mg) 
Phosphorus lOSmg 13
I Magnesium 20mg 67
(from magnesium oxide leomg)
(from magnesium citrate 21mg)
Boron 3mg
HERBS (dried and powdered)
Horsetail 90mg
"RDAn EC Recommended Daily Allowance_________
All mineral values are essential.
No sugar, salt, soy, yeast, wheat, dairy, animal 
products, artificial preservatives, flavours or 
colours.
O S T E O
F O O D
V I T A M I N  A N D  M IN E R A L  F O R M U L A
W IT H  CITRATE MINERALS  
FOR EASY AB SO R PTIO N
3 0  ta b le ts
V E G E T A R I A N
In » c&ol. dry piKe.SciC S«fof« Cod: (S««
OSTEO FOOD 30 tablet*
Take 3 tablets a day,to prevent deficieny of 
calcium and other nutrients needed to maintain 
healthy bones, A daiiy multivitamin is also 
recommended.
INGREDIENTS: Calcium carbonate, calcium citrate, vitamin C prep., magnesium oxide, dibasic caiclum phosphate, magnesium citrate, maize starch, horsetail powder, acacia, stearic acid, boron pro te inate , magnesium stearate, glazing agent shellac, vitamin D (as cholecaiciferol p rep.antioxidant: d l-a lpha tocopherol). '
Store out of the reach of children.
H IG H E R  N A TU R E
Burwash Common, East Sussex TN19 7l X
Smg 23 
Smg 2S0
INFORMATION 
Each tablet typically provides: 
VITAMINS 
Niacin (vitamin B3)
Vitamin 06 
MINERALS 
Magnesium 
Zinc
AMINO ACIDS 
I  Tyrosine 3SOmg
L-Glutamine 2 SOmg
* RDA = EC R w i'iiio e nd c il D a il/A llowam e
20mg 
3 mg
No sugar, salt. soy. yeast, wheat, dairy, artificial 
preservatives, flavours or colours.
POSITIVENUTRITION
A M IN O  ACID AND VITA M IN  COMPLEX
Nutrients used in maintaining 
norm al brain function
30 tablets
V E G E T A R I A N
POSITIVE NUTRITION 30 tablets
Take I 2 tablets up to three timesa day between 
meals.
The amino acids Tyrosine and glutamine are 
normally obtained from protein in the diet. 
Discontinue if headaches are experienced.
INGREDIENTS: L tyrosine. L-glutamine.
tribasic calcium phosphate, maize starch, 
stearic acid, magnesium citrate, maize pro­
tein coating, B6(pyridoxinehydrochioride), 
niacin (as niacinamide), zinc citrate.________
HIGHER NATURE 
Burwash Common, East Sussex TN 19 7LX
NFORMATION Thive Vegicaps® typically provide: I VITAMINS S4S0A* jVitamin C ISOmg ÎSONiacin 30rng 167Vitamin B6 60mg 3.CC0(from pyridaxine hydrochloride SAmg) I(and pyridoxal-S-phosphate Smg) IBiotin 0.1 Smg 100 !
MIN6HAIS iMagnesium I3Smg 45(from magnesiirm oxide USmg)(from magnesium citrate 9mg) I
Zinc (from zinc citrate) ISmg 100 ,HERBS (dried and powdered) jPong quai (Angelica sinensis) 37Smg |White Peony Root 19Smg '■Biack Cohosh ISOmg ILeonun Heterophylli ISOmg i
P R E - M E N SP R E V E N T I O N
VITAMIN, MINERAL AND HERBAL FORMULA
w ith  DONG QUAI 
and W HITE PEONY ROOT
3 0  capsules
V E G E T A R I A N
Store m a cool, dry pix? Soit bffoM <nd: {See b j» )
P R E -M E N S  P R E V E N T IO N  3 0  c a p s u le s  
Take 3 Vegicaps® a day with a main meal, or as your 
practitioner advises, to help prevent dietary deficiency 
of the nutrients needed to maintain normal sex 
hormone balance during the menstrual cycle. A daily 
multivitamin is also recommended.
INGREOIEVTSCong quai (Angelica sinensis).white peony root, black cohosh, Leonun heterophylli. Vegicaps® capsule 1 (hydroxypropylmethyl cellulose, glycerin, water), magnesium I oxide, vitamin C prep., magnesium citrate, vitamin BS (as j pyridaxine hydrochloride), zinc citrate, vitamin 86 (as j pyridoxal-5-phosphate), biotin. (Herbs dried and powdered) |
Vtçigapi## (I A re^irtered tndemarl; of ô  &. TctÂnpfogkl USA
Store out of the reach of children.
HIGHER NATURE
Burwash Common, East Sussex TN19 7LX
INFORMATION TVve Vegicaps® typically provide; 
VITAMIN %RDA*
Vitamin E fJOO/u) 67mg 670
MINERAL
Zinc (from zfnc citrate) IZmg 80
= EC Recommended Daily Allowance 
HERBS (dried and powdered)
Small Flowered Willow herb 400mg 
Saw Palmetto ZOOmg
Juniper berries ZOOmg
No sugar, salt. corn, soy, yeasL wheaL dairy, 
animal products, artificial preservatives, flavours 
or colours. Vegan formula.
VbpcapoiUs a registered trademark td G.S. Techndcgies USA
PROSTAFLORUMV IT A M IN  E, ZINC A N D  HERBAL F O R M U L A  
with WILLOW HERB 
SAW  PALMETTO and JUNIPER 
3 0  capsules
V E G  E T A R I A N
in A dfy 9 lx«  3 « u  Before End: (See beie)
PROSTAFLORUM 30 capsules
Men should take 2 Vegicaps® a day with a main 
meal, or as their practitioner advises. This 
product contains zinc citra ta for easy absorption. 
A  dally multivitamin is also recommended.
INGREDIENTS; Willow herb (Epilobium parviflorum), taw palm etto , juniper berries, Vegicaps capsule (hydroxypropylmethyl cellulose, glycerin, water), vitamin E (as d alpha tocopheryl succinate), zinc citrate. (Herbs dried and powdered)
Store out of the reach of children.
HIGHER NATURE
Burwash Common, East Sussex T.N 19 7LX
INFORMATION
Each protein-coated tablet typically provides;
VITAMINS
Vitamin C lOOOmg
MINERALS (from Dolomite)
Calcium 74mg
Magnesium 43mg
OTHER INGREDIENTS 
Citrus Bioflavonoid Complex 400mg
Rutin lOOmg
Citrus Hesperidin SOmg
HERBS
Rose Kips powder lOOmg
Bilberry Extract 4:1 lOmg
^ROAb EC Recommended Daily Allowance
%RDA*
1667
All mineral values are elemental.
Free from sugar, salL soy. yeast w heat dairy, animal 
products, artificial preservatives, flavours or colours.
ULTRA C PLUS SO tablets
Take one to three tablets a day with meals, or as 
your practitioner advises.A daiiy multivitamin is also 
recommended.
ULTRA C 
R L U S
V I T A M I N  C  F O R M U L A
W IT H
M U L T I-B IO F L A V O N O ID
FACTORS
INGREDIENTS: Vitamin C prep„ bioflavonoid complex, dolomite, microciystaline cellulose, rutin, rosehips powder, citrus hesperidin, bilberry extract, stearic acid, magnesium stearate, glazing agent shellac.
Store out of the reach of children.
9 0  ta b le ts
E G E T A R I A N
Swi* in x re in g ,r jto r. f l i i t  Scfvr*|5e* bxie)
HIGHER NATURE
Burwash Common, East Sussex TN19 71X
INFORMATION
One tablet typically provide 
Vitamin A (S275iu)
(from retinol acetate 
(from beta carotene (Smg)
VitaminC    .
Vitamin E (STiu) 4Sma 450 I
Riboflavin (vitamin B2)
Iron (from citrate)
Zinc (from c/tratej 
Manganese (from citrate)
Selenium
Copper (from citrate)
N-Aretyl Cysteine 
L-Cysteine
.Reduced Glutathione 
Milk Thistle extract 4:1 
Bilberry extract 4:1 
Pycnogenol 
*RDA= EC Recommended Oaily Allowance
%fiOA*
1584pg 198
TSIpg)
S33pg)
167mg 278
 g S
Smg 313
Img 7
4mg 272mg
SOpg
300pg
Smg
Smg
Smg
lOmg
lOmg2mg
Contains citrate minerals for easy absorption. 
All mineral values are elemental.
No sugar, salt, yeast, dairy, animal products, 
preservatives, flavours or colours.
il
VITAMIN, MINERAL 
AND HERBAL FORMULA 
with Glutathione 
and Bilberry
90 tablets
V E G E T A R IA N
ACeot, dfy place Ben Before End;(Si« base]
SUPER ANTIOXIDANT 90 tablets 
Take one to three tablets a day, to safeguard 
dietary intake of protective antioxidants. A 
daily multivitamin is also recommended.
INGREDIENTS: Dibasic cakium phosphate, vitamin | C prep., microcryttaliine cellulose, vitamin E (as 1 d-alpna tocopheryl succinate), beta carotene prep,, ] acacia gum, milk thistle extract, bilberry extract, une citrate, selenomethionine prep., stearic acid, vitamm ' A, (as retinol acetate prep)., manganese citrate, j glazing agent shellac, riboflavin, N-aceiyl cysteine, ( L-cysteine, reduced glutathione, copper citrate, iron 1 titrate, pycnogenol, magnesium stearate. '
Store out of the reach of children.
This product contains Vitamin A. Do not take 
if  pregnant or likely to became so except on 
advice of your doctor or antenatal clinic.
HIGHER NATURE 
Burwash Common, East Sussex TN19 7LX
INFORMATION Two Vegicaps® typically provide:VITAMIN KRDA-Vitamin E flOOiuJ 67mg 670MINERAL
Zinc (fram she citrate) 9mg 60
-RDA = EC Recommended Oaily Allowance
HERBS (dried and powdered)Astragalus ZOOmg
Siberian Ginseng ZOOmg
Damiana aphrodlslaca ZOOmg
Saw Palmetto lOOmg
Panax Ginseng lOOmg
Rubi Sructus SOmg
Fiff Avyar, xm, tom , svy, yeaM, wnçoi, uarry, animai 
producU, artificiat preservative;, flavours o r colours. Vegan formula.
Vegicaps® is a registered trademark of GS. Technologies USA
YANG DRIVEV IT A M IN  E. ZINC A N D  HERBAL F O R M U L A  
W ith ASTRAGALUS, GINSENG 
and D A M IA N A  
3 0  capsules
V E G E T A R I A N
Store In a cool, dry pï*<e. Bert before ereJ: (Sm  b«e)
YANG DRIVE 30 capsules
Men should take 2 Vegicaps® a day with a main 
meal, or as their practitioner advises. A daily 
multivitamin is also recommended. Contains zinc 
as citrate, a readily absorbable mineral salt.
INGREDIENTS: Astragalus, Siberian ginseng, Damiana aphrodislaca. Vegicaps capsule (hydroxypropylmethyl cellulose, glycerin, water).saw palmetto, Panaxginseng, vitamin E (as d alpha tocopheryl sucdnate), Rubi fructus. zinc dtrate. (Herbs dried and powdered)._____________
Store out of the reach of children.
HIGHER NATURE
Burwash Common, East Sussex TN19 7LX
NUTRITIONAL INFORMATION 
One tablet typically provides:
MINERALS % RDA*
Zinc 20mg 133
Copper 1.25mg
•RDAa f  C Recommended Daily Allowance
Contains Zinc as citrate, a readily absorbable 
mineral salt. All mineral values are elemental.
No sugar, salt, soy, yeast, wheat, dairy, animal 
products, artificial preservatives, flavours or 
colours.
Z I N C  20m g
W I T H  C O P P E R
CITRATE MINERAL FORMULA 
90 ta b le ts
V E G E T A R I A N
ZINC 20mg with Copper 90 tablets 
Take one tablet a day, or as your practitioner 
advises, with a main meal. Adaily multivitamin 
formula is also recommended.
INGREDIENTS; Tribasic calcium pliosph.ite, zinc 
citrate, copper citrate, acacia, stearic acid, glazing agent shellac, magnesium stearate.
Storein a cool, dry place, outof reach of children. 
Best Before End: (see base)
HIGHER NATURE 
Burwash (Tommon, East Sussex TN 19 7LX
INFORMATION
Each 400 mg measure typically provides: 
VITAMIN %RDA*
Vitamin C 35mg 58
MINERAL
Zinc ISmg 100
'RDA= EC Recommended Daily Allowance
Contains zinc as citrate, a readily absorbable 
mineral salt.
No sugar, salt, soy, yeast, wheat, dairy, animai 
products, artificial preservatives, flavours or 
colours. Vegan formula.
ZINC CITRATE
SUBIINGUALPOW DER  
Zinc and v itam in  C form ula  
for oral absorption  
4 8  g
V E G E T A R I A N
ZINC CITRATE 
Sublingual P ow der 48g
Take onelevel measure (riOOmg) aday under the 
tongue, or as your practitioner advises. A daily 
multivitamin/mineral is also recommended.
INGREDIENTS: Maltoilextriii, beetroot powder, brown rice flour (stonegroinul). spinach powder, asparagus powder, carrot powtlcr, orange pow­der, yitaniin C (ascorbic acid prep.), zinc citrate. 
Sfo're ir’s à côôl, dry place, out of reach cf childreli. 
Best before end: (See base)
HIGHER NATURE 
Burwash Common, East Sussex TNI97LX
Biocai contains (per 3 tablets):
Calcium 450 mg Magnesium 20.25 mg
Iron 0.9 mg Copper 3pg
Zinc 6.9 pg Molybdenum 3 pg
Spirocal contains (per 1 tablet):
Calcium 612mg Chromium 7.4 pg
Copper 36pg Iron 1.32 mg
Magnesium 17.5mg Manganese 7.8 pg
Molybdenum 3 pg Zinc 0.24 mg
Easy Iron contains (per 1 capsule):
Easy Magnesium contains (per 1 tablet):
Magnesium 50 mg
Supernutrition Plus contains (per 3 tablets):
Calcium 100 mg Chromium 100 pg
Copper 1 mg Iron 5 mg
Magnesium 30 mg Manganese 2 mg
Molybdenum 250 pg Zinc lOmg
